data_1cop_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cop _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.461 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.461 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD11 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.554 ' CB ' ' CD1' ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.474 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 65.0 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.517 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.488 ' HG ' ' CG1' ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.443 HD11 HD13 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' D' ' 40' ' ' ILE . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' D' ' 33' ' ' ALA . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.443 ' O ' HG23 ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.517 ' CG2' ' HB3' ' D' ' 22' ' ' ASP . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.577 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.526 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.577 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.594 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.594 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.456 ' CZ ' HG22 ' E' ' 43' ' ' THR . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.491 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.546 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.479 HG21 HD13 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.479 HD13 HG21 ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.521 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' E' ' 7' ' ' LEU . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.416 HG21 HD11 ' E' ' 34' ' ' ILE . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' E' ' 4' ' ' ARG . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.4 HD13 HG12 ' E' ' 5' ' ' ILE . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.406 ' N ' HG11 ' E' ' 50' ' ' VAL . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.462 ' CB ' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.485 ' CG2' ' C ' ' E' ' 54' ' ' GLU . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.613 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.613 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.585 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.462 ' O ' HD13 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.472 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' D' ' 12' ' ' MET . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.528 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.489 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' D' ' 18' ' ' LYS . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.419 ' HA ' ' CG2' ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' E' ' 59' ' ' PRO . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.449 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.442 ' O ' ' HB1' ' D' ' 33' ' ' ALA . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.427 HG12 ' O ' ' D' ' 26' ' ' TYR . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' D' ' 29' ' ' ALA . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.527 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.456 HG22 HD11 ' D' ' 40' ' ' ILE . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.496 ' CB ' ' OD1' ' D' ' 47' ' ' ASP . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' E' ' 58' ' ' PHE . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.527 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.48 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.636 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.636 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.42 ' C ' ' HD3' ' E' ' 4' ' ' ARG . 3.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.394 0.616 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.457 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.495 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.478 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.434 ' OE1' ' OD1' ' E' ' 31' ' ' ASN . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.49 HG23 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.411 ' HB3' HG23 ' E' ' 50' ' ' VAL . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.512 HD22 ' CG1' ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' E' ' 19' ' ' THR . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.466 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.466 ' O ' HG21 ' E' ' 34' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 22.8 m-70 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.574 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.453 HG21 ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' E' ' 47' ' ' ASP . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.453 ' O ' HG21 ' E' ' 44' ' ' ILE . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.512 ' CG1' HD22 ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.469 ' HB1' HD13 ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.519 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.222 0.534 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.52 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' ' OG1' ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.503 ' CG ' ' CB ' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.523 ' OG1' ' CD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.525 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' D' ' 25' ' ' VAL . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' D' ' 23' ' ' LEU . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' D' ' 8' ' ' LYS . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 0.2 OUTLIER -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.565 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.47 HD12 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' D' ' 55' ' ' VAL . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 0.7 OUTLIER -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' D' ' 40' ' ' ILE . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.586 HG22 ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.545 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.545 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.174 0.512 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.469 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.455 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' E' ' 42' ' ' LEU . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.455 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' E' ' 34' ' ' ILE . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.429 ' HE1' HG23 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.472 HG22 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.518 ' CB ' HD11 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' E' ' 50' ' ' VAL . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.511 ' CD2' ' HD3' ' D' ' 59' ' ' PRO . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.559 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 50.7 t30 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.459 HD13 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 6.4 m170 -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.532 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.464 HG13 HD22 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.29 0.567 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.406 ' C ' HD13 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.411 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' D' ' 12' ' ' MET . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' THR . . . . . 0.409 HG21 ' CD ' ' D' ' 27' ' ' GLN . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.465 ' CG2' HD13 ' D' ' 7' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.488 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . 0.409 ' CD ' HG21 ' D' ' 17' ' ' THR . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.481 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 20.9 t-20 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.481 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 17.0 m170 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.517 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.594 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.44 HG12 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.594 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.477 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.342 0.591 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.473 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.511 ' CB ' HG23 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.474 ' HA ' ' OD1' ' E' ' 22' ' ' ASP . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' E' ' 19' ' ' THR . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.452 HD11 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.517 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.477 HG12 ' O ' ' E' ' 3' ' ' GLN . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.436 ' CG2' ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.437 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.579 ' CB ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.312 0.577 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.453 ' O ' HD11 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' D' ' 9' ' ' ASP . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.527 ' CD1' HD23 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' THR . . . . . 0.468 HG21 ' N ' ' D' ' 18' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.468 ' N ' HG21 ' D' ' 17' ' ' THR . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.402 HG21 HD13 ' D' ' 23' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.459 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . 0.495 ' O ' ' ND2' ' D' ' 31' ' ' ASN . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.459 HG12 ' O ' ' D' ' 26' ' ' TYR . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' D' ' 27' ' ' GLN . 80.8 m-20 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' D' ' 8' ' ' LYS . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.49 ' CG ' HD13 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.458 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.577 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.436 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.436 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.592 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.509 ' NH1' ' HG3' ' E' ' 4' ' ' ARG . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.451 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.491 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.491 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' E' ' 10' ' ' TYR . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.585 ' CB ' ' CD1' ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.546 ' CG ' HG13 ' E' ' 50' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' E' ' 23' ' ' LEU . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.458 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.536 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.546 HG13 ' CG ' ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.536 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.447 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HB3' ' NH2' ' D' ' 38' ' ' ARG . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' D' ' 12' ' ' MET . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.446 HG21 HD13 ' D' ' 23' ' ' LEU . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.451 ' HB3' HG23 ' D' ' 25' ' ' VAL . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' D' ' 39' ' ' LYS . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.533 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.44 HG21 ' O ' ' E' ' 40' ' ' ILE . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.491 ' CD1' HG22 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.467 ' HB ' ' NE2' ' E' ' 27' ' ' GLN . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.491 HG22 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.49 ' CG ' ' CG2' ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.478 ' HG ' ' CG1' ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.457 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . 0.467 ' NE2' ' HB ' ' E' ' 17' ' ' THR . 65.4 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.455 HD12 HG22 ' E' ' 30' ' ' ILE . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.44 ' O ' HG21 ' E' ' 6' ' ' THR . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.461 HG21 ' O ' ' E' ' 49' ' ' SER . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.49 ' CG2' ' CG ' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.443 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.587 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.587 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.481 ' O ' ' CD1' ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.466 ' O ' HG13 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.518 HD11 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.519 ' HA ' ' CD2' ' D' ' 14' ' ' PHE . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.482 ' CE ' ' O ' ' D' ' 8' ' ' LYS . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.503 ' HA ' HG21 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.455 ' OD2' ' CG2' ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.504 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.57 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.513 HD21 ' CB ' ' D' ' 10' ' ' TYR . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' D' ' 49' ' ' SER . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.471 HG13 HD22 ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.57 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo . . . . . 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.482 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.462 HG21 ' O ' ' E' ' 40' ' ' ILE . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.521 HG22 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.441 ' HB3' HG23 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' E' ' 7' ' ' LEU . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.462 ' O ' HG21 ' E' ' 6' ' ' THR . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' E' ' 39' ' ' LYS . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.531 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.452 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.531 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.452 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.4 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo . . . . . 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.531 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.521 ' HA ' ' CD1' ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.44 HG21 ' CD1' ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' D' ' 50' ' ' VAL . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.442 HD11 HG22 ' D' ' 30' ' ' ILE . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' D' ' 55' ' ' VAL . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.458 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' D' ' 22' ' ' ASP . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.281 0.563 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.481 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.511 HG21 ' N ' ' E' ' 6' ' ' THR . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.511 ' N ' HG21 ' E' ' 5' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB2' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.521 ' CG ' ' HB2' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.487 ' CG2' ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' E' ' 50' ' ' VAL . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.424 HG13 ' HB1' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.577 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.616 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' E' ' 7' ' ' LEU . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.478 ' HB ' HD22 ' E' ' 23' ' ' LEU . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.582 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.447 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.494 HD11 ' N ' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' D' ' 40' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.506 ' CB ' HD21 ' D' ' 42' ' ' LEU . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.52 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.537 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' D' ' 19' ' ' THR . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.45 HD11 HG22 ' D' ' 34' ' ' ILE . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' D' ' 7' ' ' LEU . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' D' ' 10' ' ' TYR . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' D' ' 53' ' ' GLU . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' D' ' 42' ' ' LEU . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.431 HG21 ' N ' ' E' ' 7' ' ' LEU . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.512 ' CD1' HG23 ' E' ' 19' ' ' THR . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.585 ' CD2' ' OG1' ' E' ' 19' ' ' THR . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.585 ' OG1' ' CD2' ' E' ' 10' ' ' TYR . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' E' ' 50' ' ' VAL . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.458 ' HB3' ' CG2' ' E' ' 25' ' ' VAL . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 23' ' ' LEU . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' E' ' 43' ' ' THR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.454 HD11 HG22 ' E' ' 44' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' E' ' 22' ' ' ASP . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.505 ' HB3' ' CG2' ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.52 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.556 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.442 ' O ' HD12 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.481 ' HB2' HD12 ' D' ' 42' ' ' LEU . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.512 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.512 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.555 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.511 ' HA ' ' CE2' ' D' ' 10' ' ' TYR . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.48 HD11 ' O ' ' D' ' 19' ' ' THR . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' D' ' 29' ' ' ALA . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.449 HG13 ' HB3' ' D' ' 20' ' ' ALA . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.488 ' HD3' HD12 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.488 HD12 ' HD3' ' D' ' 38' ' ' ARG . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.645 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.482 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' E' ' 19' ' ' THR . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.555 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.528 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.487 ' OG1' ' NE2' ' E' ' 27' ' ' GLN . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.503 HG22 ' CD1' ' E' ' 7' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' E' ' 25' ' ' VAL . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . 0.487 ' NE2' ' OG1' ' E' ' 17' ' ' THR . 7.2 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.482 ' CD1' HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.631 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.49 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.327 0.584 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.467 ' O ' HD13 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.48 ' HB3' ' CG2' ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' THR . . . . . 0.516 HG21 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.516 ' N ' HG21 ' D' ' 17' ' ' THR . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.473 ' CB ' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB1' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' D' ' 16' ' ' GLN . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' D' ' 8' ' ' LYS . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.504 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.504 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.546 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.446 HG13 HD22 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.5 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo . . . . . 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.191 0.52 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.462 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.403 ' N ' ' CG2' ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.538 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.485 HG21 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.485 ' N ' HG21 ' E' ' 17' ' ' THR . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.439 ' O ' HD13 ' E' ' 23' ' ' LEU . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.472 ' CA ' HD12 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.472 HD12 ' CA ' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.404 ' OD1' ' CE1' ' E' ' 35' ' ' HIS . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.404 ' CE1' ' OD1' ' E' ' 31' ' ' ASN . 0.4 OUTLIER -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.16 0.505 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.443 HG21 ' N ' ' D' ' 6' ' ' THR . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.443 ' N ' HG21 ' D' ' 5' ' ' ILE . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' D' ' 11' ' ' ALA . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.517 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.506 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.507 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.52 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.52 HG23 ' CB ' ' D' ' 23' ' ' LEU . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.588 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.504 ' CD1' ' HB2' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.437 HG12 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.486 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.467 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.561 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.512 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.737 0.78 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' E' ' 3' ' ' GLN . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' E' ' 9' ' ' ASP . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.512 ' CG ' ' HB2' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.519 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.51 ' N ' ' HG2' ' E' ' 18' ' ' LYS . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' E' ' 18' ' ' LYS . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.454 ' O ' HD11 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.457 ' O ' HG21 ' E' ' 34' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 23.8 m-80 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.524 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.467 ' HB2' HD11 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.463 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' D' ' 7' ' ' LEU . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.458 ' O ' ' OG1' ' D' ' 19' ' ' THR . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 7.5 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' THR . . . . . 0.496 HG21 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.508 ' N ' ' HG2' ' D' ' 18' ' ' LYS . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.521 HD23 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . 0.496 ' NE2' HG21 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.472 HG12 ' O ' ' D' ' 26' ' ' TYR . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 4.3 t-20 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' D' ' 7' ' ' LEU . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 7.4 m170 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.401 ' O ' HG21 ' D' ' 6' ' ' THR . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.521 ' CG1' HD23 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.529 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.529 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.63 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.63 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' E' ' 42' ' ' LEU . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.475 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.48 ' CB ' HG22 ' E' ' 25' ' ' VAL . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.48 HG22 ' CB ' ' E' ' 23' ' ' LEU . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.429 HD11 HG22 ' E' ' 30' ' ' ILE . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' E' ' 8' ' ' LYS . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.468 HD12 HG22 ' E' ' 40' ' ' ILE . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.575 ' CE1' HG21 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.575 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.496 ' C ' ' CD1' ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.496 ' CD1' ' C ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.482 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' THR . . . . . 0.511 ' HB ' ' NE2' ' D' ' 27' ' ' GLN . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' D' ' 18' ' ' LYS . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' D' ' 50' ' ' VAL . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.464 HG22 HD13 ' D' ' 30' ' ' ILE . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . 0.511 ' NE2' ' HB ' ' D' ' 17' ' ' THR . 3.9 mt-30 -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.471 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.464 HD13 HG22 ' D' ' 25' ' ' VAL . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.533 ' HD3' ' CD1' ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.563 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.533 ' CD1' ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.7 m120 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.472 HG12 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.458 ' HG2' HD12 ' E' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.415 ' HB ' ' OD2' ' E' ' 9' ' ' ASP . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' E' ' 42' ' ' LEU . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.479 ' CG ' ' HB3' ' E' ' 11' ' ' ALA . 61.6 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.526 ' HA ' ' CE2' ' E' ' 10' ' ' TYR . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.476 ' CB ' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' E' ' 50' ' ' VAL . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.474 HG13 ' CB ' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' E' ' 25' ' ' VAL . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 18.1 m170 -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.506 HD11 ' CB ' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.457 HG12 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.567 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.633 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.453 ' O ' HD11 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.461 ' C ' ' CD1' ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.461 ' CD1' ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' D' ' 19' ' ' THR . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.528 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.527 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.524 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.507 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.536 HG22 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.502 ' CB ' HG22 ' D' ' 25' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.443 HG21 HD13 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' D' ' 8' ' ' LYS . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' D' ' 52' ' ' ALA . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.468 HG21 ' O ' ' D' ' 49' ' ' SER . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.8 m-80 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.543 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.476 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.436 ' O ' HG12 ' E' ' 44' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.447 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.481 ' HB2' HD11 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.482 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.5 ' CB ' HG23 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.428 ' HB3' HG22 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' E' ' 20' ' ' ALA . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.449 ' HB1' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.414 HD13 ' CB ' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.514 ' NE ' HD13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.518 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.619 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.619 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.601 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.601 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . 0.554 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.554 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.546 HG22 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.532 ' CB ' HG23 ' D' ' 40' ' ' ILE . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.44 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.546 ' CB ' HG22 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.503 ' CB ' HG22 ' D' ' 25' ' ' VAL . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' D' ' 23' ' ' LEU . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.462 HD11 HG22 ' D' ' 30' ' ' ILE . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' D' ' 29' ' ' ALA . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.463 ' CD2' HG21 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' D' ' 52' ' ' ALA . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.492 HD12 ' CD2' ' D' ' 10' ' ' TYR . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.579 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.579 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.544 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.279 0.562 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.414 ' N ' HG21 ' E' ' 5' ' ' ILE . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.467 ' HB2' HD11 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.53 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.451 ' OG1' ' CE1' ' E' ' 10' ' ' TYR . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.447 ' CB ' HG22 ' E' ' 25' ' ' VAL . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.419 HD11 HD13 ' E' ' 7' ' ' LEU . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HB2' HD22 ' E' ' 7' ' ' LEU . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.503 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.449 HG22 HD11 ' E' ' 40' ' ' ILE . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.598 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 55.1 m-80 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.544 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.598 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.507 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.494 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.134 0.492 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HG12 ' D' ' 44' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.487 ' HB2' HD12 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.458 ' O ' ' HD2' ' D' ' 18' ' ' LYS . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.419 ' CG ' ' HB2' ' D' ' 11' ' ' ALA . 0.2 OUTLIER -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.441 ' OG1' ' CE1' ' D' ' 10' ' ' TYR . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.518 ' CA ' HD13 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.501 ' CG ' HG13 ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.462 ' HB2' HG13 ' D' ' 25' ' ' VAL . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' D' ' 32' ' ' LYS . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.527 ' CB ' ' HD3' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.485 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' SER . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.501 HG13 ' CG ' ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.503 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.481 HG12 ' CD1' ' E' ' 44' ' ' ILE . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.455 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' E' ' 42' ' ' LEU . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.455 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.437 ' CB ' HG23 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.47 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 17' ' ' THR . . . . . 0.523 HG21 ' N ' ' E' ' 18' ' ' LYS . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.523 ' N ' HG21 ' E' ' 17' ' ' THR . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.485 ' HB ' HD11 ' E' ' 30' ' ' ILE . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.495 ' CA ' HD12 ' E' ' 30' ' ' ILE . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.531 ' CG ' HG13 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.539 ' CG1' ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.525 HG22 HD11 ' E' ' 30' ' ' ILE . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.497 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.43 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' E' ' 5' ' ' ILE . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.531 HG13 ' CG ' ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . 0.435 ' HB3' HD11 ' D' ' 44' ' ' ILE . 9.7 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.465 HG22 ' CD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.514 ' CB ' HD13 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' D' ' 29' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' D' ' 25' ' ' VAL . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.514 HD13 ' CB ' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' D' ' 5' ' ' ILE . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.525 HG13 ' CD2' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.637 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.453 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.458 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.5 ' CA ' HD13 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.406 ' OG1' ' CD1' ' E' ' 10' ' ' TYR . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.449 ' CB ' HG22 ' E' ' 50' ' ' VAL . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.406 HD11 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.5 HD13 ' CA ' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.471 HG22 ' CE1' ' D' ' 58' ' ' PHE . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD2' HG23 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.456 HG13 ' O ' ' E' ' 3' ' ' GLN . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.449 HG22 ' CB ' ' E' ' 22' ' ' ASP . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' D' ' 57' ' ' PRO . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.588 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.469 ' O ' HG13 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.469 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.531 HD23 ' CZ ' ' E' ' 58' ' ' PHE . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.47 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.449 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.499 HG22 ' CD1' ' D' ' 7' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.518 ' CA ' HD13 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.472 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.525 HD21 ' CE1' ' E' ' 58' ' ' PHE . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.577 ' CB ' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.577 ' CD1' ' CB ' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.413 HG12 HG12 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.48 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.48 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.472 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.5 HD11 ' CD1' ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 12' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.524 ' CB ' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.481 ' HB3' HG22 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' E' ' 23' ' ' LEU . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 28' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.524 HG13 ' CB ' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.5 ' CE ' ' CD ' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.528 HD11 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.528 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.5 ' CD ' ' CE ' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.478 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 5' ' ' ILE . . . . . 0.473 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 6' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' LEU . . . . . 0.406 ' HA ' HD11 ' D' ' 7' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' TYR . . . . . 0.497 ' CD2' ' CD2' ' D' ' 42' ' ' LEU . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' THR . . . . . 0.495 ' HA ' ' CE2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' ASP . . . . . 0.445 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . 0.462 ' HB2' HG23 ' D' ' 25' ' ' VAL . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' D' ' 23' ' ' LEU . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.434 ' O ' HG21 ' D' ' 30' ' ' ILE . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' D' ' 35' ' ' HIS . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' D' ' 31' ' ' ASN . 18.7 m-70 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.512 ' CB ' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CB ' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . 0.498 HD11 HG22 ' D' ' 44' ' ' ILE . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.9 m-80 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' TYR . . . . . 0.501 ' HB3' ' CG2' ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' GLU . . . . . 0.489 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.636 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . 0.507 ' HD2' ' CD ' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' PHE . . . . . 0.599 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 5' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 6' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 7' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 8' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 9' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 10' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 13' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 19' ' ' THR . . . . . 0.501 HG22 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.494 ' N ' HD12 ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 22' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.461 HG13 ' CB ' ' E' ' 29' ' ' ALA . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 28' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' E' ' 25' ' ' VAL . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 30' ' ' ILE . . . . . 0.494 HD12 ' N ' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 31' ' ' ASN . . . . . 0.559 ' ND2' ' NE2' ' E' ' 35' ' ' HIS . 5.1 t30 -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 32' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 35' ' ' HIS . . . . . 0.559 ' NE2' ' ND2' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 44' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 52' ' ' ALA . . . . . 0.599 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 53' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 54' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 55' ' ' VAL . . . . . 0.643 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 56' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . 0.491 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 58' ' ' PHE . . . . . 0.536 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 59' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.03 124.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.392 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.461 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.461 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD11 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.554 ' CB ' ' CD1' ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.474 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 65.0 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.517 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.488 ' HG ' ' CG1' ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.443 HD11 HD13 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' D' ' 40' ' ' ILE . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' D' ' 33' ' ' ALA . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.526 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.443 ' O ' HG23 ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.517 ' CG2' ' HB3' ' D' ' 22' ' ' ASP . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.577 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.526 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.577 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.594 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.594 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -80.7 -160.36 2.33 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.0 t -85.77 -46.01 11.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.235 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.86 -156.27 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.404 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.28 -176.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.163 -0.961 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -147.87 132.42 17.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.468 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.45 168.46 19.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.26 156.64 17.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.388 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.392 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.315 0.579 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.46 174.9 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -78.97 109.07 12.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.292 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.456 ' CZ ' HG22 ' E' ' 43' ' ' THR . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.491 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.546 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.479 HG21 HD13 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.479 HD13 HG21 ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.521 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' E' ' 7' ' ' LEU . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.416 HG21 HD11 ' E' ' 34' ' ' ILE . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.456 HG22 ' CZ ' ' E' ' 4' ' ' ARG . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.4 HD13 HG12 ' E' ' 5' ' ' ILE . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.406 ' N ' HG11 ' E' ' 50' ' ' VAL . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.462 ' CB ' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.485 ' CG2' ' C ' ' E' ' 54' ' ' GLU . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.613 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.613 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.15 -70.68 0.01 OUTLIER 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -83.24 -80.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -145.3 111.74 5.75 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.38 120.41 5.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.605 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -80.21 -45.93 17.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.953 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.8 p -129.32 121.16 26.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.392 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 3.4 t -81.33 126.59 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.6 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -106.26 115.62 30.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.462 ' O ' HD13 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.472 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' D' ' 12' ' ' MET . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.528 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.489 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' D' ' 18' ' ' LYS . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.419 ' HA ' ' CG2' ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' E' ' 59' ' ' PRO . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.449 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.442 ' O ' ' HB1' ' D' ' 33' ' ' ALA . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.427 HG12 ' O ' ' D' ' 26' ' ' TYR . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' D' ' 29' ' ' ALA . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.527 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.456 HG22 HD11 ' D' ' 40' ' ' ILE . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.496 ' CB ' ' OD1' ' D' ' 47' ' ' ASP . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' E' ' 58' ' ' PHE . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.527 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.48 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.636 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.636 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -79.91 -160.01 2.21 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.4 93.61 9.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 109.817 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -98.35 159.83 14.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.041 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' D' ' 62' ' ' LYS . 4.1 ttmt 48.3 41.04 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.127 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -102.17 110.23 22.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.643 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 116.41 24.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.359 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -139.5 121.09 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.473 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.351 0.596 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.08 65.35 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.42 ' C ' ' HD3' ' E' ' 4' ' ' ARG . 3.6 mt-30 -89.43 89.88 8.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.716 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.457 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.495 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.478 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.434 ' OE1' ' OD1' ' E' ' 31' ' ' ASN . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.49 HG23 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.411 ' HB3' HG23 ' E' ' 50' ' ' VAL . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.512 HD22 ' CG1' ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.467 HD12 ' HB ' ' E' ' 19' ' ' THR . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.466 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.466 ' O ' HG21 ' E' ' 34' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 22.8 m-70 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.574 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.453 HG21 ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' E' ' 47' ' ' ASP . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.453 ' O ' HG21 ' E' ' 44' ' ' ILE . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.512 ' CG1' HD22 ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.469 ' HB1' HD13 ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.519 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo -79.7 -178.34 23.09 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -84.37 86.91 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.381 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.87 112.02 16.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.697 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.09 150.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 131.56 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.05 -26.71 7.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -111.18 130.05 55.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.425 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -137.97 67.17 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.605 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.52 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' ' OG1' ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.503 ' CB ' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.48 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.503 ' CG ' ' CB ' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.523 ' OG1' ' CD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.525 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' D' ' 25' ' ' VAL . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' D' ' 23' ' ' LEU . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' D' ' 8' ' ' LYS . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 0.2 OUTLIER -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.565 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.47 HD12 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' D' ' 55' ' ' VAL . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 0.7 OUTLIER -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.47 ' OE2' HD12 ' D' ' 40' ' ' ILE . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.586 HG22 ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.545 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.545 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.5 Cg_endo -81.92 -157.39 1.42 Allowed 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 70.4 m -60.51 -164.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.386 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -80.97 168.77 18.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -137.99 125.04 21.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.11 87.95 2.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -107.66 106.8 17.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -151.47 26.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 109.504 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.48 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 29.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 54.71 26.56 7.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.289 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.9 113.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.469 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.455 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.475 ' HB2' HD12 ' E' ' 42' ' ' LEU . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.455 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.449 ' HB2' HD12 ' E' ' 34' ' ' ILE . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.429 ' HE1' HG23 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.472 HG22 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.518 ' CB ' HD11 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.403 ' HB3' HG23 ' E' ' 50' ' ' VAL . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.511 ' CD2' ' HD3' ' D' ' 59' ' ' PRO . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.518 HD11 ' CB ' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.559 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 50.7 t30 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.459 HD13 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 6.4 m170 -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.481 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.532 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.464 HG13 HD22 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.44 175.96 43.64 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -66.72 -149.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.44 113.21 21.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.087 -1.008 . . . . 0.0 109.349 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.65 110.8 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -91.54 -146.89 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.265 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.93 123.05 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 20.0 m -154.33 88.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.477 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.408 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.79 138.29 31.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.406 ' C ' HD13 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.411 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' D' ' 12' ' ' MET . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' THR . . . . . 0.409 HG21 ' CD ' ' D' ' 27' ' ' GLN . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.465 ' CG2' HD13 ' D' ' 7' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.488 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . 0.409 ' CD ' HG21 ' D' ' 17' ' ' THR . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.481 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 20.9 t-20 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.517 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.481 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 17.0 m170 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.583 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.517 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.594 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.44 HG12 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.594 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.444 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.444 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -81.4 -173.21 11.86 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 2.56 36.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.54 76.73 1.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.236 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.451 ' HD2' HG22 ' D' ' 64' ' ' THR . 0.0 OUTLIER -164.17 68.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.905 . . . . 0.0 109.401 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 102.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.451 HG22 ' HD2' ' D' ' 62' ' ' LYS . 0.9 OUTLIER -125.06 -172.02 2.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 109.408 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.61 101.36 13.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.47 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.472 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.414 ' O ' ' HB2' ' E' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.351 0.596 . . . . 0.0 109.395 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' E' ' 1' ' ' MET . 0.0 OUTLIER 173.06 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.128 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.477 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER -72.61 111.57 7.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.473 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.511 ' CB ' HG23 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.474 ' HA ' ' OD1' ' E' ' 22' ' ' ASP . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' E' ' 19' ' ' THR . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.452 HD11 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.517 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.477 HG12 ' O ' ' E' ' 3' ' ' GLN . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.436 ' CG2' ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.437 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.579 ' CB ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo -76.83 -179.32 26.91 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -89.62 139.7 30.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.814 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 142.95 36.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 0.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.49 27.31 16.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 58.6 2.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 72.8 p -99.44 74.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -112.27 62.47 0.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.495 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.406 ' O ' ' OE1' ' D' ' 2' ' ' GLU . 2.0 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' D' ' 1' ' ' MET . 2.7 tp10 -163.9 -74.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.453 ' O ' HD11 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' D' ' 9' ' ' ASP . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.527 ' CD1' HD23 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' THR . . . . . 0.468 HG21 ' N ' ' D' ' 18' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.468 ' N ' HG21 ' D' ' 17' ' ' THR . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.402 HG21 HD13 ' D' ' 23' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.459 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . 0.495 ' O ' ' ND2' ' D' ' 31' ' ' ASN . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.459 HG12 ' O ' ' D' ' 26' ' ' TYR . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' D' ' 27' ' ' GLN . 80.8 m-20 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' D' ' 8' ' ' LYS . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.49 ' CG ' HD13 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.458 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.458 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.577 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.436 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.436 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.592 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -82.12 -87.77 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.29 155.57 19.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.629 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -155.33 167.56 29.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.518 ' HE3' ' N ' ' D' ' 62' ' ' LYS . 0.0 OUTLIER -139.31 81.15 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.51 173.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.71 60.63 2.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 -164.32 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.531 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' E' ' 1' ' ' MET . 2.1 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' E' ' 1' ' ' MET . 1.2 mt-10 62.43 108.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 -79.28 79.5 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.509 ' NH1' ' HG3' ' E' ' 4' ' ' ARG . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.451 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.491 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.491 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' E' ' 10' ' ' TYR . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.585 ' CB ' ' CD1' ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.546 ' CG ' HG13 ' E' ' 50' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' E' ' 23' ' ' LEU . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.458 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.536 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.546 HG13 ' CG ' ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.536 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo -77.39 175.21 48.89 Favored 'Cis proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -82.52 -14.21 55.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.68 -179.21 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.545 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 123.84 12.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.772 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -148.29 63.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.52 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -103.88 37.32 2.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -159.72 0.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.392 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.295 0.569 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.1 112.28 19.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.447 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HB3' ' NH2' ' D' ' 38' ' ' ARG . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' D' ' 12' ' ' MET . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.446 HG21 HD13 ' D' ' 23' ' ' LEU . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.451 ' HB3' HG23 ' D' ' 25' ' ' VAL . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.508 HG22 ' CD1' ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.457 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' D' ' 39' ' ' LYS . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.533 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.5 ' CE1' HG21 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.515 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo -76.62 -160.31 2.27 Favored 'Cis proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t -64.0 167.93 5.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' D' ' 62' ' ' LYS . 14.3 p30 -97.51 -158.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.397 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' D' ' 61' ' ' ASN . 1.6 mttp -86.84 140.73 29.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.26 141.83 21.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.947 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -146.13 -87.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.458 HG21 ' O ' ' D' ' 65' ' ' THR . 21.8 m -115.24 43.78 1.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.53 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.8 173.47 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -79.81 111.4 16.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.44 HG21 ' O ' ' E' ' 40' ' ' ILE . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.491 ' CD1' HG22 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.487 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.461 ' HG2' ' HB3' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.467 ' HB ' ' NE2' ' E' ' 27' ' ' GLN . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.491 HG22 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.49 ' CG ' ' CG2' ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.478 ' HG ' ' CG1' ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.457 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . 0.467 ' NE2' ' HB ' ' E' ' 17' ' ' THR . 65.4 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.455 HD12 HG22 ' E' ' 30' ' ' ILE . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.44 ' O ' HG21 ' E' ' 6' ' ' THR . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.461 HG21 ' O ' ' E' ' 49' ' ' SER . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.49 ' CG2' ' CG ' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.443 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.587 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.587 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo -78.86 -162.01 2.87 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -90.02 -13.52 35.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -90.36 -170.69 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 139.92 30.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 -159.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.212 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.61 142.34 29.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -115.38 129.81 56.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.373 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 -61.91 170.68 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.481 ' O ' ' CD1' ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.466 ' O ' HG13 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.518 HD11 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.459 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.519 ' HA ' ' CD2' ' D' ' 14' ' ' PHE . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.482 ' CE ' ' O ' ' D' ' 8' ' ' LYS . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.503 ' HA ' HG21 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.455 ' OD2' ' CG2' ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.504 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.57 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.513 HD21 ' CB ' ' D' ' 10' ' ' TYR . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' D' ' 49' ' ' SER . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.471 HG13 HD22 ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.469 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.57 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo -82.76 -6.74 48.83 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -53.49 154.36 3.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.55 -156.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -107.87 178.66 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 109.386 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -81.97 -70.16 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 41.63 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.43 149.19 23.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.401 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 131.93 45.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.73 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 109.551 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.482 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.462 HG21 ' O ' ' E' ' 40' ' ' ILE . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.521 HG22 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.441 ' HB3' HG23 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.415 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' E' ' 7' ' ' LEU . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.462 ' O ' HG21 ' E' ' 6' ' ' THR . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' E' ' 39' ' ' LYS . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.531 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.452 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.531 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.452 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.4 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo -76.83 -160.22 2.26 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -46.56 -27.37 1.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -116.86 141.09 48.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.63 26.81 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.159 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . 0.453 ' O ' ' CG2' ' E' ' 64' ' ' THR . 0.3 OUTLIER -176.59 -72.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.376 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' E' ' 63' ' ' LYS . 44.8 p -157.16 -171.77 3.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.547 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' THR . . . . . 0.407 ' O ' ' O ' ' E' ' 66' ' ' ALA . 1.8 m -85.51 75.36 10.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.297 0.57 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -117.08 103.97 10.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.531 ' O ' ' CD1' ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.521 ' HA ' ' CD1' ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.44 HG21 ' CD1' ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.461 ' OD1' HG22 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' D' ' 50' ' ' VAL . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.442 HD11 HG22 ' D' ' 30' ' ' ILE . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' D' ' 55' ' ' VAL . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.458 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.461 HG22 ' OD1' ' D' ' 22' ' ' ASP . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.524 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -77.13 -179.3 26.85 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 31.5 m -89.99 173.04 8.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' D' ' 61' ' ' ASN . 35.7 p30 -139.15 26.06 2.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.682 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.64 28.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.444 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 95.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.673 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -89.73 161.28 16.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.274 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -171.18 2.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.308 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.406 ' HE1' ' HB3' ' E' ' 1' ' ' MET . 2.0 ttp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.261 0.553 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.61 93.54 3.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -90.31 117.83 29.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.84 . . . . 0.0 110.031 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.481 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.511 HG21 ' N ' ' E' ' 6' ' ' THR . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.511 ' N ' HG21 ' E' ' 5' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB2' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.521 ' CG ' ' HB2' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.487 ' CG2' ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' E' ' 50' ' ' VAL . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.424 HG13 ' HB1' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.577 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.616 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' E' ' 7' ' ' LEU . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.478 ' HB ' HD22 ' E' ' 23' ' ' LEU . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.486 ' HB1' HD13 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.465 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.582 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -79.53 -158.99 1.86 Allowed 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 16.7 m -83.49 -147.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.311 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' E' ' 62' ' ' LYS . 8.3 p-10 -104.68 173.76 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . 0.464 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 0.1 OUTLIER -83.78 175.38 9.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 175.14 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.372 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -154.82 123.97 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -138.57 82.6 1.91 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.196 -0.94 . . . . 0.0 109.38 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.271 0.558 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 -103.4 136.17 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.447 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.494 HD11 ' N ' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' D' ' 40' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.506 ' CB ' HD21 ' D' ' 42' ' ' LEU . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.52 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.537 ' HB3' ' CG2' ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.549 ' CD2' HG13 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' D' ' 19' ' ' THR . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.45 HD11 HG22 ' D' ' 34' ' ' ILE . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' D' ' 7' ' ' LEU . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.578 ' CD2' HG22 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' D' ' 10' ' ' TYR . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CD2' ' OE2' ' D' ' 53' ' ' GLU . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' D' ' 42' ' ' LEU . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -80.16 176.82 39.36 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.6 t -89.96 -66.92 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.176 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.88 149.91 20.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.312 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -100.55 42.05 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.03 34.51 0.82 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 19.9 m -98.0 48.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.77 90.37 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.428 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.67 166.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.2 110.24 18.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.26 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.431 HG21 ' N ' ' E' ' 7' ' ' LEU . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.512 ' CD1' HG23 ' E' ' 19' ' ' THR . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.585 ' CD2' ' OG1' ' E' ' 19' ' ' THR . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.585 ' OG1' ' CD2' ' E' ' 10' ' ' TYR . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' E' ' 50' ' ' VAL . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.458 ' HB3' ' CG2' ' E' ' 25' ' ' VAL . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' E' ' 23' ' ' LEU . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' E' ' 43' ' ' THR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.454 HD11 HG22 ' E' ' 44' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' E' ' 22' ' ' ASP . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.505 ' HB3' ' CG2' ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.571 HG22 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.52 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.556 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.26 150.33 81.08 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -90.2 25.04 2.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 0.0 109.797 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -98.61 166.43 11.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' E' ' 63' ' ' LYS . 5.9 mtpp -82.55 170.71 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' E' ' 62' ' ' LYS . 25.0 tptt 65.62 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -111.82 118.01 34.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.56 158.89 16.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.551 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.519 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -119.71 136.01 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.442 ' O ' HD12 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.481 ' HB2' HD12 ' D' ' 42' ' ' LEU . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.512 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.512 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.555 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.511 ' HA ' ' CE2' ' D' ' 10' ' ' TYR . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.48 HD11 ' O ' ' D' ' 19' ' ' THR . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' D' ' 29' ' ' ALA . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.449 HG13 ' HB3' ' D' ' 20' ' ' ALA . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.488 ' HD3' HD12 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.545 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.488 HD12 ' HD3' ' D' ' 38' ' ' ARG . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.645 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.482 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.482 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -79.04 175.23 47.19 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 18.9 t -81.08 166.01 21.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.235 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -141.94 168.04 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 33.87 16.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.568 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . 0.508 ' HG3' ' N ' ' D' ' 64' ' ' THR . 10.3 ptmt -81.39 -34.7 31.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' D' ' 63' ' ' LYS . 0.2 OUTLIER -103.27 85.29 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 109.494 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -94.25 130.49 40.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.536 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -114.32 177.87 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.569 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 107.03 6.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.188 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' E' ' 19' ' ' THR . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.555 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.528 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.487 ' OG1' ' NE2' ' E' ' 27' ' ' GLN . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.503 HG22 ' CD1' ' E' ' 7' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.488 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' E' ' 25' ' ' VAL . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . 0.487 ' NE2' ' OG1' ' E' ' 17' ' ' THR . 7.2 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.482 ' CD1' HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.631 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.49 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -78.53 169.58 72.25 Favored 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 99.9 p -89.66 -161.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 76.21 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -134.62 138.88 44.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 90.03 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -127.64 161.29 29.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 109.311 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' E' ' 66' ' ' ALA . 7.8 t -123.57 159.0 30.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.327 0.584 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -47.97 114.67 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.705 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.467 ' O ' HD13 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.48 ' HB3' ' CG2' ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' THR . . . . . 0.516 HG21 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.516 ' N ' HG21 ' D' ' 17' ' ' THR . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.473 ' CB ' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB1' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' D' ' 16' ' ' GLN . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' D' ' 8' ' ' LYS . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.504 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.504 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.546 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.446 HG13 HD22 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.5 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.5 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo -75.87 156.29 98.87 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 41.7 t -73.88 118.9 17.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -141.82 -173.47 3.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.226 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' D' ' 63' ' ' LYS . 2.2 mtmt -96.06 82.99 3.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' D' ' 62' ' ' LYS . 2.3 mttt 42.96 50.68 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 127.87 39.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.986 . . . . 0.0 109.314 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -154.98 101.19 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.532 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' E' ' 4' ' ' ARG . 10.2 tt0 -144.99 84.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.461 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.0 OUTLIER -86.4 81.71 8.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.902 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.462 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.403 ' N ' ' CG2' ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.538 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.485 HG21 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.485 ' N ' HG21 ' E' ' 17' ' ' THR . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.439 ' O ' HD13 ' E' ' 23' ' ' LEU . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.472 ' CA ' HD12 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.472 HD12 ' CA ' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.404 ' OD1' ' CE1' ' E' ' 35' ' ' HIS . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.404 ' CE1' ' OD1' ' E' ' 31' ' ' ASN . 0.4 OUTLIER -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.472 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo -78.3 162.21 89.09 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -75.24 134.76 41.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.388 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' E' ' 62' ' ' LYS . 0.4 OUTLIER -113.01 120.9 42.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.613 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' E' ' 61' ' ' ASN . 1.1 tptt -153.26 130.03 10.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.88 144.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 64' ' ' THR . . . . . 0.45 ' O ' HG21 ' E' ' 64' ' ' THR . 1.3 t -151.36 98.96 2.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 65' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' E' ' 66' ' ' ALA . 16.7 m -133.47 162.02 33.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.541 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -153.21 19.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.443 HG21 ' N ' ' D' ' 6' ' ' THR . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.443 ' N ' HG21 ' D' ' 5' ' ' ILE . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.47 ' O ' ' HB1' ' D' ' 11' ' ' ALA . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.517 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.506 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.507 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.52 ' CB ' HG23 ' D' ' 25' ' ' VAL . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.52 HG23 ' CB ' ' D' ' 23' ' ' LEU . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.588 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.504 ' CD1' ' HB2' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.437 HG12 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.486 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.467 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.561 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -81.21 -84.79 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.99 174.06 8.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . 0.435 ' HB2' ' HG2' ' D' ' 57' ' ' PRO . 4.2 t30 -139.14 151.26 46.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.291 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.45 23.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.07 -159.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 8.3 t -90.37 12.21 19.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -100.31 94.03 5.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.602 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.585 179.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -171.23 -175.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.379 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.512 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 -87.64 58.49 4.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.13 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' E' ' 3' ' ' GLN . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' E' ' 9' ' ' ASP . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.512 ' CG ' ' HB2' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.519 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.51 ' N ' ' HG2' ' E' ' 18' ' ' LYS . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' E' ' 18' ' ' LYS . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.42 ' CD1' ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.454 ' O ' HD11 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.457 ' O ' HG21 ' E' ' 34' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 23.8 m-80 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.524 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo -80.62 -162.8 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.1 m -82.81 -25.17 32.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.905 . . . . 0.0 109.116 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.47 100.42 10.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 109.064 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -110.02 119.7 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 160.93 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.113 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -115.58 75.78 0.97 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.075 -1.016 . . . . 0.0 109.631 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 65' ' ' THR . . . . . 0.41 ' O ' HG23 ' E' ' 65' ' ' THR . 17.9 m -142.18 39.99 1.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.421 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -98.07 85.6 3.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.445 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.467 ' HB2' HD11 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.463 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' D' ' 7' ' ' LEU . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.458 ' O ' ' OG1' ' D' ' 19' ' ' THR . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 7.5 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' THR . . . . . 0.496 HG21 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.508 ' N ' ' HG2' ' D' ' 18' ' ' LYS . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.521 HD23 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . 0.496 ' NE2' HG21 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.472 HG12 ' O ' ' D' ' 26' ' ' TYR . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 4.3 t-20 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' D' ' 7' ' ' LEU . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 7.4 m170 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.401 ' O ' HG21 ' D' ' 6' ' ' THR . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.521 ' CG1' HD23 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.529 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.529 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.63 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.63 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo -80.51 153.01 83.65 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.01 167.59 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.593 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' D' ' 62' ' ' LYS . 10.3 t30 -94.17 119.47 33.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' D' ' 61' ' ' ASN . 0.3 OUTLIER 172.24 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.662 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -113.08 -176.94 3.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.472 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.31 83.96 0.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 109.568 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.64 151.1 26.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.403 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.264 0.554 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.43 99.2 6.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.449 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER -82.09 118.23 22.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.431 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.486 ' HB2' HD12 ' E' ' 42' ' ' LEU . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.482 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.475 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.48 ' CB ' HG22 ' E' ' 25' ' ' VAL . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.48 HG22 ' CB ' ' E' ' 23' ' ' LEU . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.519 ' HB3' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.429 HD11 HG22 ' E' ' 30' ' ' ILE . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' E' ' 8' ' ' LYS . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.468 HD12 HG22 ' E' ' 40' ' ' ILE . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.575 ' CE1' HG21 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.575 HG21 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.5 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.71 122.75 8.81 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' SER . . . . . 0.496 ' CB ' ' HE2' ' E' ' 56' ' ' LYS . 74.9 p -58.93 177.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 24.9 p30 -111.93 151.36 29.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 59.34 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -117.14 28.46 8.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.72 120.5 38.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 65' ' ' THR . . . . . 0.446 ' O ' HG23 ' E' ' 65' ' ' THR . 27.6 m -121.77 35.04 4.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.513 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.243 0.544 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' D' ' 1' ' ' MET . 1.2 pt-20 164.78 86.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.496 ' C ' ' CD1' ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.496 ' CD1' ' C ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' D' ' 7' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.482 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' THR . . . . . 0.511 ' HB ' ' NE2' ' D' ' 27' ' ' GLN . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' D' ' 18' ' ' LYS . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.472 ' HG ' HG12 ' D' ' 50' ' ' VAL . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.464 HG22 HD13 ' D' ' 30' ' ' ILE . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . 0.511 ' NE2' ' HB ' ' D' ' 17' ' ' THR . 3.9 mt-30 -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.471 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.464 HD13 HG22 ' D' ' 25' ' ' VAL . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.533 ' HD3' ' CD1' ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.563 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.533 ' CD1' ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' D' ' 5' ' ' ILE . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.7 m120 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.472 HG12 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.463 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo -77.33 -179.22 26.54 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.1 p -54.02 174.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 109.641 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -125.29 138.36 54.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.35 100.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.433 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.94 42.06 2.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -113.9 157.19 22.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' D' ' 65' ' ' THR . 0.7 OUTLIER -129.18 36.72 4.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.463 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -119.64 81.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.458 ' HG2' HD12 ' E' ' 5' ' ' ILE . 0.3 OUTLIER -86.25 113.55 22.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.415 ' HB ' ' OD2' ' E' ' 9' ' ' ASP . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.49 ' HB2' HD12 ' E' ' 42' ' ' LEU . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.479 ' CG ' ' HB3' ' E' ' 11' ' ' ALA . 61.6 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.526 ' HA ' ' CE2' ' E' ' 10' ' ' TYR . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.476 ' CB ' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.457 ' HG ' HG12 ' E' ' 50' ' ' VAL . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.474 HG13 ' CB ' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' E' ' 25' ' ' VAL . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 18.1 m170 -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.598 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' E' ' 39' ' ' LYS . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.506 HD11 ' CB ' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.457 HG12 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.567 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.633 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' E' ' 60' ' ' SER . 35.4 Cg_endo -78.57 -168.75 7.24 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' SER . . . . . 0.456 ' O ' ' O ' ' E' ' 59' ' ' PRO . 92.5 p -57.48 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.59 64.61 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -51.03 161.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.346 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt 57.51 34.81 25.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -80.74 158.93 25.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 109.488 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -93.22 48.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.51 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.461 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tmm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.94 -178.55 0.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.385 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.453 ' O ' HD11 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.461 ' C ' ' CD1' ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.461 ' CD1' ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' D' ' 19' ' ' THR . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.528 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.527 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.524 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.507 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.536 HG22 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.502 ' CB ' HG22 ' D' ' 25' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.443 HG21 HD13 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' D' ' 8' ' ' LYS . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' D' ' 52' ' ' ALA . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.468 HG21 ' O ' ' D' ' 49' ' ' SER . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.8 m-80 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.458 HG13 ' CD2' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.543 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.476 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -78.66 174.65 50.24 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -89.87 42.86 1.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.336 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -126.08 59.0 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.63 168.46 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -138.92 178.62 7.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.5 p -115.11 119.76 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 146.24 37.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.391 179.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.454 ' O ' ' HG2' ' E' ' 2' ' ' GLU . 1.5 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.295 0.569 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' E' ' 1' ' ' MET . 6.7 mt-10 -149.54 129.5 13.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.436 ' O ' HG12 ' E' ' 44' ' ' ILE . 1.0 OUTLIER -76.48 110.69 11.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.138 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.447 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.482 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.481 ' HB2' HD11 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.482 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.5 ' CB ' HG23 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' E' ' 25' ' ' VAL . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.428 ' HB3' HG22 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' E' ' 20' ' ' ALA . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.449 ' HB1' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.414 HD13 ' CB ' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.514 ' NE ' HD13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.518 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.619 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.485 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.619 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.601 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.601 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -81.0 -86.1 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 165.83 23.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -124.84 131.76 53.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 158.88 5.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 109.561 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.28 98.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 61.9 m -99.53 151.42 21.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.26 163.74 15.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.504 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.471 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.479 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 32.3 mtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.327 0.584 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.554 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER 74.73 140.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.245 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.554 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.546 HG22 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.532 ' CB ' HG23 ' D' ' 40' ' ' ILE . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.44 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.546 ' CB ' HG22 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.455 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' D' ' 11' ' ' ALA . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.503 ' CB ' HG22 ' D' ' 25' ' ' VAL . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' D' ' 23' ' ' LEU . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.462 HD11 HG22 ' D' ' 30' ' ' ILE . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' D' ' 29' ' ' ALA . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.445 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.463 ' CD2' HG21 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' D' ' 52' ' ' ALA . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.492 HD12 ' CD2' ' D' ' 10' ' ' TYR . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.579 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.579 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.477 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.544 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -80.22 -22.22 16.31 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.8 p -43.46 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 0.0 110.234 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' D' ' 59' ' ' PRO . 2.0 m120 -160.73 28.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.13 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.1 -175.03 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.849 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 -161.24 1.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 19.3 m -104.58 -88.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.328 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.97 38.4 1.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.416 -179.882 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' E' ' 1' ' ' MET . 13.3 ptt? . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.309 0.576 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.3 115.46 6.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.465 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -78.52 78.97 4.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.414 ' N ' HG21 ' E' ' 5' ' ' ILE . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.467 ' HB2' HD11 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.53 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.53 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.451 ' OG1' ' CE1' ' E' ' 10' ' ' TYR . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.447 ' CB ' HG22 ' E' ' 25' ' ' VAL . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.419 HD11 HD13 ' E' ' 7' ' ' LEU . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.419 ' HB2' HD22 ' E' ' 7' ' ' LEU . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.503 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.449 HG22 HD11 ' E' ' 40' ' ' ILE . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.598 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.544 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 55.1 m-80 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.544 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.598 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.507 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.494 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo -78.63 144.81 75.38 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 60' ' ' SER . . . . . 0.468 ' HB3' ' HE3' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -89.73 -65.61 1.0 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 6.8 p30 -146.57 69.51 1.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.895 . . . . 0.0 109.565 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 117.24 28.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.08 71.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.31 76.9 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.97 106.83 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.5 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' D' ' 1' ' ' MET . 11.5 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' D' ' 1' ' ' MET . 1.9 pt-20 177.06 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HG12 ' D' ' 44' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.487 ' HB2' HD12 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' D' ' 15' ' ' GLY . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.458 ' O ' ' HD2' ' D' ' 18' ' ' LYS . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.419 ' CG ' ' HB2' ' D' ' 11' ' ' ALA . 0.2 OUTLIER -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.441 ' OG1' ' CE1' ' D' ' 10' ' ' TYR . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.518 ' CA ' HD13 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.501 ' CG ' HG13 ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.462 ' HB2' HG13 ' D' ' 25' ' ' VAL . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' D' ' 32' ' ' LYS . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.411 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.527 ' CB ' ' HD3' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.485 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' D' ' 49' ' ' SER . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.501 HG13 ' CG ' ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.503 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.548 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo -80.07 172.14 59.08 Favored 'Cis proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -49.6 -23.32 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.45 167.32 20.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' D' ' 63' ' ' LYS . 46.3 mttt -137.64 109.04 6.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.669 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' D' ' 62' ' ' LYS . 0.7 OUTLIER 43.05 -149.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -140.48 146.72 38.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.427 ' O ' ' O ' ' D' ' 66' ' ' ALA . 6.7 m -128.86 116.34 19.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.423 ' O ' ' N ' ' E' ' 3' ' ' GLN . 2.9 mtm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -58.03 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.965 . . . . 0.0 109.567 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' E' ' 1' ' ' MET . 0.0 OUTLIER -69.64 100.82 1.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.481 HG12 ' CD1' ' E' ' 44' ' ' ILE . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.455 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' E' ' 42' ' ' LEU . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.455 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.437 ' CB ' HG23 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.47 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 17' ' ' THR . . . . . 0.523 HG21 ' N ' ' E' ' 18' ' ' LYS . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.523 ' N ' HG21 ' E' ' 17' ' ' THR . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.485 ' HB ' HD11 ' E' ' 30' ' ' ILE . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.495 ' CA ' HD12 ' E' ' 30' ' ' ILE . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.531 ' CG ' HG13 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.539 ' CG1' ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.525 HG22 HD11 ' E' ' 30' ' ' ILE . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.43 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.497 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.43 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' E' ' 5' ' ' ILE . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.531 HG13 ' CG ' ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.543 HG21 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 35.1 Cg_endo -79.64 175.55 44.88 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -62.07 -173.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' E' ' 62' ' ' LYS . 10.7 p30 -91.56 158.39 16.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' E' ' 61' ' ' ASN . 0.0 OUTLIER -43.35 122.93 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.48 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -137.53 113.27 9.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.45 67.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.371 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.13 89.24 3.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.547 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.492 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.55 100.65 5.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . 0.435 ' HB3' HD11 ' D' ' 44' ' ' ILE . 9.7 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.482 ' HA ' ' HB3' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.465 HG22 ' CD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.514 ' CB ' HD13 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' D' ' 29' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' D' ' 25' ' ' VAL . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.514 HD13 ' CB ' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.448 ' CD1' ' HB3' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' D' ' 5' ' ' ILE . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.525 HG13 ' CD2' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' D' ' 42' ' ' LEU . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.637 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.453 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.458 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.553 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo -79.43 -176.61 18.8 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 20.4 p -55.02 -58.09 9.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.196 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.37 -168.89 2.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -139.07 -159.98 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -93.59 -162.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.384 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 63.44 1.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.579 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -153.76 72.78 0.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.879 -1.058 . . . . 0.0 109.475 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' E' ' 1' ' ' MET . 8.4 tpt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' E' ' 4' ' ' ARG . 58.9 mt-10 -143.84 61.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 -44.99 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' E' ' 2' ' ' GLU . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.526 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.5 ' CA ' HD13 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.406 ' OG1' ' CD1' ' E' ' 10' ' ' TYR . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CD1' ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.449 ' CB ' HG22 ' E' ' 50' ' ' VAL . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.406 HD11 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.5 HD13 ' CA ' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.471 HG22 ' CE1' ' D' ' 58' ' ' PHE . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD2' HG23 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' E' ' 52' ' ' ALA . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.456 HG13 ' O ' ' E' ' 3' ' ' GLN . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.449 HG22 ' CB ' ' E' ' 22' ' ' ASP . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' D' ' 57' ' ' PRO . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.588 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 36.2 Cg_endo -79.0 3.62 30.93 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 60' ' ' SER . . . . . 0.459 ' O ' ' HE2' ' E' ' 56' ' ' LYS . 1.1 t -43.24 110.13 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . 0.458 ' HA ' ' HE2' ' E' ' 56' ' ' LYS . 78.0 m-20 -121.81 -167.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -48.58 119.15 2.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -81.62 164.15 22.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -97.73 106.33 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.487 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 11.0 t -158.99 158.24 32.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.391 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.36 -177.7 6.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.601 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.469 ' O ' HG13 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.469 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.531 HD23 ' CZ ' ' E' ' 58' ' ' PHE . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.47 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' D' ' 14' ' ' PHE . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.449 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.499 HG22 ' CD1' ' D' ' 7' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.518 ' CA ' HD13 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.472 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.525 HD21 ' CE1' ' E' ' 58' ' ' PHE . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.577 ' CB ' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.577 ' CD1' ' CB ' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.527 HD13 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.413 HG12 HG12 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.48 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.48 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -81.37 -161.67 2.71 Favored 'Cis proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.74 158.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.79 47.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp 53.23 78.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.212 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -110.79 146.63 36.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.763 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 37.8 p -127.59 128.42 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.0 -168.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.432 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -91.53 159.13 16.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -84.77 118.87 24.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.247 -0.908 . . . . 0.0 109.165 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.472 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' E' ' 42' ' ' LEU . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.5 HD11 ' CD1' ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 12' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' E' ' 11' ' ' ALA . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.524 ' CB ' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.481 ' HB3' HG22 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' E' ' 23' ' ' LEU . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 28' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.524 HG13 ' CB ' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . 0.464 ' HB3' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.5 ' CE ' ' CD ' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' E' ' 33' ' ' ALA . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.528 HD11 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.528 ' CB ' HD11 ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.5 ' CD ' ' CE ' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.478 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.65 -162.75 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -79.53 104.77 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -144.83 47.65 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' E' ' 63' ' ' LYS . 0.1 OUTLIER -138.98 166.33 24.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.59 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' E' ' 62' ' ' LYS . 0.0 OUTLIER -164.83 34.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.04 136.07 40.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -155.24 109.57 2.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.626 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.16 164.35 30.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ILE . . . . . 0.473 HG13 ' O ' ' D' ' 4' ' ' ARG . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' THR . . . . . 0.434 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' LEU . . . . . 0.406 ' HA ' HD11 ' D' ' 7' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' TYR . . . . . 0.497 ' CD2' ' CD2' ' D' ' 42' ' ' LEU . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' THR . . . . . 0.495 ' HA ' ' CE2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' ASP . . . . . 0.445 ' HB3' HG22 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . 0.462 ' HB2' HG23 ' D' ' 25' ' ' VAL . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' D' ' 23' ' ' LEU . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.434 ' O ' HG21 ' D' ' 30' ' ' ILE . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' D' ' 35' ' ' HIS . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' D' ' 31' ' ' ASN . 18.7 m-70 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.512 ' CB ' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CB ' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . 0.498 HD11 HG22 ' D' ' 44' ' ' ILE . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.9 m-80 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' TYR . . . . . 0.501 ' HB3' ' CG2' ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' GLU . . . . . 0.489 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.636 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . 0.507 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . 0.507 ' HD2' ' CD ' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' PHE . . . . . 0.599 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.36 -169.05 7.49 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.09 115.51 4.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -111.36 -171.77 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.56 149.1 40.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.9 . . . . 0.0 109.587 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -99.18 -173.62 2.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.333 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.97 88.65 4.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.46 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.77 41.38 3.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.478 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.328 0.585 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.86 35.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -60.8 96.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 5' ' ' ILE . . . . . 0.531 HD11 ' CD1' ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 6' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 7' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 8' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 9' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 10' ' ' TYR . . . . . 0.516 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 13' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.501 HG22 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.494 ' N ' HD12 ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 22' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.461 HG13 ' CB ' ' E' ' 29' ' ' ALA . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 28' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' E' ' 25' ' ' VAL . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 30' ' ' ILE . . . . . 0.494 HD12 ' N ' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 31' ' ' ASN . . . . . 0.559 ' ND2' ' NE2' ' E' ' 35' ' ' HIS . 5.1 t30 -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 32' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 35' ' ' HIS . . . . . 0.559 ' NE2' ' ND2' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' E' ' 5' ' ' ILE . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 44' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . 0.599 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 53' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 54' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . 0.643 ' CG2' ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . 0.491 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 58' ' ' PHE . . . . . 0.536 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 59' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -81.81 -166.57 5.16 Favored 'Cis proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 60' ' ' SER . . . . . 0.433 ' O ' ' O ' ' E' ' 59' ' ' PRO . 87.2 p -47.35 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.672 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -111.77 116.85 31.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -141.41 38.33 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.75 116.97 26.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 11.77 26.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.267 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.07 111.92 8.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.482 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.45 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.627 ' HA ' HD22 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.658 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' D' ' 19' ' ' THR . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.84 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.84 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 25.5 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.587 HG23 ' CD2' ' D' ' 10' ' ' TYR . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' D' ' 29' ' ' ALA . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.564 HD12 HD11 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.595 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.465 HG22 ' O ' ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.557 HG23 ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.557 ' O ' HG23 ' D' ' 44' ' ' ILE . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.587 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.675 ' CE1' HG11 ' E' ' 25' ' ' VAL . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.683 ' HG3' HG12 ' E' ' 25' ' ' VAL . 36.6 Cg_endo . . . . . 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.825 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.825 HD13 ' C ' ' E' ' 4' ' ' ARG . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.63 ' HA ' HD22 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.457 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.698 ' HB2' HG22 ' E' ' 5' ' ' ILE . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.567 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.622 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.669 ' O ' HD12 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 1.043 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.669 HD12 ' O ' ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' E' ' 7' ' ' LEU . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.741 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.468 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.585 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.506 ' O ' HD12 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.572 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.572 HD12 ' C ' ' D' ' 4' ' ' ARG . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.66 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.542 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.593 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' D' ' 18' ' ' LYS . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.593 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.683 ' O ' HD12 ' D' ' 23' ' ' LEU . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.867 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.785 HG13 ' HB2' ' D' ' 20' ' ' ALA . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.546 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.782 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.694 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.506 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.694 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.546 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.483 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.417 ' HB3' HD12 ' E' ' 44' ' ' ILE . 3.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.394 0.616 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.445 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' E' ' 9' ' ' ASP . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.46 HG21 ' HE2' ' E' ' 8' ' ' LYS . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.553 HD13 HD11 ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' E' ' 6' ' ' THR . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.434 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.523 HG21 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.617 ' O ' HD12 ' E' ' 34' ' ' ILE . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.617 HD12 ' O ' ' E' ' 30' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.458 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' E' ' 7' ' ' LEU . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.564 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.725 ' HB3' HG13 ' D' ' 25' ' ' VAL . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.222 0.534 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 1.043 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 1.043 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.509 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.628 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 1.017 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 1.017 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.628 HG23 ' HD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.8 ' HB2' HD13 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.851 ' HB3' HG21 ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.504 HD12 ' O ' ' D' ' 19' ' ' THR . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.572 HG23 HD11 ' D' ' 30' ' ' ILE . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.653 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 27' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' D' ' 31' ' ' ASN . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' D' ' 27' ' ' GLN . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.445 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.432 HD11 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.686 HG23 ' NE ' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.2 m-20 -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.866 ' HZ ' HG11 ' E' ' 25' ' ' VAL . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' E' ' 23' ' ' LEU . 36.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.41 ' HB3' HD11 ' E' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.174 0.512 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.464 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' E' ' 5' ' ' ILE . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' E' ' 19' ' ' THR . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.479 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.439 ' CE ' HG21 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.766 HG21 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.722 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 21' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.674 HD12 ' O ' ' E' ' 19' ' ' THR . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.866 HG11 ' HZ ' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.816 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.444 HD12 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.816 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' E' ' 7' ' ' LEU . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.64 HG11 ' HG ' ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 55' ' ' VAL . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.29 0.567 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.665 ' HB3' HD11 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.621 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.712 HD12 ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.534 HD12 HG21 ' D' ' 19' ' ' THR . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.94 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.76 ' O ' HD12 ' D' ' 23' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.729 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.76 HD12 ' O ' ' D' ' 19' ' ' THR . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.419 ' ND2' ' NE2' ' D' ' 35' ' ' HIS . 35.6 t30 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.92 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' HIS . . . . . 0.419 ' NE2' ' ND2' ' D' ' 31' ' ' ASN . 2.5 m-70 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.92 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.647 ' CE2' HG23 ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.486 HG22 ' O ' ' D' ' 43' ' ' THR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.749 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.647 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.45 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.768 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.49 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.342 0.591 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' E' ' 9' ' ' ASP . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.702 ' HB2' HG22 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.763 ' HD2' HG23 ' E' ' 19' ' ' THR . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.763 HG23 ' HD2' ' E' ' 10' ' ' TYR . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.941 ' OD2' HG21 ' E' ' 50' ' ' VAL . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.638 HD12 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.768 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.675 ' O ' HD12 ' E' ' 34' ' ' ILE . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.675 HD12 ' O ' ' E' ' 30' ' ' ILE . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' E' ' 55' ' ' VAL . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.839 ' O ' HD13 ' E' ' 44' ' ' ILE . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.839 HD13 ' O ' ' E' ' 43' ' ' THR . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.941 HG21 ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' HD12 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.622 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.312 0.577 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.45 ' O ' HD12 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.73 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.73 HD12 ' C ' ' D' ' 4' ' ' ARG . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.883 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.495 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 16' ' ' GLN . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' D' ' 11' ' ' ALA . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' D' ' 21' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' D' ' 14' ' ' PHE . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.687 HG21 ' CD1' ' D' ' 7' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.719 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.499 ' HG ' HG11 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.719 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.469 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HD1' ' D' ' 26' ' ' TYR . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.496 ' O ' HD12 ' D' ' 34' ' ' ILE . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.496 HD12 ' O ' ' D' ' 30' ' ' ILE . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.704 ' CD ' HD11 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.883 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.563 ' CD1' HD13 ' D' ' 5' ' ' ILE . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.499 HG11 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.433 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.565 ' HE ' HG23 ' E' ' 43' ' ' THR . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' E' ' 9' ' ' ASP . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.682 ' HB2' HG22 ' E' ' 5' ' ' ILE . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.529 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.529 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.461 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.476 ' O ' HD12 ' E' ' 23' ' ' LEU . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.583 ' CB ' HG23 ' E' ' 25' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.759 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' E' ' 29' ' ' ALA . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' E' ' 25' ' ' VAL . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.496 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.565 HG23 ' HE ' ' E' ' 4' ' ' ARG . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.544 ' CG1' HD21 ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 1.014 ' O ' HD13 ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 1.014 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.405 ' H ' HG22 ' D' ' 5' ' ' ILE . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.68 HD11 HG23 ' D' ' 30' ' ' ILE . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' D' ' 8' ' ' LYS . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.618 ' HD2' HG23 ' D' ' 19' ' ' THR . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.683 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.683 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.618 HG23 ' HD2' ' D' ' 10' ' ' TYR . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.593 HD12 ' O ' ' D' ' 19' ' ' THR . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.68 HG23 HD11 ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' D' ' 7' ' ' LEU . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.556 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.801 HD11 HG13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' D' ' 23' ' ' LEU . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.71 HG23 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.556 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.647 ' CE1' HD22 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.481 ' O ' HD12 ' E' ' 44' ' ' ILE . 28.2 mt-30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG21 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.489 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.549 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.549 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.599 HG23 ' N ' ' E' ' 18' ' ' LYS . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.599 ' N ' HG23 ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.868 HG21 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.831 ' HB3' HG21 ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.784 ' HG ' HG11 ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.72 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 HG21 ' E' ' 34' ' ' ILE . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.557 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.41 HD13 ' HB1' ' E' ' 33' ' ' ALA . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.735 ' CD2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.573 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.481 HD12 ' O ' ' E' ' 3' ' ' GLN . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' E' ' 59' ' ' PRO . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.828 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.544 ' C ' HD12 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.57 HD12 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.542 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' D' ' 19' ' ' THR . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' D' ' 13' ' ' ARG . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' D' ' 12' ' ' MET . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.845 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.827 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.845 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.494 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.401 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.828 HD12 ' O ' ' D' ' 3' ' ' GLN . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.535 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo . . . . . 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.698 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.742 HG21 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.5 ' CB ' HG22 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.5 HG22 ' CB ' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' E' ' 8' ' ' LYS . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.575 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.684 ' CE1' HG23 ' E' ' 55' ' ' VAL . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.461 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.676 ' CZ ' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo . . . . . 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 1.025 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 1.025 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 1.003 ' HB2' HD13 ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.586 ' HA ' HD11 ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.659 ' O ' HD12 ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.659 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' D' ' 20' ' ' ALA . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' D' ' 38' ' ' ARG . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.845 ' HD2' ' HB1' ' D' ' 36' ' ' ALA . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.565 HG11 ' HG ' ' D' ' 23' ' ' LEU . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.555 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.745 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.281 0.563 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.471 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.643 HG23 ' O ' ' E' ' 40' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.949 ' HB2' HD13 ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' E' ' 19' ' ' THR . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.52 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' E' ' 14' ' ' PHE . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.672 HG21 ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.745 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' E' ' 20' ' ' ALA . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.633 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.592 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.643 ' O ' HG23 ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 1.13 HD12 ' HB2' ' E' ' 52' ' ' ALA . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 1.13 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.664 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.593 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.593 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.434 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.673 HG22 ' H ' ' D' ' 6' ' ' THR . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.673 ' H ' HG22 ' D' ' 5' ' ' ILE . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.634 HD11 HG23 ' D' ' 30' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.578 ' CD1' HG23 ' D' ' 19' ' ' THR . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.569 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.569 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 4.3 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.61 HG22 HD12 ' D' ' 23' ' ' LEU . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.703 ' HG ' HG11 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' D' ' 20' ' ' ALA . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.583 ' CD2' HG21 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' D' ' 7' ' ' LEU . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.703 HG11 ' HG ' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' E' ' 57' ' ' PRO . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 1.047 ' CG1' HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 1.064 ' O ' HD13 ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 1.064 HD13 ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' E' ' 42' ' ' LEU . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.523 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.45 ' H ' HG22 ' E' ' 17' ' ' THR . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.677 ' O ' HD12 ' E' ' 23' ' ' LEU . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.677 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.549 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.549 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' E' ' 8' ' ' LYS . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.468 HD13 ' HB1' ' E' ' 33' ' ' ALA . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.741 HG22 ' O ' ' E' ' 51' ' ' TYR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.692 HD11 HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.741 ' O ' HG22 ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.5 ' O ' HG12 ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 1.047 HG13 ' CG1' ' D' ' 55' ' ' VAL . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.775 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.775 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.655 HD11 HD12 ' D' ' 30' ' ' ILE . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.567 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.456 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.643 HG21 ' CD1' ' D' ' 7' ' ' LEU . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' E' ' 58' ' ' PHE . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.655 HD12 HD11 ' D' ' 7' ' ' LEU . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' D' ' 34' ' ' ILE . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.508 ' CG ' HG13 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.762 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.533 HG23 ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.533 ' O ' HG23 ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.643 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.479 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.924 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.924 HD13 ' C ' ' E' ' 4' ' ' ARG . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.926 HD11 HD12 ' E' ' 30' ' ' ILE . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.502 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.598 ' CB ' HG22 ' E' ' 5' ' ' ILE . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.568 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.696 ' O ' HD12 ' E' ' 23' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.975 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.696 HD12 ' O ' ' E' ' 19' ' ' THR . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.926 HD12 HD11 ' E' ' 7' ' ' LEU . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.558 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.558 HD13 ' HB1' ' E' ' 33' ' ' ALA . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.533 HD12 HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.975 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.497 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.327 0.584 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.507 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' D' ' 19' ' ' THR . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.536 ' HB3' HG21 ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 17' ' ' THR . . . . . 0.486 HG23 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.992 ' O ' HD12 ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.992 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.74 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.74 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 20' ' ' ALA . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.54 HD11 ' HG ' ' D' ' 7' ' ' LEU . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.512 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' HG22 ' D' ' 43' ' ' THR . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.519 HG12 HD21 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo . . . . . 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.497 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.191 0.52 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.55 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.55 HD12 ' C ' ' E' ' 4' ' ' ARG . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.45 ' N ' HG22 ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD13 ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.603 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.446 HG23 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' E' ' 14' ' ' PHE . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.603 HG23 ' CD2' ' E' ' 10' ' ' TYR . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.768 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.942 ' HB3' HG21 ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.548 ' O ' HD12 ' E' ' 30' ' ' ILE . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.768 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.16 0.505 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.835 ' HA ' HD22 ' D' ' 42' ' ' LEU . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.535 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.517 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.95 ' O ' HD12 ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.906 ' HB2' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' D' ' 50' ' ' VAL . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.95 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' E' ' 58' ' ' PHE . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.403 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.906 ' CD1' ' HB2' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.894 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.447 HD12 ' O ' ' D' ' 30' ' ' ILE . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.894 HD12 ' HB1' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.835 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.79 HG11 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' E' ' 58' ' ' PHE . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' E' ' 25' ' ' VAL . 36.6 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.522 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.737 0.78 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.808 ' C ' HD12 ' E' ' 5' ' ' ILE . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.813 HD13 HD11 ' E' ' 44' ' ' ILE . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.643 ' HA ' HD22 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.689 ' HB2' HG22 ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.958 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.958 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.527 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.903 ' O ' HD12 ' E' ' 23' ' ' LEU . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.679 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.85 ' HB3' HG21 ' E' ' 50' ' ' VAL . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.903 HD12 ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.701 HG22 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.702 ' O ' HD12 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.702 HD12 ' O ' ' E' ' 30' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' E' ' 38' ' ' ARG . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.47 ' HD3' ' HB1' ' E' ' 36' ' ' ALA . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.713 ' CE1' HG23 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.813 HD11 HD13 ' E' ' 5' ' ' ILE . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 7.8 m120 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.85 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.48 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.713 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' D' ' 25' ' ' VAL . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' D' ' 19' ' ' THR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 30.2 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' THR . . . . . 0.57 HG23 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.806 ' O ' HD12 ' D' ' 23' ' ' LEU . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.81 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.812 HD21 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' D' ' 20' ' ' ALA . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 27' ' ' GLN . . . . . 0.57 ' NE2' HG23 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.714 ' CG1' ' HB2' ' D' ' 20' ' ' ALA . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.576 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.576 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.447 ' H ' HD12 ' D' ' 44' ' ' ILE . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.812 ' CG1' HD21 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.55 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.588 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.592 ' CD1' HG21 ' E' ' 19' ' ' THR . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.588 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.521 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.928 ' O ' HD12 ' E' ' 23' ' ' LEU . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.928 HD12 ' O ' ' E' ' 19' ' ' THR . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.759 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 27' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' E' ' 27' ' ' GLN . 6.7 mm100 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' E' ' 34' ' ' ILE . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.808 ' CE1' HG23 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.707 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.707 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.808 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG11 ' D' ' 25' ' ' VAL . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.677 ' O ' HD12 ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.936 ' O ' HD13 ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.936 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HA ' HD22 ' D' ' 42' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.736 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.895 ' O ' HD12 ' D' ' 23' ' ' LEU . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.678 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.895 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' D' ' 20' ' ' ALA . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.476 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.669 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 34' ' ' ILE . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.842 ' HD3' HD11 ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.842 HD11 ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.677 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 4.3 m-20 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.442 ' OE1' HG23 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' E' ' 5' ' ' ILE . 1.6 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.935 HD12 HG21 ' E' ' 19' ' ' THR . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' E' ' 5' ' ' ILE . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.578 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 15' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.578 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 28.9 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.935 HG21 HD12 ' E' ' 7' ' ' LEU . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.96 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.442 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.442 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.96 HG13 ' HB2' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.479 ' O ' ' CG ' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 35' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' E' ' 31' ' ' ASN . 0.3 OUTLIER -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' E' ' 55' ' ' VAL . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.789 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.576 HG11 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.677 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.724 ' O ' HD12 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.825 ' C ' HD12 ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.825 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' D' ' 42' ' ' LEU . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.544 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.602 ' CD2' HG23 ' D' ' 19' ' ' THR . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.803 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.623 HG21 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' D' ' 50' ' ' VAL . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.75 ' HG ' HG11 ' D' ' 50' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.573 ' O ' HD12 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.573 HD12 ' O ' ' D' ' 30' ' ' ILE . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.424 HD12 ' HB1' ' D' ' 33' ' ' ALA . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' D' ' 55' ' ' VAL . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.724 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 3.2 m120 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.75 HG11 ' HG ' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.642 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.504 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.484 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.442 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.721 ' N ' HD12 ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.663 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.663 ' HG1' ' HD1' ' E' ' 10' ' ' TYR . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.857 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' E' ' 24' ' ' GLY . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.543 HD12 ' O ' ' E' ' 30' ' ' ILE . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.621 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.62 ' C ' HD13 ' E' ' 44' ' ' ILE . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.79 ' N ' HD13 ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.621 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.559 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 2' ' ' GLU . . . . . 0.564 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.564 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.534 HG21 ' HE3' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.691 ' HA ' HD22 ' D' ' 42' ' ' LEU . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.557 ' CB ' HG23 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.764 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' D' ' 50' ' ' VAL . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.764 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.426 ' HB3' HG12 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' D' ' 20' ' ' ALA . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.519 ' CD2' HG23 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.645 HG21 ' HB3' ' D' ' 22' ' ' ASP . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.576 HG13 HG13 ' E' ' 55' ' ' VAL . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.488 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.421 ' HB3' HD12 ' E' ' 44' ' ' ILE . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.279 0.562 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.591 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.591 HD12 ' C ' ' E' ' 4' ' ' ARG . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD22 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 15' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.547 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.607 HG22 HD12 ' E' ' 23' ' ' LEU . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' E' ' 30' ' ' ILE . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.609 ' CB ' HG21 ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.607 HD12 HG22 ' E' ' 19' ' ' THR . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.692 ' CG1' ' HB2' ' E' ' 20' ' ' ALA . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.723 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 26.3 m120 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.879 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.134 0.492 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' D' ' 5' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.52 ' NE ' HG23 ' D' ' 43' ' ' THR . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.607 HD11 ' OE1' ' D' ' 3' ' ' GLN . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.614 ' HA ' HD22 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.798 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.798 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 2.2 mt-30 -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.602 HG22 HD12 ' D' ' 23' ' ' LEU . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.626 HD21 ' CG1' ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.604 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.504 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.879 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.65 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.52 HG23 ' NE ' ' D' ' 4' ' ' ARG . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.681 HD13 ' N ' ' D' ' 44' ' ' ILE . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.626 ' CG1' HD21 ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.65 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 1.06 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.664 ' O ' HD12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 1.013 ' O ' HD13 ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 1.013 HD13 ' O ' ' E' ' 4' ' ' ARG . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' E' ' 19' ' ' THR . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' E' ' 34' ' ' ILE . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.443 ' O ' HD12 ' E' ' 30' ' ' ILE . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.7 HG21 ' CD1' ' E' ' 7' ' ' LEU . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.863 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 1.01 HD21 HG12 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 1.06 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.703 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 43' ' ' THR . . . . . 0.746 HG23 ' NE ' ' E' ' 4' ' ' ARG . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.664 HD12 ' O ' ' E' ' 3' ' ' GLN . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 1.01 HG12 HD21 ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' E' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 3' ' ' GLN . . . . . 0.53 ' O ' HD12 ' D' ' 44' ' ' ILE . 26.9 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.614 ' C ' HD13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.614 HD13 ' C ' ' D' ' 4' ' ' ARG . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.762 HD12 ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.557 ' HD1' ' HG1' ' D' ' 19' ' ' THR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.712 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.557 ' HG1' ' HD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.732 ' HG ' HG11 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.403 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.72 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.53 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.732 HG11 ' HG ' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.584 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.584 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.457 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.566 HD13 HD11 ' E' ' 44' ' ' ILE . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.735 ' HA ' HD22 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.553 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.525 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.773 ' O ' HD12 ' E' ' 23' ' ' LEU . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.773 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.553 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.553 HD13 ' HB1' ' E' ' 33' ' ' ALA . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.566 HD11 HD13 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.661 ' C ' HD12 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.661 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HA ' HD22 ' D' ' 42' ' ' LEU . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' D' ' 19' ' ' THR . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 12' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.899 ' O ' HD12 ' D' ' 23' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.617 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.899 HD12 ' O ' ' D' ' 19' ' ' THR . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.463 ' H ' HG22 ' D' ' 25' ' ' VAL . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 1.127 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 1.127 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.486 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.599 ' HE1' HG11 ' E' ' 25' ' ' VAL . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 59' ' ' PRO . . . . . 0.58 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 3' ' ' GLN . . . . . 0.441 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.7 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.467 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.594 HD13 HD13 ' E' ' 44' ' ' ILE . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' E' ' 34' ' ' ILE . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 12' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 17' ' ' THR . . . . . 0.621 HG23 HE21 ' E' ' 27' ' ' GLN . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 18' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.488 HG23 ' CD1' ' E' ' 10' ' ' TYR . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.931 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.501 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 27' ' ' GLN . . . . . 0.621 HE21 HG23 ' E' ' 17' ' ' THR . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 28' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.931 HG13 ' HB2' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.56 HD11 ' CB ' ' E' ' 11' ' ' ALA . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.516 ' HE3' ' HD2' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 40' ' ' ILE . . . . . 0.498 HG21 HD22 ' E' ' 7' ' ' LEU . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.905 HG23 ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.905 ' O ' HG23 ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.516 ' HD2' ' HE3' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.487 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.665 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 4' ' ' ARG . . . . . 0.479 ' C ' HD12 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 5' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' D' ' 9' ' ' ASP . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 7' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' D' ' 42' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.671 ' HA ' HD11 ' D' ' 34' ' ' ILE . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 10' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' D' ' 19' ' ' THR . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.617 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 19' ' ' THR . . . . . 0.773 HG23 ' CD2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 22' ' ' ASP . . . . . 0.791 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.679 HG11 ' HE1' ' E' ' 58' ' ' PHE . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.897 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 34' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' D' ' 8' ' ' LYS . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.817 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' LYS . . . . . 0.585 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 40' ' ' ILE . . . . . 0.56 HD13 ' HB1' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.872 HD12 ' HB2' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 43' ' ' THR . . . . . 0.576 HG23 ' O ' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 3.9 m120 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.791 HG21 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 51' ' ' TYR . . . . . 0.569 ' O ' HG22 ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 54' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 57' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' PHE . . . . . 0.83 ' CE2' ' HB1' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.555 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 5' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 6' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 7' ' ' LEU . . . . . 0.799 ' CD1' HG21 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 8' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 9' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG23 ' E' ' 19' ' ' THR . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.744 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.744 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 19' ' ' THR . . . . . 0.799 HG21 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.779 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 22' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.637 HG12 ' H ' ' E' ' 26' ' ' TYR . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 26' ' ' TYR . . . . . 0.637 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 28' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' E' ' 26' ' ' TYR . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 30' ' ' ILE . . . . . 0.779 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 31' ' ' ASN . . . . . 0.541 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 0.7 OUTLIER -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 32' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 35' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 44' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 52' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 53' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 54' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 56' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 58' ' ' PHE . . . . . 0.679 ' HE1' HG11 ' D' ' 25' ' ' VAL . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.03 124.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.392 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.45 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.627 ' HA ' HD22 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.658 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' D' ' 19' ' ' THR . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.84 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.84 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 25.5 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.587 HG23 ' CD2' ' D' ' 10' ' ' TYR . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' D' ' 29' ' ' ALA . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.564 HD12 HD11 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.595 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.465 HG22 ' O ' ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.557 HG23 ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.557 ' O ' HG23 ' D' ' 44' ' ' ILE . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.587 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.675 ' CE1' HG11 ' E' ' 25' ' ' VAL . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.683 ' HG3' HG12 ' E' ' 25' ' ' VAL . 36.6 Cg_endo -80.7 -160.36 2.33 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.0 t -85.77 -46.01 11.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.235 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.86 -156.27 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.404 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.28 -176.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.163 -0.961 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -147.87 132.42 17.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.468 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.45 168.46 19.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.26 156.64 17.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.388 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.392 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.315 0.579 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.46 174.9 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -78.97 109.07 12.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.292 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.825 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.825 HD13 ' C ' ' E' ' 4' ' ' ARG . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.63 ' HA ' HD22 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.457 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.698 ' HB2' HG22 ' E' ' 5' ' ' ILE . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.567 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.622 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.669 ' O ' HD12 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 1.043 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.669 HD12 ' O ' ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' E' ' 7' ' ' LEU . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.741 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.468 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.15 -70.68 0.01 OUTLIER 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -83.24 -80.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' E' ' 61' ' ' ASN . 0.5 OUTLIER -145.3 111.74 5.75 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.38 120.41 5.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.605 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -80.21 -45.93 17.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.953 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.8 p -129.32 121.16 26.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.392 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.412 ' O ' HG23 ' E' ' 65' ' ' THR . 3.4 t -81.33 126.59 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.6 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -106.26 115.62 30.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.506 ' O ' HD12 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.572 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.572 HD12 ' C ' ' D' ' 4' ' ' ARG . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.66 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.542 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.593 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' D' ' 18' ' ' LYS . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.593 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.683 ' O ' HD12 ' D' ' 23' ' ' LEU . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.867 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.785 HG13 ' HB2' ' D' ' 20' ' ' ALA . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.546 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.782 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.694 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.506 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.694 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.546 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.483 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -79.91 -160.01 2.21 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.4 93.61 9.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 109.817 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -98.35 159.83 14.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.041 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' D' ' 62' ' ' LYS . 4.1 ttmt 48.3 41.04 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.127 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -102.17 110.23 22.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.643 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 116.41 24.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.359 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -139.5 121.09 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.473 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.351 0.596 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.08 65.35 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.417 ' HB3' HD12 ' E' ' 44' ' ' ILE . 3.6 mt-30 -89.43 89.88 8.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.716 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.445 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' E' ' 9' ' ' ASP . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.46 HG21 ' HE2' ' E' ' 8' ' ' LYS . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.553 HD13 HD11 ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' E' ' 6' ' ' THR . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.434 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.523 HG21 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.617 ' O ' HD12 ' E' ' 34' ' ' ILE . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.617 HD12 ' O ' ' E' ' 30' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.458 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' E' ' 7' ' ' LEU . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.564 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.725 ' HB3' HG13 ' D' ' 25' ' ' VAL . 36.1 Cg_endo -79.7 -178.34 23.09 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -84.37 86.91 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.381 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.87 112.02 16.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.697 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.09 150.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 131.56 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.05 -26.71 7.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -111.18 130.05 55.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.425 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -137.97 67.17 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.605 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 1.043 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 1.043 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.509 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.628 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 1.017 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 1.017 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.628 HG23 ' HD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.8 ' HB2' HD13 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.851 ' HB3' HG21 ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.504 HD12 ' O ' ' D' ' 19' ' ' THR . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.572 HG23 HD11 ' D' ' 30' ' ' ILE . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.653 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 27' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' D' ' 31' ' ' ASN . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' D' ' 27' ' ' GLN . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.445 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.432 HD11 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.686 HG23 ' NE ' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.2 m-20 -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.866 ' HZ ' HG11 ' E' ' 25' ' ' VAL . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' E' ' 23' ' ' LEU . 36.5 Cg_endo -81.92 -157.39 1.42 Allowed 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 70.4 m -60.51 -164.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.386 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -80.97 168.77 18.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -137.99 125.04 21.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.11 87.95 2.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -107.66 106.8 17.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -151.47 26.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 109.504 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.48 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 29.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 54.71 26.56 7.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.289 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.41 ' HB3' HD11 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -56.9 113.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.464 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' E' ' 5' ' ' ILE . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' E' ' 19' ' ' THR . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.479 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.439 ' CE ' HG21 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.766 HG21 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.722 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.674 HD12 ' O ' ' E' ' 19' ' ' THR . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.866 HG11 ' HZ ' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.816 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.444 HD12 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.816 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' E' ' 7' ' ' LEU . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.64 HG11 ' HG ' ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 55' ' ' VAL . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.44 175.96 43.64 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -66.72 -149.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.44 113.21 21.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.087 -1.008 . . . . 0.0 109.349 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.65 110.8 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -91.54 -146.89 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.265 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.93 123.05 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 20.0 m -154.33 88.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.477 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.408 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.79 138.29 31.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.665 ' HB3' HD11 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.621 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.712 HD12 ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.534 HD12 HG21 ' D' ' 19' ' ' THR . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.94 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.76 ' O ' HD12 ' D' ' 23' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.729 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.76 HD12 ' O ' ' D' ' 19' ' ' THR . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.419 ' ND2' ' NE2' ' D' ' 35' ' ' HIS . 35.6 t30 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.92 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' HIS . . . . . 0.419 ' NE2' ' ND2' ' D' ' 31' ' ' ASN . 2.5 m-70 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.92 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.647 ' CE2' HG23 ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.486 HG22 ' O ' ' D' ' 43' ' ' THR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.749 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.647 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.45 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.768 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -81.4 -173.21 11.86 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 2.56 36.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.54 76.73 1.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.236 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.17 68.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.905 . . . . 0.0 109.401 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 102.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.06 -172.02 2.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 109.408 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.61 101.36 13.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.47 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.472 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.351 0.596 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.06 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.128 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.49 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER -72.61 111.57 7.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' E' ' 9' ' ' ASP . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.702 ' HB2' HG22 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.763 ' HD2' HG23 ' E' ' 19' ' ' THR . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.763 HG23 ' HD2' ' E' ' 10' ' ' TYR . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.941 ' OD2' HG21 ' E' ' 50' ' ' VAL . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.638 HD12 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.768 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.675 ' O ' HD12 ' E' ' 34' ' ' ILE . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.675 HD12 ' O ' ' E' ' 30' ' ' ILE . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' E' ' 55' ' ' VAL . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.839 ' O ' HD13 ' E' ' 44' ' ' ILE . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.839 HD13 ' O ' ' E' ' 43' ' ' THR . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.941 HG21 ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' HD12 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.622 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo -76.83 -179.32 26.91 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -89.62 139.7 30.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.814 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 142.95 36.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 0.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.49 27.31 16.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 58.6 2.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 72.8 p -99.44 74.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.45 ' O ' HG22 ' E' ' 65' ' ' THR . 66.6 m -112.27 62.47 0.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.495 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.406 ' O ' ' OE1' ' D' ' 2' ' ' GLU . 2.0 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' D' ' 1' ' ' MET . 2.7 tp10 -163.9 -74.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.45 ' O ' HD12 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.73 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.73 HD12 ' C ' ' D' ' 4' ' ' ARG . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.883 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.495 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 16' ' ' GLN . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' D' ' 11' ' ' ALA . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' D' ' 21' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' D' ' 14' ' ' PHE . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.687 HG21 ' CD1' ' D' ' 7' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.719 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.499 ' HG ' HG11 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.719 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.469 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HD1' ' D' ' 26' ' ' TYR . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.496 ' O ' HD12 ' D' ' 34' ' ' ILE . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.496 HD12 ' O ' ' D' ' 30' ' ' ILE . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.704 ' CD ' HD11 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.883 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.563 ' CD1' HD13 ' D' ' 5' ' ' ILE . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.499 HG11 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.433 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -82.12 -87.77 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.29 155.57 19.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.629 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.41 ' C ' ' HE3' ' D' ' 62' ' ' LYS . 19.9 m120 -155.33 167.56 29.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.534 ' HE3' ' N ' ' D' ' 62' ' ' LYS . 0.0 OUTLIER -139.31 81.15 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.51 173.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.71 60.63 2.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.409 HG22 ' H ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -120.41 -164.32 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.409 ' H ' HG22 ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' E' ' 1' ' ' MET . 2.1 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 62.43 108.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 -79.28 79.5 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.565 ' HE ' HG23 ' E' ' 43' ' ' THR . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' E' ' 9' ' ' ASP . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.682 ' HB2' HG22 ' E' ' 5' ' ' ILE . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.529 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.529 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.461 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.476 ' O ' HD12 ' E' ' 23' ' ' LEU . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.583 ' CB ' HG23 ' E' ' 25' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.759 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' E' ' 29' ' ' ALA . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' E' ' 25' ' ' VAL . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.496 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.565 HG23 ' HE ' ' E' ' 4' ' ' ARG . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.544 ' CG1' HD21 ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo -77.39 175.21 48.89 Favored 'Cis proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -82.52 -14.21 55.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.68 -179.21 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.545 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 123.84 12.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.772 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -148.29 63.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.52 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -103.88 37.32 2.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -159.72 0.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.392 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.295 0.569 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.1 112.28 19.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 1.014 ' O ' HD13 ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 1.014 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.405 ' H ' HG22 ' D' ' 5' ' ' ILE . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.68 HD11 HG23 ' D' ' 30' ' ' ILE . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' D' ' 8' ' ' LYS . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.618 ' HD2' HG23 ' D' ' 19' ' ' THR . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.683 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.683 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.618 HG23 ' HD2' ' D' ' 10' ' ' TYR . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.593 HD12 ' O ' ' D' ' 19' ' ' THR . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.68 HG23 HD11 ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' D' ' 7' ' ' LEU . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.556 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.801 HD11 HG13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' D' ' 23' ' ' LEU . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.71 HG23 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.556 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.647 ' CE1' HD22 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo -76.62 -160.31 2.27 Favored 'Cis proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t -64.0 167.93 5.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' D' ' 62' ' ' LYS . 14.3 p30 -97.51 -158.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.397 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' D' ' 61' ' ' ASN . 1.6 mttp -86.84 140.73 29.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.26 141.83 21.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.947 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -146.13 -87.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.458 HG22 ' O ' ' D' ' 65' ' ' THR . 21.8 m -115.24 43.78 1.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.53 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.8 173.47 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.481 ' O ' HD12 ' E' ' 44' ' ' ILE . 28.2 mt-30 -79.81 111.4 16.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG21 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.489 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.549 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.549 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.599 HG23 ' N ' ' E' ' 18' ' ' LYS . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.599 ' N ' HG23 ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.868 HG21 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.831 ' HB3' HG21 ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.784 ' HG ' HG11 ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.72 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 HG21 ' E' ' 34' ' ' ILE . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.557 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.41 HD13 ' HB1' ' E' ' 33' ' ' ALA . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.735 ' CD2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.573 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.481 HD12 ' O ' ' E' ' 3' ' ' GLN . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' E' ' 59' ' ' PRO . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo -78.86 -162.01 2.87 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -90.02 -13.52 35.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.36 -170.69 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 139.92 30.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 -159.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.212 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.61 142.34 29.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.473 ' O ' HG23 ' E' ' 65' ' ' THR . 15.3 t -115.38 129.81 56.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.373 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 -61.91 170.68 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.828 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.544 ' C ' HD12 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.57 HD12 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.542 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' D' ' 19' ' ' THR . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' D' ' 13' ' ' ARG . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' D' ' 12' ' ' MET . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.845 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.827 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.845 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.494 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.401 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.828 HD12 ' O ' ' D' ' 3' ' ' GLN . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.535 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo -82.76 -6.74 48.83 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -53.49 154.36 3.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.55 -156.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -107.87 178.66 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 109.386 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -81.97 -70.16 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 41.63 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.43 149.19 23.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.401 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 131.93 45.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.73 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 109.551 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.698 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.742 HG21 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.5 ' CB ' HG22 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.5 HG22 ' CB ' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' E' ' 8' ' ' LYS . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.575 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.684 ' CE1' HG23 ' E' ' 55' ' ' VAL . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.461 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.676 ' CZ ' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo -76.83 -160.22 2.26 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -46.56 -27.37 1.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -116.86 141.09 48.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.63 26.81 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.159 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 63' ' ' LYS . . . . . 0.468 ' O ' HG23 ' E' ' 64' ' ' THR . 0.3 OUTLIER -176.59 -72.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.376 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 64' ' ' THR . . . . . 0.468 HG23 ' O ' ' E' ' 63' ' ' LYS . 44.8 p -157.16 -171.77 3.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.547 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.407 ' O ' ' O ' ' E' ' 66' ' ' ALA . 1.8 m -85.51 75.36 10.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.297 0.57 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -117.08 103.97 10.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 1.025 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 1.025 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 1.003 ' HB2' HD13 ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.586 ' HA ' HD11 ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.659 ' O ' HD12 ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.659 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' D' ' 20' ' ' ALA . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' D' ' 38' ' ' ARG . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.845 ' HD2' ' HB1' ' D' ' 36' ' ' ALA . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.565 HG11 ' HG ' ' D' ' 23' ' ' LEU . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.555 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.745 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -77.13 -179.3 26.85 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 31.5 m -89.99 173.04 8.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' D' ' 61' ' ' ASN . 35.7 p30 -139.15 26.06 2.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.682 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.64 28.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.444 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 95.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.673 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -89.73 161.28 16.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.274 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -171.18 2.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.308 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.261 0.553 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.61 93.54 3.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -90.31 117.83 29.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.84 . . . . 0.0 110.031 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.471 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.643 HG23 ' O ' ' E' ' 40' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.949 ' HB2' HD13 ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' E' ' 19' ' ' THR . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.52 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' E' ' 14' ' ' PHE . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.672 HG21 ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.745 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' E' ' 20' ' ' ALA . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.633 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.592 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.643 ' O ' HG23 ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 1.13 HD12 ' HB2' ' E' ' 52' ' ' ALA . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 1.13 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.664 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.593 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.593 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -79.53 -158.99 1.86 Allowed 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 16.7 m -83.49 -147.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.311 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' E' ' 62' ' ' LYS . 8.3 p-10 -104.68 173.76 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 62' ' ' LYS . . . . . 0.464 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 0.1 OUTLIER -83.78 175.38 9.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 63' ' ' LYS . . . . . 0.46 ' O ' HG23 ' E' ' 64' ' ' THR . 0.0 OUTLIER -178.54 175.14 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.372 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 64' ' ' THR . . . . . 0.46 HG23 ' O ' ' E' ' 63' ' ' LYS . 1.1 p -154.82 123.97 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -138.57 82.6 1.91 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.196 -0.94 . . . . 0.0 109.38 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.271 0.558 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 -103.4 136.17 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.434 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.673 HG22 ' H ' ' D' ' 6' ' ' THR . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.673 ' H ' HG22 ' D' ' 5' ' ' ILE . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.634 HD11 HG23 ' D' ' 30' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.578 ' CD1' HG23 ' D' ' 19' ' ' THR . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.569 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.569 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 4.3 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.61 HG22 HD12 ' D' ' 23' ' ' LEU . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.703 ' HG ' HG11 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' D' ' 20' ' ' ALA . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.583 ' CD2' HG21 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' D' ' 7' ' ' LEU . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.703 HG11 ' HG ' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' E' ' 57' ' ' PRO . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 1.047 ' CG1' HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -80.16 176.82 39.36 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.6 t -89.96 -66.92 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.176 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.88 149.91 20.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.312 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -100.55 42.05 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.03 34.51 0.82 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.404 HG22 ' O ' ' D' ' 64' ' ' THR . 19.9 m -98.0 48.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.77 90.37 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.428 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.67 166.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.2 110.24 18.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.26 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 1.064 ' O ' HD13 ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 1.064 HD13 ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' E' ' 42' ' ' LEU . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.523 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.45 ' H ' HG22 ' E' ' 17' ' ' THR . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.677 ' O ' HD12 ' E' ' 23' ' ' LEU . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.677 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.549 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.549 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' E' ' 8' ' ' LYS . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.468 HD13 ' HB1' ' E' ' 33' ' ' ALA . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.741 HG22 ' O ' ' E' ' 51' ' ' TYR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.692 HD11 HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.741 ' O ' HG22 ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.5 ' O ' HG12 ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 1.047 HG13 ' CG1' ' D' ' 55' ' ' VAL . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.26 150.33 81.08 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -90.2 25.04 2.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 0.0 109.797 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -98.61 166.43 11.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' E' ' 63' ' ' LYS . 5.9 mtpp -82.55 170.71 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 63' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' E' ' 62' ' ' LYS . 25.0 tptt 65.62 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -111.82 118.01 34.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.56 158.89 16.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.551 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.519 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -119.71 136.01 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.775 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.775 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.655 HD11 HD12 ' D' ' 30' ' ' ILE . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.567 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.456 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.643 HG21 ' CD1' ' D' ' 7' ' ' LEU . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' E' ' 58' ' ' PHE . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.655 HD12 HD11 ' D' ' 7' ' ' LEU . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' D' ' 34' ' ' ILE . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.508 ' CG ' HG13 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.762 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.533 HG23 ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.533 ' O ' HG23 ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.643 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.479 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -79.04 175.23 47.19 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 18.9 t -81.08 166.01 21.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.235 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -141.94 168.04 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 33.87 16.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.568 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 64' ' ' THR . 10.3 ptmt -81.39 -34.7 31.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.519 ' N ' ' HG3' ' D' ' 63' ' ' LYS . 0.2 OUTLIER -103.27 85.29 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 109.494 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -94.25 130.49 40.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.536 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -114.32 177.87 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.569 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 107.03 6.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.188 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.924 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.924 HD13 ' C ' ' E' ' 4' ' ' ARG . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.926 HD11 HD12 ' E' ' 30' ' ' ILE . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.502 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.598 ' CB ' HG22 ' E' ' 5' ' ' ILE . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.568 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.696 ' O ' HD12 ' E' ' 23' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.975 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.696 HD12 ' O ' ' E' ' 19' ' ' THR . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.926 HD12 HD11 ' E' ' 7' ' ' LEU . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.558 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.558 HD13 ' HB1' ' E' ' 33' ' ' ALA . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.533 HD12 HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.975 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.497 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -78.53 169.58 72.25 Favored 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 99.9 p -89.66 -161.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.87 76.21 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -134.62 138.88 44.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 90.03 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -127.64 161.29 29.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 109.311 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.678 ' O ' ' HB2' ' E' ' 66' ' ' ALA . 7.8 t -123.57 159.0 30.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.327 0.584 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -47.97 114.67 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.705 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.507 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' D' ' 19' ' ' THR . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.536 ' HB3' HG21 ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 17' ' ' THR . . . . . 0.486 HG23 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.992 ' O ' HD12 ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.992 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.74 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.74 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 20' ' ' ALA . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.54 HD11 ' HG ' ' D' ' 7' ' ' LEU . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.512 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' HG22 ' D' ' 43' ' ' THR . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.519 HG12 HD21 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo -75.87 156.29 98.87 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 41.7 t -73.88 118.9 17.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -141.82 -173.47 3.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.226 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' D' ' 63' ' ' LYS . 2.2 mtmt -96.06 82.99 3.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' D' ' 62' ' ' LYS . 2.3 mttt 42.96 50.68 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 127.87 39.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.986 . . . . 0.0 109.314 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -154.98 101.19 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.532 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 2' ' ' GLU . . . . . 0.408 ' HG2' ' CG ' ' E' ' 4' ' ' ARG . 10.2 tt0 -144.99 84.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.497 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.2 OUTLIER -86.4 81.71 8.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.902 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.55 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.55 HD12 ' C ' ' E' ' 4' ' ' ARG . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.45 ' N ' HG22 ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD13 ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.603 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.446 HG23 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' E' ' 14' ' ' PHE . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.603 HG23 ' CD2' ' E' ' 10' ' ' TYR . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.768 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.942 ' HB3' HG21 ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.548 ' O ' HD12 ' E' ' 30' ' ' ILE . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.768 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo -78.3 162.21 89.09 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -75.24 134.76 41.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.388 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' E' ' 62' ' ' LYS . 1.8 p-10 -113.01 120.9 42.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.613 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 62' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' E' ' 61' ' ' ASN . 1.1 tptt -153.26 130.03 10.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.88 144.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 64' ' ' THR . . . . . 0.439 ' O ' HG23 ' E' ' 64' ' ' THR . 1.3 t -151.36 98.96 2.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.522 HG22 ' N ' ' E' ' 66' ' ' ALA . 16.7 m -133.47 162.02 33.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.541 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -153.21 19.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.835 ' HA ' HD22 ' D' ' 42' ' ' LEU . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.535 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.517 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.95 ' O ' HD12 ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.906 ' HB2' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' D' ' 50' ' ' VAL . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.95 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' E' ' 58' ' ' PHE . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.403 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.906 ' CD1' ' HB2' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.894 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.447 HD12 ' O ' ' D' ' 30' ' ' ILE . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.894 HD12 ' HB1' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.835 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.79 HG11 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' E' ' 58' ' ' PHE . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' E' ' 25' ' ' VAL . 36.6 Cg_endo -81.21 -84.79 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.99 174.06 8.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.452 ' HB2' ' HG2' ' D' ' 57' ' ' PRO . 4.2 t30 -139.14 151.26 46.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.291 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.45 23.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.07 -159.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 8.3 t -90.37 12.21 19.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -100.31 94.03 5.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.602 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.585 179.899 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -171.23 -175.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.379 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.522 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 -87.64 58.49 4.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.13 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.808 ' C ' HD12 ' E' ' 5' ' ' ILE . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.813 HD13 HD11 ' E' ' 44' ' ' ILE . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.643 ' HA ' HD22 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.689 ' HB2' HG22 ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.958 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.958 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.527 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.903 ' O ' HD12 ' E' ' 23' ' ' LEU . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.679 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.85 ' HB3' HG21 ' E' ' 50' ' ' VAL . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.903 HD12 ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.701 HG22 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.702 ' O ' HD12 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.702 HD12 ' O ' ' E' ' 30' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' E' ' 38' ' ' ARG . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.47 ' HD3' ' HB1' ' E' ' 36' ' ' ALA . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.713 ' CE1' HG23 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.813 HD11 HD13 ' E' ' 5' ' ' ILE . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 7.8 m120 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.85 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.48 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.713 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' D' ' 25' ' ' VAL . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo -80.62 -162.8 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.1 m -82.81 -25.17 32.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.905 . . . . 0.0 109.116 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.47 100.42 10.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 109.064 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -110.02 119.7 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 160.93 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.113 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -115.58 75.78 0.97 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.075 -1.016 . . . . 0.0 109.631 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.459 ' O ' HG22 ' E' ' 65' ' ' THR . 17.9 m -142.18 39.99 1.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.421 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -98.07 85.6 3.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' D' ' 19' ' ' THR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 30.2 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' THR . . . . . 0.57 HG23 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.806 ' O ' HD12 ' D' ' 23' ' ' LEU . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.81 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.812 HD21 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' D' ' 20' ' ' ALA . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 27' ' ' GLN . . . . . 0.57 ' NE2' HG23 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.714 ' CG1' ' HB2' ' D' ' 20' ' ' ALA . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.576 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.576 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.447 ' H ' HD12 ' D' ' 44' ' ' ILE . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.812 ' CG1' HD21 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.55 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.588 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo -80.51 153.01 83.65 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.01 167.59 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.593 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' D' ' 62' ' ' LYS . 10.3 t30 -94.17 119.47 33.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' D' ' 61' ' ' ASN . 0.3 OUTLIER 172.24 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.662 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -113.08 -176.94 3.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.472 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.31 83.96 0.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 109.568 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.64 151.1 26.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.403 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.264 0.554 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.43 99.2 6.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER -82.09 118.23 22.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.592 ' CD1' HG21 ' E' ' 19' ' ' THR . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.588 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.521 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.928 ' O ' HD12 ' E' ' 23' ' ' LEU . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.928 HD12 ' O ' ' E' ' 19' ' ' THR . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.759 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 27' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' E' ' 27' ' ' GLN . 6.7 mm100 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' E' ' 34' ' ' ILE . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.808 ' CE1' HG23 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.707 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.707 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.808 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.507 ' HE2' ' CB ' ' E' ' 60' ' ' SER . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG11 ' D' ' 25' ' ' VAL . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.71 122.75 8.81 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 60' ' ' SER . . . . . 0.507 ' CB ' ' HE2' ' E' ' 56' ' ' LYS . 74.9 p -58.93 177.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 24.9 p30 -111.93 151.36 29.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 59.34 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -117.14 28.46 8.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.72 120.5 38.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' E' ' 66' ' ' ALA . 27.6 m -121.77 35.04 4.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.513 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.243 0.544 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' D' ' 1' ' ' MET . 1.2 pt-20 164.78 86.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.677 ' O ' HD12 ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.936 ' O ' HD13 ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.936 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HA ' HD22 ' D' ' 42' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.736 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.895 ' O ' HD12 ' D' ' 23' ' ' LEU . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.678 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.895 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' D' ' 20' ' ' ALA . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.476 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.669 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 34' ' ' ILE . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.842 ' HD3' HD11 ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.842 HD11 ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.677 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 4.3 m-20 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.442 ' OE1' HG23 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo -77.33 -179.22 26.54 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.1 p -54.02 174.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 109.641 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -125.29 138.36 54.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.35 100.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.433 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.94 42.06 2.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -113.9 157.19 22.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.18 36.72 4.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.463 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.4 ' HG2' ' HG3' ' E' ' 2' ' ' GLU . 1.9 ttp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 2' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' E' ' 1' ' ' MET . 9.5 mt-10 -119.64 81.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' E' ' 5' ' ' ILE . 1.6 tt0 -86.25 113.55 22.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.935 HD12 HG21 ' E' ' 19' ' ' THR . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' E' ' 5' ' ' ILE . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.578 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 15' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.578 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 28.9 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.935 HG21 HD12 ' E' ' 7' ' ' LEU . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.96 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.442 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.442 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.96 HG13 ' HB2' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.479 ' O ' ' CG ' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 35' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' E' ' 31' ' ' ASN . 0.3 OUTLIER -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' E' ' 55' ' ' VAL . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.789 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.576 HG11 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.677 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' E' ' 60' ' ' SER . 35.4 Cg_endo -78.57 -168.75 7.24 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 60' ' ' SER . . . . . 0.456 ' O ' ' O ' ' E' ' 59' ' ' PRO . 92.5 p -57.48 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.59 64.61 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -51.03 161.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.346 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt 57.51 34.81 25.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -80.74 158.93 25.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 109.488 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.572 ' O ' HG23 ' E' ' 65' ' ' THR . 13.2 t -93.22 48.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.461 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tmm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.94 -178.55 0.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.385 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.724 ' O ' HD12 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.825 ' C ' HD12 ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.825 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' D' ' 42' ' ' LEU . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.544 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.602 ' CD2' HG23 ' D' ' 19' ' ' THR . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.803 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.623 HG21 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' D' ' 50' ' ' VAL . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.75 ' HG ' HG11 ' D' ' 50' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.573 ' O ' HD12 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.573 HD12 ' O ' ' D' ' 30' ' ' ILE . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.424 HD12 ' HB1' ' D' ' 33' ' ' ALA . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' D' ' 55' ' ' VAL . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.724 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 3.2 m120 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.75 HG11 ' HG ' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.642 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.504 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -78.66 174.65 50.24 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -89.87 42.86 1.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.336 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -126.08 59.0 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.63 168.46 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -138.92 178.62 7.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.5 p -115.11 119.76 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -111.53 146.24 37.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' E' ' 2' ' ' GLU . 1.5 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.295 0.569 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 2' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' E' ' 1' ' ' MET . 6.7 mt-10 -149.54 129.5 13.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.484 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.0 OUTLIER -76.48 110.69 11.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.138 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.442 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.721 ' N ' HD12 ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.663 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.663 ' HG1' ' HD1' ' E' ' 10' ' ' TYR . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.857 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' E' ' 24' ' ' GLY . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.543 HD12 ' O ' ' E' ' 30' ' ' ILE . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.621 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.62 ' C ' HD13 ' E' ' 44' ' ' ILE . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.79 ' N ' HD13 ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.621 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.559 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -81.0 -86.1 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 165.83 23.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -124.84 131.76 53.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 158.88 5.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 109.561 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.28 98.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 61.9 m -99.53 151.42 21.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.26 163.74 15.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.504 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.471 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.479 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 32.3 mtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.327 0.584 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.564 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER 74.73 140.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.245 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.564 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.534 HG21 ' HE3' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.691 ' HA ' HD22 ' D' ' 42' ' ' LEU . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.557 ' CB ' HG23 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.764 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' D' ' 50' ' ' VAL . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.764 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.426 ' HB3' HG12 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' D' ' 20' ' ' ALA . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.519 ' CD2' HG23 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.645 HG21 ' HB3' ' D' ' 22' ' ' ASP . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.576 HG13 HG13 ' E' ' 55' ' ' VAL . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.488 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -80.22 -22.22 16.31 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.8 p -43.46 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 0.0 110.234 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' D' ' 59' ' ' PRO . 6.8 m-80 -160.73 28.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.13 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.1 -175.03 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.849 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 -161.24 1.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.544 HG22 ' N ' ' D' ' 65' ' ' THR . 19.3 m -104.58 -88.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.544 ' N ' HG22 ' D' ' 64' ' ' THR . 0.7 OUTLIER -93.97 38.4 1.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.416 -179.882 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' E' ' 1' ' ' MET . 13.3 ptt? . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.309 0.576 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.3 115.46 6.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.465 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.421 ' HB3' HD12 ' E' ' 44' ' ' ILE . 5.1 mt-30 -78.52 78.97 4.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.591 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.591 HD12 ' C ' ' E' ' 4' ' ' ARG . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD22 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 15' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.547 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.607 HG22 HD12 ' E' ' 23' ' ' LEU . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' E' ' 30' ' ' ILE . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.609 ' CB ' HG21 ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.607 HD12 HG22 ' E' ' 19' ' ' THR . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.692 ' CG1' ' HB2' ' E' ' 20' ' ' ALA . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.723 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 26.3 m120 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.879 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo -78.63 144.81 75.38 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 60' ' ' SER . . . . . 0.482 ' HB3' ' HE3' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -89.73 -65.61 1.0 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 6.8 p30 -146.57 69.51 1.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.895 . . . . 0.0 109.565 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 117.24 28.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.08 71.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.31 76.9 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.97 106.83 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.5 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.839 ' HG3' ' HB2' ' D' ' 46' ' ' ALA . 11.5 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 2' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 1' ' ' MET . 1.9 pt-20 177.06 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' D' ' 5' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.52 ' NE ' HG23 ' D' ' 43' ' ' THR . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.607 HD11 ' OE1' ' D' ' 3' ' ' GLN . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.614 ' HA ' HD22 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.798 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.798 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 2.2 mt-30 -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.602 HG22 HD12 ' D' ' 23' ' ' LEU . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.626 HD21 ' CG1' ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.604 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.504 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.879 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.65 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.52 HG23 ' NE ' ' D' ' 4' ' ' ARG . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.681 HD13 ' N ' ' D' ' 44' ' ' ILE . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.839 ' HB2' ' HG3' ' D' ' 1' ' ' MET . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.626 ' CG1' HD21 ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.65 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 1.06 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo -80.07 172.14 59.08 Favored 'Cis proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -49.6 -23.32 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.45 167.32 20.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' D' ' 63' ' ' LYS . 46.3 mttt -137.64 109.04 6.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.669 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 63' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' D' ' 62' ' ' LYS . 0.7 OUTLIER 43.05 -149.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -140.48 146.72 38.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.427 ' O ' ' O ' ' D' ' 66' ' ' ALA . 6.7 m -128.86 116.34 19.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.423 ' O ' ' N ' ' E' ' 3' ' ' GLN . 2.9 mtm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -58.03 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.965 . . . . 0.0 109.567 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.664 ' O ' HD12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER -69.64 100.82 1.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 1.013 ' O ' HD13 ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 1.013 HD13 ' O ' ' E' ' 4' ' ' ARG . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' E' ' 19' ' ' THR . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' E' ' 34' ' ' ILE . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.443 ' O ' HD12 ' E' ' 30' ' ' ILE . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.7 HG21 ' CD1' ' E' ' 7' ' ' LEU . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.863 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 1.01 HD21 HG12 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 1.06 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.703 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 43' ' ' THR . . . . . 0.746 HG23 ' NE ' ' E' ' 4' ' ' ARG . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.664 HD12 ' O ' ' E' ' 3' ' ' GLN . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 1.01 HG12 HD21 ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' E' ' 58' ' ' PHE . 35.1 Cg_endo -79.64 175.55 44.88 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -62.07 -173.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' E' ' 62' ' ' LYS . 10.7 p30 -91.56 158.39 16.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 62' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' E' ' 61' ' ' ASN . 0.0 OUTLIER -43.35 122.93 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.48 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -137.53 113.27 9.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.45 67.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.371 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 65' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' E' ' 66' ' ' ALA . 0.1 OUTLIER -123.13 89.24 3.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.547 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.55 100.65 5.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLN . . . . . 0.53 ' O ' HD12 ' D' ' 44' ' ' ILE . 26.9 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.614 ' C ' HD13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.614 HD13 ' C ' ' D' ' 4' ' ' ARG . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.762 HD12 ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.557 ' HD1' ' HG1' ' D' ' 19' ' ' THR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.712 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.557 ' HG1' ' HD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.732 ' HG ' HG11 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.403 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.72 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.53 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.732 HG11 ' HG ' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.584 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.584 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo -79.43 -176.61 18.8 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 20.4 p -55.02 -58.09 9.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.196 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.37 -168.89 2.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -139.07 -159.98 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -93.59 -162.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.384 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 63.44 1.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.579 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -153.76 72.78 0.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.879 -1.058 . . . . 0.0 109.475 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' E' ' 1' ' ' MET . 8.4 tpt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 2' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' E' ' 4' ' ' ARG . 58.9 mt-10 -143.84 61.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.457 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 -44.99 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' E' ' 2' ' ' GLU . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.566 HD13 HD11 ' E' ' 44' ' ' ILE . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.735 ' HA ' HD22 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.553 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.525 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.773 ' O ' HD12 ' E' ' 23' ' ' LEU . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.773 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.553 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.553 HD13 ' HB1' ' E' ' 33' ' ' ALA . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.566 HD11 HD13 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' E' ' 61' ' ' ASN . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 36.2 Cg_endo -79.0 3.62 30.93 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 60' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' E' ' 56' ' ' LYS . 1.1 t -43.24 110.13 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 61' ' ' ASN . . . . . 0.487 ' HA ' ' HE2' ' E' ' 56' ' ' LYS . 78.0 m-20 -121.81 -167.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -48.58 119.15 2.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -81.62 164.15 22.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -97.73 106.33 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.487 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 11.0 t -158.99 158.24 32.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.391 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.36 -177.7 6.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.601 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.661 ' C ' HD12 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.661 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HA ' HD22 ' D' ' 42' ' ' LEU . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' D' ' 19' ' ' THR . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 12' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.899 ' O ' HD12 ' D' ' 23' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.617 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.899 HD12 ' O ' ' D' ' 19' ' ' THR . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.463 ' H ' HG22 ' D' ' 25' ' ' VAL . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 1.127 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 1.127 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.486 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.599 ' HE1' HG11 ' E' ' 25' ' ' VAL . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 59' ' ' PRO . . . . . 0.58 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -81.37 -161.67 2.71 Favored 'Cis proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.74 158.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.79 47.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp 53.23 78.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.212 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -110.79 146.63 36.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.763 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 37.8 p -127.59 128.42 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.0 -168.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.432 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -91.53 159.13 16.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.441 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.7 mt-30 -84.77 118.87 24.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.247 -0.908 . . . . 0.0 109.165 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.467 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.594 HD13 HD13 ' E' ' 44' ' ' ILE . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' E' ' 34' ' ' ILE . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 12' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 17' ' ' THR . . . . . 0.621 HG23 HE21 ' E' ' 27' ' ' GLN . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 18' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.488 HG23 ' CD1' ' E' ' 10' ' ' TYR . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.931 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.501 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 27' ' ' GLN . . . . . 0.621 HE21 HG23 ' E' ' 17' ' ' THR . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 28' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.931 HG13 ' HB2' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.56 HD11 ' CB ' ' E' ' 11' ' ' ALA . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.516 ' HE3' ' HD2' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 40' ' ' ILE . . . . . 0.498 HG21 HD22 ' E' ' 7' ' ' LEU . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.905 HG23 ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.905 ' O ' HG23 ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.516 ' HD2' ' HE3' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.487 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.665 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.65 -162.75 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -79.53 104.77 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -144.83 47.65 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 62' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' E' ' 63' ' ' LYS . 0.1 OUTLIER -138.98 166.33 24.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.59 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 63' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' E' ' 62' ' ' LYS . 0.0 OUTLIER -164.83 34.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.04 136.07 40.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -155.24 109.57 2.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.626 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.16 164.35 30.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 4' ' ' ARG . . . . . 0.479 ' C ' HD12 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' D' ' 9' ' ' ASP . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 7' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' D' ' 42' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.671 ' HA ' HD11 ' D' ' 34' ' ' ILE . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 10' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' D' ' 19' ' ' THR . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.617 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 19' ' ' THR . . . . . 0.773 HG23 ' CD2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 22' ' ' ASP . . . . . 0.791 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.679 HG11 ' HE1' ' E' ' 58' ' ' PHE . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.897 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 34' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' D' ' 8' ' ' LYS . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.817 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' LYS . . . . . 0.585 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' ILE . . . . . 0.56 HD13 ' HB1' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.872 HD12 ' HB2' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 43' ' ' THR . . . . . 0.576 HG23 ' O ' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 3.9 m120 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.791 HG21 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 51' ' ' TYR . . . . . 0.569 ' O ' HG22 ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 54' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 57' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' PHE . . . . . 0.83 ' CE2' ' HB1' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.36 -169.05 7.49 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.09 115.51 4.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -111.36 -171.77 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.56 149.1 40.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.9 . . . . 0.0 109.587 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -99.18 -173.62 2.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.333 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.97 88.65 4.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.46 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.77 41.38 3.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.478 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.328 0.585 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.86 35.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -60.8 96.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.555 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 5' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 6' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 7' ' ' LEU . . . . . 0.799 ' CD1' HG21 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 8' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 9' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG23 ' E' ' 19' ' ' THR . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.744 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.744 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.799 HG21 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.779 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 22' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.637 HG12 ' H ' ' E' ' 26' ' ' TYR . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 26' ' ' TYR . . . . . 0.637 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 28' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' E' ' 26' ' ' TYR . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 30' ' ' ILE . . . . . 0.779 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 31' ' ' ASN . . . . . 0.541 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 0.7 OUTLIER -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 32' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 35' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 44' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 53' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 54' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 56' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 58' ' ' PHE . . . . . 0.679 ' HE1' HG11 ' D' ' 25' ' ' VAL . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -81.81 -166.57 5.16 Favored 'Cis proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 60' ' ' SER . . . . . 0.433 ' O ' ' O ' ' E' ' 59' ' ' PRO . 87.2 p -47.35 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.672 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -111.77 116.85 31.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -141.41 38.33 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.75 116.97 26.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 11.77 26.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.267 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.07 111.92 8.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.482 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.45 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.627 ' HA ' HD22 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.658 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' D' ' 19' ' ' THR . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.84 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.84 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 65.0 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.587 HG23 ' CD2' ' D' ' 10' ' ' TYR . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' D' ' 29' ' ' ALA . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.564 HD12 HD11 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.595 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.465 HG22 ' O ' ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.557 HG23 ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.557 ' O ' HG23 ' D' ' 44' ' ' ILE . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.587 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.675 ' CE1' HG11 ' E' ' 25' ' ' VAL . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.683 ' HG3' HG12 ' E' ' 25' ' ' VAL . 36.6 Cg_endo . . . . . 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.825 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.825 HD13 ' C ' ' E' ' 4' ' ' ARG . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.63 ' HA ' HD22 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.457 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.698 ' HB2' HG22 ' E' ' 5' ' ' ILE . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.567 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.622 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.669 ' O ' HD12 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 1.043 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.669 HD12 ' O ' ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' E' ' 7' ' ' LEU . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.741 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.468 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.585 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.506 ' O ' HD12 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.572 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.572 HD12 ' C ' ' D' ' 4' ' ' ARG . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.66 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.542 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.593 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' D' ' 18' ' ' LYS . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.593 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.683 ' O ' HD12 ' D' ' 23' ' ' LEU . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.867 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.785 HG13 ' HB2' ' D' ' 20' ' ' ALA . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.546 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.782 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.694 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.506 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.694 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.546 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.483 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.417 ' HB3' HD12 ' E' ' 44' ' ' ILE . 3.6 mt-30 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.394 0.616 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.445 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' E' ' 9' ' ' ASP . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.46 HG21 ' HE2' ' E' ' 8' ' ' LYS . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.553 HD13 HD11 ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' E' ' 6' ' ' THR . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.434 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.523 HG21 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.617 ' O ' HD12 ' E' ' 34' ' ' ILE . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.466 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.617 HD12 ' O ' ' E' ' 30' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 22.8 m-70 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.458 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' E' ' 7' ' ' LEU . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.564 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.725 ' HB3' HG13 ' D' ' 25' ' ' VAL . 36.1 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.222 0.534 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 1.043 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 1.043 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.509 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.628 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 1.017 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 1.017 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.628 HG23 ' HD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.8 ' HB2' HD13 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.851 ' HB3' HG21 ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.504 HD12 ' O ' ' D' ' 19' ' ' THR . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.572 HG23 HD11 ' D' ' 30' ' ' ILE . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.653 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' D' ' 31' ' ' ASN . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 0.2 OUTLIER -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.445 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.432 HD11 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.686 HG23 ' NE ' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 0.7 OUTLIER -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.866 ' HZ ' HG11 ' E' ' 25' ' ' VAL . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' E' ' 23' ' ' LEU . 36.5 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.41 ' HB3' HD11 ' E' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.174 0.512 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.464 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' E' ' 5' ' ' ILE . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' E' ' 19' ' ' THR . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.479 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.439 ' CE ' HG21 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.766 HG21 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.722 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.674 HD12 ' O ' ' E' ' 19' ' ' THR . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.866 HG11 ' HZ ' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.559 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 50.7 t30 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.816 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.444 HD12 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 6.4 m170 -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.816 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' E' ' 7' ' ' LEU . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.64 HG11 ' HG ' ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 55' ' ' VAL . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.29 0.567 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.665 ' HB3' HD11 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.621 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.712 HD12 ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.534 HD12 HG21 ' D' ' 19' ' ' THR . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.94 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.76 ' O ' HD12 ' D' ' 23' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.729 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.76 HD12 ' O ' ' D' ' 19' ' ' THR . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.481 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 20.9 t-20 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.92 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.481 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 17.0 m170 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.92 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.647 ' CE2' HG23 ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.486 HG22 ' O ' ' D' ' 43' ' ' THR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.749 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.647 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.45 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.768 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.49 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.342 0.591 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' E' ' 9' ' ' ASP . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.702 ' HB2' HG22 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.763 ' HD2' HG23 ' E' ' 19' ' ' THR . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.763 HG23 ' HD2' ' E' ' 10' ' ' TYR . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.941 ' OD2' HG21 ' E' ' 50' ' ' VAL . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.638 HD12 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.768 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.675 ' O ' HD12 ' E' ' 34' ' ' ILE . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.675 HD12 ' O ' ' E' ' 30' ' ' ILE . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' E' ' 55' ' ' VAL . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.839 ' O ' HD13 ' E' ' 44' ' ' ILE . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.839 HD13 ' O ' ' E' ' 43' ' ' THR . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.941 HG21 ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' HD12 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.622 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo . . . . . 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.312 0.577 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.45 ' O ' HD12 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.73 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.73 HD12 ' C ' ' D' ' 4' ' ' ARG . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.883 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.495 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 16' ' ' GLN . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' D' ' 11' ' ' ALA . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' D' ' 21' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' D' ' 14' ' ' PHE . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.687 HG21 ' CD1' ' D' ' 7' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.719 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.499 ' HG ' HG11 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.719 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.469 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . 0.495 ' O ' ' ND2' ' D' ' 31' ' ' ASN . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HD1' ' D' ' 26' ' ' TYR . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.496 ' O ' HD12 ' D' ' 34' ' ' ILE . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' D' ' 27' ' ' GLN . 80.8 m-20 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.496 HD12 ' O ' ' D' ' 30' ' ' ILE . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.704 ' CD ' HD11 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.883 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.563 ' CD1' HD13 ' D' ' 5' ' ' ILE . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.499 HG11 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.433 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.294 0.569 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.565 ' HE ' HG23 ' E' ' 43' ' ' THR . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' E' ' 9' ' ' ASP . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.682 ' HB2' HG22 ' E' ' 5' ' ' ILE . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.529 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.529 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.461 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.476 ' O ' HD12 ' E' ' 23' ' ' LEU . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.583 ' CB ' HG23 ' E' ' 25' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.759 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' E' ' 29' ' ' ALA . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' E' ' 25' ' ' VAL . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.496 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.565 HG23 ' HE ' ' E' ' 4' ' ' ARG . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.544 ' CG1' HD21 ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 1.014 ' O ' HD13 ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 1.014 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.405 ' H ' HG22 ' D' ' 5' ' ' ILE . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.68 HD11 HG23 ' D' ' 30' ' ' ILE . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' D' ' 8' ' ' LYS . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.618 ' HD2' HG23 ' D' ' 19' ' ' THR . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.683 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.683 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.618 HG23 ' HD2' ' D' ' 10' ' ' TYR . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.593 HD12 ' O ' ' D' ' 19' ' ' THR . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.68 HG23 HD11 ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' D' ' 7' ' ' LEU . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.556 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.801 HD11 HG13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' D' ' 23' ' ' LEU . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.71 HG23 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.556 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.647 ' CE1' HD22 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.481 ' O ' HD12 ' E' ' 44' ' ' ILE . 9.3 mt-30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG21 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.489 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.549 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.549 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.599 HG23 ' N ' ' E' ' 18' ' ' LYS . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.599 ' N ' HG23 ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.868 HG21 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.831 ' HB3' HG21 ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.784 ' HG ' HG11 ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.72 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . 0.476 ' NE2' ' HB ' ' E' ' 17' ' ' THR . 65.4 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 HG21 ' E' ' 34' ' ' ILE . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.557 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.41 HD13 ' HB1' ' E' ' 33' ' ' ALA . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.735 ' CD2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.573 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.481 HD12 ' O ' ' E' ' 3' ' ' GLN . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' E' ' 59' ' ' PRO . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo . . . . . 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.828 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.544 ' C ' HD12 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.57 HD12 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.542 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' D' ' 19' ' ' THR . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' D' ' 13' ' ' ARG . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' D' ' 12' ' ' MET . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.845 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.827 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.845 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.494 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.401 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.828 HD12 ' O ' ' D' ' 3' ' ' GLN . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.535 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo . . . . . 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.698 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.742 HG21 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.5 ' CB ' HG22 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.5 HG22 ' CB ' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' E' ' 8' ' ' LYS . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.575 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.684 ' CE1' HG23 ' E' ' 55' ' ' VAL . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.461 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.676 ' CZ ' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo . . . . . 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 1.025 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 1.025 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 1.003 ' HB2' HD13 ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.586 ' HA ' HD11 ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.466 HE21 HG22 ' D' ' 30' ' ' ILE . 17.6 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.659 ' O ' HD12 ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.659 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' D' ' 20' ' ' ALA . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' D' ' 38' ' ' ARG . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.845 ' HD2' ' HB1' ' D' ' 36' ' ' ALA . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.565 HG11 ' HG ' ' D' ' 23' ' ' LEU . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.555 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.745 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.281 0.563 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.471 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.643 HG23 ' O ' ' E' ' 40' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.949 ' HB2' HD13 ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' E' ' 19' ' ' THR . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.52 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' E' ' 14' ' ' PHE . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.672 HG21 ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.745 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' E' ' 20' ' ' ALA . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.633 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.592 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.643 ' O ' HG23 ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 1.13 HD12 ' HB2' ' E' ' 52' ' ' ALA . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 1.13 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.664 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.593 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.593 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.434 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.673 HG22 ' H ' ' D' ' 6' ' ' THR . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.673 ' H ' HG22 ' D' ' 5' ' ' ILE . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.634 HD11 HG23 ' D' ' 30' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.578 ' CD1' HG23 ' D' ' 19' ' ' THR . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.569 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.569 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 2.2 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.61 HG22 HD12 ' D' ' 23' ' ' LEU . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.703 ' HG ' HG11 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' D' ' 20' ' ' ALA . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.583 ' CD2' HG21 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' D' ' 7' ' ' LEU . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.703 HG11 ' HG ' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' E' ' 57' ' ' PRO . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 1.047 ' CG1' HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 1.064 ' O ' HD13 ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 1.064 HD13 ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' E' ' 42' ' ' LEU . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.523 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.45 ' H ' HG22 ' E' ' 17' ' ' THR . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.677 ' O ' HD12 ' E' ' 23' ' ' LEU . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.677 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.549 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.549 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' E' ' 8' ' ' LYS . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.468 HD13 ' HB1' ' E' ' 33' ' ' ALA . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.741 HG22 ' O ' ' E' ' 51' ' ' TYR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.692 HD11 HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.741 ' O ' HG22 ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.5 ' O ' HG12 ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 1.047 HG13 ' CG1' ' D' ' 55' ' ' VAL . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.775 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.775 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.655 HD11 HD12 ' D' ' 30' ' ' ILE . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.567 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.456 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.643 HG21 ' CD1' ' D' ' 7' ' ' LEU . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' E' ' 58' ' ' PHE . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.655 HD12 HD11 ' D' ' 7' ' ' LEU . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' D' ' 34' ' ' ILE . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.508 ' CG ' HG13 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.762 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.533 HG23 ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.533 ' O ' HG23 ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.643 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.479 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.924 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.924 HD13 ' C ' ' E' ' 4' ' ' ARG . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.926 HD11 HD12 ' E' ' 30' ' ' ILE . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.502 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.598 ' CB ' HG22 ' E' ' 5' ' ' ILE . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.568 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.487 ' OG1' ' NE2' ' E' ' 27' ' ' GLN . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.696 ' O ' HD12 ' E' ' 23' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.975 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.696 HD12 ' O ' ' E' ' 19' ' ' THR . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . 0.487 ' NE2' ' OG1' ' E' ' 17' ' ' THR . 7.2 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.926 HD12 HD11 ' E' ' 7' ' ' LEU . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.558 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.558 HD13 ' HB1' ' E' ' 33' ' ' ALA . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.533 HD12 HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.975 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.497 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.327 0.584 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.507 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' D' ' 19' ' ' THR . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.536 ' HB3' HG21 ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . 0.486 HG23 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.992 ' O ' HD12 ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.992 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.74 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.74 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 20' ' ' ALA . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.54 HD11 ' HG ' ' D' ' 7' ' ' LEU . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.512 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' HG22 ' D' ' 43' ' ' THR . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.519 HG12 HD21 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo . . . . . 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.497 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.191 0.52 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.55 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.55 HD12 ' C ' ' E' ' 4' ' ' ARG . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.45 ' N ' HG22 ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD13 ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.603 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.446 HG23 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' E' ' 14' ' ' PHE . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.603 HG23 ' CD2' ' E' ' 10' ' ' TYR . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.768 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.942 ' HB3' HG21 ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.548 ' O ' HD12 ' E' ' 30' ' ' ILE . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.768 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.404 ' OD1' ' CE1' ' E' ' 35' ' ' HIS . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.404 ' CE1' ' OD1' ' E' ' 31' ' ' ASN . 0.4 OUTLIER -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.16 0.505 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.835 ' HA ' HD22 ' D' ' 42' ' ' LEU . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.535 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.517 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . 0.522 HG23 HE21 ' D' ' 27' ' ' GLN . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.95 ' O ' HD12 ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.906 ' HB2' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' D' ' 50' ' ' VAL . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.95 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' E' ' 58' ' ' PHE . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.403 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . 0.522 HE21 HG23 ' D' ' 17' ' ' THR . 0.5 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.906 ' CD1' ' HB2' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.894 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.447 HD12 ' O ' ' D' ' 30' ' ' ILE . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.894 HD12 ' HB1' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.835 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.79 HG11 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' E' ' 58' ' ' PHE . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' E' ' 25' ' ' VAL . 36.6 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.522 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.737 0.78 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.808 ' C ' HD12 ' E' ' 5' ' ' ILE . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.813 HD13 HD11 ' E' ' 44' ' ' ILE . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.643 ' HA ' HD22 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.689 ' HB2' HG22 ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.958 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.958 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.527 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.903 ' O ' HD12 ' E' ' 23' ' ' LEU . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.679 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.85 ' HB3' HG21 ' E' ' 50' ' ' VAL . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.903 HD12 ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.701 HG22 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.702 ' O ' HD12 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.702 HD12 ' O ' ' E' ' 30' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' E' ' 38' ' ' ARG . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.47 ' HD3' ' HB1' ' E' ' 36' ' ' ALA . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.713 ' CE1' HG23 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.813 HD11 HD13 ' E' ' 5' ' ' ILE . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 23.8 m-80 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.85 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.48 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.713 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' D' ' 25' ' ' VAL . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' D' ' 19' ' ' THR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 7.5 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . 0.57 HG23 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.806 ' O ' HD12 ' D' ' 23' ' ' LEU . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.81 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.812 HD21 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' D' ' 20' ' ' ALA . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . 0.57 ' NE2' HG23 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.714 ' CG1' ' HB2' ' D' ' 20' ' ' ALA . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 4.3 t-20 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.576 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 7.4 m170 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.576 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.447 ' H ' HD12 ' D' ' 44' ' ' ILE . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.812 ' CG1' HD21 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.55 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.588 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.592 ' CD1' HG21 ' E' ' 19' ' ' THR . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.588 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.521 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.928 ' O ' HD12 ' E' ' 23' ' ' LEU . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.624 ' HB3' HE22 ' E' ' 27' ' ' GLN . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.928 HD12 ' O ' ' E' ' 19' ' ' THR . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.759 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . 0.624 HE22 ' HB3' ' E' ' 20' ' ' ALA . 35.7 mm-40 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' E' ' 34' ' ' ILE . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.808 ' CE1' HG23 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.707 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.707 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.808 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG11 ' D' ' 25' ' ' VAL . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.677 ' O ' HD12 ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.936 ' O ' HD13 ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.936 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HA ' HD22 ' D' ' 42' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.736 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . 0.52 ' HB ' ' NE2' ' D' ' 27' ' ' GLN . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.895 ' O ' HD12 ' D' ' 23' ' ' LEU . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.678 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.895 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' D' ' 17' ' ' THR . 3.9 mt-30 -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' D' ' 20' ' ' ALA . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.476 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.669 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 34' ' ' ILE . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.842 ' HD3' HD11 ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.842 HD11 ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.677 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.7 m120 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.442 ' OE1' HG23 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' E' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.935 HD12 HG21 ' E' ' 19' ' ' THR . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' E' ' 5' ' ' ILE . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.578 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.578 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 61.6 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.935 HG21 HD12 ' E' ' 7' ' ' LEU . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.96 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.442 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.442 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.96 HG13 ' HB2' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 18.1 m170 -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' E' ' 55' ' ' VAL . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.789 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.576 HG11 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.677 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo . . . . . 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.724 ' O ' HD12 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.825 ' C ' HD12 ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.825 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' D' ' 42' ' ' LEU . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.544 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.602 ' CD2' HG23 ' D' ' 19' ' ' THR . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.803 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.623 HG21 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' D' ' 50' ' ' VAL . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.75 ' HG ' HG11 ' D' ' 50' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.573 ' O ' HD12 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.573 HD12 ' O ' ' D' ' 30' ' ' ILE . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.424 HD12 ' HB1' ' D' ' 33' ' ' ALA . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' D' ' 55' ' ' VAL . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.724 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.8 m-80 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.75 HG11 ' HG ' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.642 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.504 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.484 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.442 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.721 ' N ' HD12 ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.663 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.663 ' HG1' ' HD1' ' E' ' 10' ' ' TYR . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.857 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' E' ' 24' ' ' GLY . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.543 HD12 ' O ' ' E' ' 30' ' ' ILE . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.621 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.62 ' C ' HD13 ' E' ' 44' ' ' ILE . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.79 ' N ' HD13 ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.621 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.559 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . 0.564 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.564 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.534 HG21 ' HE3' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.691 ' HA ' HD22 ' D' ' 42' ' ' LEU . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.557 ' CB ' HG23 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.764 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' D' ' 50' ' ' VAL . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.764 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.426 ' HB3' HG12 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' D' ' 20' ' ' ALA . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.519 ' CD2' HG23 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.645 HG21 ' HB3' ' D' ' 22' ' ' ASP . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.576 HG13 HG13 ' E' ' 55' ' ' VAL . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.488 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.421 ' HB3' HD12 ' E' ' 44' ' ' ILE . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.279 0.562 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.591 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.591 HD12 ' C ' ' E' ' 4' ' ' ARG . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD22 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.547 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.607 HG22 HD12 ' E' ' 23' ' ' LEU . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' E' ' 30' ' ' ILE . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.609 ' CB ' HG21 ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.607 HD12 HG22 ' E' ' 19' ' ' THR . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.692 ' CG1' ' HB2' ' E' ' 20' ' ' ALA . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.723 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 55.1 m-80 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.879 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.134 0.492 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' D' ' 5' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.52 ' NE ' HG23 ' D' ' 43' ' ' THR . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.607 HD11 ' OE1' ' D' ' 3' ' ' GLN . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.614 ' HA ' HD22 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.798 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.798 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.2 OUTLIER -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.602 HG22 HD12 ' D' ' 23' ' ' LEU . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.626 HD21 ' CG1' ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.604 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.504 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.879 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.65 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.52 HG23 ' NE ' ' D' ' 4' ' ' ARG . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.681 HD13 ' N ' ' D' ' 44' ' ' ILE . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.626 ' CG1' HD21 ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.65 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 1.06 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.664 ' O ' HD12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 1.013 ' O ' HD13 ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 1.013 HD13 ' O ' ' E' ' 4' ' ' ARG . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' E' ' 19' ' ' THR . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' E' ' 34' ' ' ILE . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.443 ' O ' HD12 ' E' ' 30' ' ' ILE . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.7 HG21 ' CD1' ' E' ' 7' ' ' LEU . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.863 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 1.01 HD21 HG12 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 1.06 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.703 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . 0.746 HG23 ' NE ' ' E' ' 4' ' ' ARG . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.664 HD12 ' O ' ' E' ' 3' ' ' GLN . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 1.01 HG12 HD21 ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' E' ' 58' ' ' PHE . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . 0.53 ' O ' HD12 ' D' ' 44' ' ' ILE . 9.7 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.614 ' C ' HD13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.614 HD13 ' C ' ' D' ' 4' ' ' ARG . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.762 HD12 ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.557 ' HD1' ' HG1' ' D' ' 19' ' ' THR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.712 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.557 ' HG1' ' HD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.732 ' HG ' HG11 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.403 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.72 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.53 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.732 HG11 ' HG ' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.584 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.584 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.457 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.566 HD13 HD11 ' E' ' 44' ' ' ILE . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.735 ' HA ' HD22 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.553 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.525 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.773 ' O ' HD12 ' E' ' 23' ' ' LEU . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.773 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.553 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.553 HD13 ' HB1' ' E' ' 33' ' ' ALA . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.566 HD11 HD13 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.661 ' C ' HD12 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.661 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HA ' HD22 ' D' ' 42' ' ' LEU . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' D' ' 19' ' ' THR . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.899 ' O ' HD12 ' D' ' 23' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.617 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.899 HD12 ' O ' ' D' ' 19' ' ' THR . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.463 ' H ' HG22 ' D' ' 25' ' ' VAL . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 1.127 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 1.127 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.486 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.599 ' HE1' HG11 ' E' ' 25' ' ' VAL . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . 0.58 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . 0.441 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.7 mt-30 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.467 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.594 HD13 HD13 ' E' ' 44' ' ' ILE . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' E' ' 34' ' ' ILE . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . 0.621 HG23 HE21 ' E' ' 27' ' ' GLN . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.488 HG23 ' CD1' ' E' ' 10' ' ' TYR . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.931 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.501 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . 0.621 HE21 HG23 ' E' ' 17' ' ' THR . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.931 HG13 ' HB2' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.56 HD11 ' CB ' ' E' ' 11' ' ' ALA . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.516 ' HE3' ' HD2' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . 0.498 HG21 HD22 ' E' ' 7' ' ' LEU . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.905 HG23 ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.905 ' O ' HG23 ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.516 ' HD2' ' HE3' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.487 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.665 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.27 0.557 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 4' ' ' ARG . . . . . 0.479 ' C ' HD12 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 5' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' D' ' 9' ' ' ASP . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' D' ' 42' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.671 ' HA ' HD11 ' D' ' 34' ' ' ILE . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' D' ' 19' ' ' THR . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.617 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' THR . . . . . 0.773 HG23 ' CD2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' ASP . . . . . 0.791 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.679 HG11 ' HE1' ' E' ' 58' ' ' PHE . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.897 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' D' ' 35' ' ' HIS . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' D' ' 8' ' ' LYS . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' D' ' 31' ' ' ASN . 18.7 m-70 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.817 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' LYS . . . . . 0.585 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' ILE . . . . . 0.56 HD13 ' HB1' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.872 HD12 ' HB2' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' THR . . . . . 0.576 HG23 ' O ' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.9 m-80 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.791 HG21 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' TYR . . . . . 0.569 ' O ' HG22 ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' PHE . . . . . 0.83 ' CE2' ' HB1' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.555 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 5' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 6' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 7' ' ' LEU . . . . . 0.799 ' CD1' HG21 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 8' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 9' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG23 ' E' ' 19' ' ' THR . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.744 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.744 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 19' ' ' THR . . . . . 0.799 HG21 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.779 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 22' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.637 HG12 ' H ' ' E' ' 26' ' ' TYR . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 26' ' ' TYR . . . . . 0.637 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 28' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' E' ' 26' ' ' TYR . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 30' ' ' ILE . . . . . 0.779 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 31' ' ' ASN . . . . . 0.559 ' ND2' ' NE2' ' E' ' 35' ' ' HIS . 5.1 t30 -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 32' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 35' ' ' HIS . . . . . 0.559 ' NE2' ' ND2' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 44' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 52' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 53' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 54' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 56' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 58' ' ' PHE . . . . . 0.679 ' HE1' HG11 ' D' ' 25' ' ' VAL . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.03 124.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.392 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 110.06 12.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.45 ' O ' HG13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.49 116.12 31.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.186 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.8 mp -146.13 149.76 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -67.32 154.22 41.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.872 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.627 ' HA ' HD22 ' D' ' 42' ' ' LEU . 16.7 tp -61.05 -25.04 66.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.658 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.3 OUTLIER -86.56 -28.01 23.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.887 . . . . 0.0 110.034 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 59.5 m-20 -81.19 -26.86 35.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.0 . . . . 0.0 109.546 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' D' ' 19' ' ' THR . 14.3 t80 -87.1 -33.76 19.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 108.659 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.84 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -82.15 -28.84 31.91 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.455 -0.778 . . . . 0.0 109.751 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.5 OUTLIER -90.68 -39.93 12.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.99 . . . . 0.0 110.159 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 1.2 mtp85 -80.77 -26.94 36.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.4 m-85 -111.41 -33.23 6.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.897 -1.127 . . . . 0.0 109.629 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.13 131.13 3.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.84 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 65.0 mt-30 -66.17 -23.93 66.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -1.151 . . . . 0.0 109.3 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.1 m -65.6 -40.67 92.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.87 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -76.71 -33.36 58.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.658 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.587 HG23 ' CD2' ' D' ' 10' ' ' TYR . 9.2 m -68.56 -30.7 69.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.067 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.16 -22.77 30.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 108.999 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' D' ' 21' ' ' LYS . 15.6 ttmt -80.84 -25.79 37.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.512 -0.743 . . . . 0.0 108.997 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 13.3 m-20 -87.94 -32.13 19.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.097 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' D' ' 50' ' ' VAL . 6.8 mt -90.24 -18.67 25.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.399 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.39 -34.19 4.42 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' D' ' 29' ' ' ALA . 0.7 OUTLIER -51.87 167.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 109.606 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.46 172.5 8.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.155 -0.966 . . . . 0.0 109.581 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.39 -26.19 67.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -75.27 -18.41 60.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.457 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -86.87 -36.86 18.19 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 108.653 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.564 HD12 HD11 ' D' ' 7' ' ' LEU . 19.4 mm -73.33 -33.76 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -40.34 65.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.407 -0.808 . . . . 0.0 108.943 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -64.21 -37.13 86.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.299 -0.876 . . . . 0.0 109.022 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.41 -46.38 86.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.288 -0.883 . . . . 0.0 108.943 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' D' ' 8' ' ' LYS . 12.3 mm -66.69 -25.95 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -32.97 69.43 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.379 -0.826 . . . . 0.0 109.394 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.46 -16.18 61.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.123 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.85 34.28 5.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -90.24 -177.31 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -1.162 . . . . 0.0 109.696 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 26.8 mmtp -79.0 80.8 5.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.648 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 5.0 mt -109.89 100.17 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 108.961 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.595 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.0 m-85 -94.39 162.3 13.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -123.37 114.09 19.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.465 HG22 ' O ' ' D' ' 43' ' ' THR . 17.1 m -100.98 86.43 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.557 HG23 ' O ' ' D' ' 49' ' ' SER . 3.5 mt -89.16 125.62 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.909 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.6 m120 -89.22 149.23 23.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.58 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.35 -18.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.862 -0.524 . . . . 0.0 110.721 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -82.98 30.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.888 -1.132 . . . . 0.0 109.861 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.23 55.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.557 ' O ' HG23 ' D' ' 44' ' ' ILE . 3.1 m -91.0 145.61 24.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.505 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.3 t -119.68 117.85 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.104 -0.997 . . . . 0.0 108.873 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 10.3 t80 -123.27 80.97 1.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.071 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.29 137.95 38.34 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.587 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 1.1 mt-10 -134.68 167.51 20.7 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.59 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.9 tt0 -119.35 135.14 54.86 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -152.29 107.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.849 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 3.5 ttpt -141.12 134.95 14.85 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 109.105 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.26 144.4 26.24 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.497 2.131 . . . . 0.0 111.155 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.675 ' CE1' HG11 ' E' ' 25' ' ' VAL . 1.3 t80 -96.93 147.71 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.683 ' HG3' HG12 ' E' ' 25' ' ' VAL . 36.6 Cg_endo -80.7 -160.36 2.33 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.371 -1.512 . . . . 0.0 110.295 -0.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.0 t -85.77 -46.01 11.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.235 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.86 -156.27 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.404 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.28 -176.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.163 -0.961 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 tttp -147.87 132.42 17.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.079 -1.013 . . . . 0.0 109.468 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.45 168.46 19.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.26 156.64 17.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.388 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.392 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.315 0.579 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.46 174.9 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -78.97 109.07 12.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.292 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.825 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -111.32 106.72 15.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.609 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.825 HD13 ' C ' ' E' ' 4' ' ' ARG . 4.9 mm -123.6 137.87 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 1.3 m -67.89 150.25 48.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.63 ' HA ' HD22 ' E' ' 42' ' ' LEU . 37.0 tp -56.38 -17.02 6.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.457 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -89.86 -31.14 17.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.698 ' HB2' HG22 ' E' ' 5' ' ' ILE . 27.6 m-20 -80.66 -29.85 36.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.063 -1.023 . . . . 0.0 110.084 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.499 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 18.9 t80 -81.33 -36.59 29.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.113 -0.992 . . . . 0.0 109.362 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -79.54 -27.9 41.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.156 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -90.54 -36.52 14.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 0.0 110.111 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.567 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 4.4 mtp180 -84.45 -17.34 39.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -122.96 -31.46 3.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.002 -1.061 . . . . 0.0 109.727 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.83 143.91 6.37 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.622 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 38.2 mt-30 -75.74 -19.33 59.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -1.141 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 32.3 m -74.27 -38.35 63.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.54 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 3.8 mttp -76.79 -42.2 41.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.669 ' O ' HD12 ' E' ' 23' ' ' LEU . 52.8 m -60.62 -35.56 76.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.583 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -76.23 -22.19 55.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.31 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -76.47 -31.63 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 1.043 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.4 OUTLIER -80.3 -38.33 30.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.379 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.669 HD12 ' O ' ' E' ' 19' ' ' THR . 1.5 mt -90.66 -2.98 57.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 47.14 62.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.683 HG12 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -115.99 -177.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -92.84 157.45 16.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.918 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.59 -31.3 72.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.097 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m -77.56 -11.61 59.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.07 -36.35 23.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.5 mt -79.51 -26.64 12.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -74.94 -35.66 62.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 108.931 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -67.32 -36.78 82.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 108.898 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.428 HD11 ' HG ' ' E' ' 7' ' ' LEU . 25.1 mm -75.97 -33.28 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.434 -0.791 . . . . 0.0 108.874 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.84 -30.66 67.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -85.07 -16.84 39.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.746 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 41.05 41.36 2.67 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -87.11 63.95 8.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -1.157 . . . . 0.0 109.782 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' E' ' 38' ' ' ARG . 7.4 mptt 37.44 71.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.79 0.805 . . . . 0.0 110.101 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.741 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 26.0 mt -109.42 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' E' ' 55' ' ' VAL . 18.4 m-85 -96.6 163.13 13.15 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.3 tp -127.58 99.64 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.514 -0.741 . . . . 0.0 109.173 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 85.9 m -90.24 114.39 26.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 109.896 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.64 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.338 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 9.0 m-20 -51.36 137.36 23.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.799 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.48 -20.98 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.835 -0.541 . . . . 0.0 110.806 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -83.69 31.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.85 -1.156 . . . . 0.0 109.758 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.87 16.63 52.6 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' E' ' 45' ' ' ASN . 0.0 OUTLIER -91.26 152.27 20.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -1.105 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' E' ' 22' ' ' ASP . 13.5 t -112.09 153.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.792 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -157.42 81.55 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.31 134.88 36.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.321 -0.862 . . . . 0.0 108.958 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -137.76 172.23 13.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 110.054 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.485 ' C ' ' CG2' ' E' ' 55' ' ' VAL . 1.8 tt0 -120.61 143.02 48.87 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.776 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -156.3 109.44 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.818 -178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.0 OUTLIER -141.85 139.9 19.04 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.468 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -74.71 171.94 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.641 2.227 . . . . 0.0 111.784 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 18.4 t80 -129.0 141.21 40.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.586 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.15 -70.68 0.01 OUTLIER 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.589 -1.421 . . . . 0.0 110.357 -0.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 43.6 t -83.24 -80.48 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -145.3 111.74 5.75 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.195 -0.941 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.38 120.41 5.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 0.0 109.605 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -80.21 -45.93 17.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.953 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.8 p -129.32 121.16 26.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.392 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.412 ' O ' HG23 ' E' ' 65' ' ' THR . 3.4 t -81.33 126.59 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.6 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -106.26 115.62 30.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.506 ' O ' HD12 ' D' ' 44' ' ' ILE . 24.9 mt-30 -77.16 87.04 3.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.588 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.572 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.1 OUTLIER -123.44 134.68 53.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.572 HD12 ' C ' ' D' ' 4' ' ' ARG . 3.8 mp -151.9 155.67 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -74.95 150.73 38.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.105 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' D' ' 42' ' ' LEU . 47.8 tp -55.73 -18.05 7.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.66 ' HA ' HD11 ' D' ' 34' ' ' ILE . 0.5 OUTLIER -86.38 -35.58 19.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.542 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.7 OUTLIER -75.02 -33.91 61.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.764 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 20.2 t80 -80.5 -30.73 37.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.418 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.593 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -81.83 -24.45 35.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.83 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.502 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 2.7 mmt -90.54 -39.79 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.982 . . . . 0.0 110.162 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.0 mtp180 -83.36 -21.66 33.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 110.219 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.2 m-85 -113.31 -36.72 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.86 -1.15 . . . . 0.0 109.883 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' D' ' 18' ' ' LYS . . . 134.66 126.9 2.67 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.593 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 26.2 mt-30 -70.95 -21.02 62.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -1.188 . . . . 0.0 109.389 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -74.97 -43.73 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 10.1 ptpt -73.57 -28.15 61.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.683 ' O ' HD12 ' D' ' 23' ' ' LEU . 60.6 m -69.11 -40.46 78.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.875 . . . . 0.0 109.266 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.867 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.56 -33.72 64.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.13 59.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 109.275 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -83.22 -38.85 21.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.109 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 1.4 mt -89.99 -3.98 57.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.467 -0.77 . . . . 0.0 109.467 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.49 -32.49 4.45 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -53.78 164.11 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.3 -1.117 . . . . 0.0 109.209 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -99.0 171.56 7.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 109.186 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.22 -20.06 66.26 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' D' ' 32' ' ' LYS . 1.6 t -75.75 -21.66 57.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.236 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.5 -25.81 26.62 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.785 HG13 ' HB2' ' D' ' 20' ' ' ALA . 9.1 mm -82.33 -28.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -78.12 -37.41 46.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.488 -0.758 . . . . 0.0 109.05 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' D' ' 28' ' ' SER . 7.5 ptpt -78.8 -28.81 44.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 0.0 108.922 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -75.13 -36.75 61.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 108.863 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.66 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.3 mm -79.01 -31.14 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.4 -40.09 74.11 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -0.788 . . . . 0.0 109.105 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -16.43 57.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.52 19.6 9.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.37 178.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.238 . . . . 0.0 109.441 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.546 ' CD ' ' HD2' ' D' ' 56' ' ' LYS . 22.6 mttm -87.62 76.42 8.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 109.704 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.782 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.9 mt -109.38 98.02 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.2 m-30 -85.81 165.32 16.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.49 -0.756 . . . . 0.0 109.81 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.694 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 2.1 tp -128.12 132.54 48.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 0.0 109.791 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 24.0 m -121.47 110.42 16.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.1 -1.0 . . . . 0.0 108.829 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.506 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.6 OUTLIER -103.47 133.95 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.032 -1.042 . . . . 0.0 109.807 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 3.4 m-20 -90.07 148.52 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.393 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.31 -23.76 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.872 -0.518 . . . . 0.0 110.581 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.496 ' OD1' ' CB ' ' D' ' 49' ' ' SER . 2.7 p30 -86.27 32.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.875 -1.141 . . . . 0.0 109.841 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.38 31.0 56.57 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.47 154.07 19.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -1.168 . . . . 0.0 109.201 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.0 t -110.5 141.48 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.657 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.536 ' CE2' ' CD ' ' D' ' 53' ' ' GLU . 17.7 t80 -150.09 73.55 1.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.048 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.694 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.63 150.15 31.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.814 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.536 ' CD ' ' CE2' ' D' ' 51' ' ' TYR . 7.0 mt-10 -140.22 163.41 32.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.4 -0.813 . . . . 0.0 109.839 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' E' ' 38' ' ' ARG . 1.4 tt0 -118.54 131.18 56.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.82 109.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.19 -0.944 . . . . 0.0 109.495 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.546 ' HD2' ' CD ' ' D' ' 39' ' ' LYS . 3.7 tptm -157.56 138.64 9.52 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 109.136 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.483 ' HD2' ' CE ' ' D' ' 56' ' ' LYS . 35.3 Cg_endo -77.0 177.51 8.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.463 2.109 . . . . 0.0 111.406 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 15.4 t80 -151.85 141.7 14.55 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.607 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -79.91 -160.01 2.21 Favored 'Cis proline' 0 C--N 1.308 -1.599 0 C-N-CA 123.666 -1.389 . . . . 0.0 110.756 -0.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.4 93.61 9.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 109.817 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -98.35 159.83 14.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.943 . . . . 0.0 109.041 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' D' ' 62' ' ' LYS . 4.1 ttmt 48.3 41.04 15.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.127 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -102.17 110.23 22.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.643 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 116.41 24.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.359 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 96.5 m -139.5 121.09 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.448 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.473 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.351 0.596 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.08 65.35 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 109.22 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.417 ' HB3' HD12 ' E' ' 44' ' ' ILE . 3.6 mt-30 -89.43 89.88 8.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.716 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.445 ' O ' HG13 ' E' ' 5' ' ' ILE . 17.1 mmt180 -111.4 130.27 55.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.873 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.597 HG23 ' HB3' ' E' ' 9' ' ' ASP . 2.5 mp -146.44 151.49 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.46 HG21 ' HE2' ' E' ' 8' ' ' LYS . 1.7 m -79.88 152.24 29.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.553 HD13 HD11 ' E' ' 42' ' ' LEU . 45.8 tp -54.86 -18.48 4.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' E' ' 6' ' ' THR . 0.9 OUTLIER -88.11 -35.13 17.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.866 -179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 1.8 t80 -81.92 -41.46 20.84 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.258 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -77.92 -25.42 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 110.011 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 6.4 mmt -90.52 -41.84 11.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.48 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.3 OUTLIER -81.96 -32.19 30.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.054 -1.028 . . . . 0.0 110.051 -179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.3 m-85 -107.58 -22.27 12.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 108.58 154.81 17.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.434 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 27.7 mt-30 -69.25 -29.76 67.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -1.12 . . . . 0.0 109.253 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.2 t -71.14 -23.72 62.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.386 -0.821 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 8.2 mttt -84.63 -36.55 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.523 HG21 ' CD1' ' E' ' 7' ' ' LEU . 95.0 m -69.04 -35.53 76.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.071 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -81.85 -20.21 39.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.312 -0.867 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -74.06 -40.81 62.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -79.06 -32.77 44.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.145 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.526 ' HG ' HG11 ' E' ' 50' ' ' VAL . 34.2 mt -90.56 -5.29 56.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.22 33.0 44.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' D' ' 59' ' ' PRO . 1.8 m -104.85 -169.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -1.112 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -105.51 160.87 14.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -71.76 -23.98 61.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -21.98 60.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.292 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.69 -33.46 21.53 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.617 ' O ' HD12 ' E' ' 34' ' ' ILE . 17.2 mt -77.41 -24.59 14.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.466 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 62.2 m-20 -79.4 -44.37 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.154 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 4.6 ptmt -69.0 -31.08 69.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.538 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -69.7 -44.86 69.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 108.996 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.617 HD12 ' O ' ' E' ' 30' ' ' ILE . 18.6 mt -68.76 -28.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 22.8 m-70 -64.05 -44.08 93.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.547 -0.721 . . . . 0.0 109.118 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.78 -24.31 66.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.346 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.31 21.57 40.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.458 ' HD3' ' OE2' ' D' ' 54' ' ' GLU . 7.7 ttm180 -69.63 175.61 4.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -1.126 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.576 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 44.3 mmtt -77.45 80.09 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 mt -108.98 95.03 3.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.6 m-30 -84.8 166.2 17.14 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.537 -0.727 . . . . 0.0 109.716 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.553 HD11 HD13 ' E' ' 7' ' ' LEU . 0.7 OUTLIER -131.14 94.37 3.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.994 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 6.1 m -84.89 119.78 25.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 0.0 109.228 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.8 mt -99.04 107.33 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 34.9 m120 -57.56 138.76 54.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.58 -23.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.726 -0.609 . . . . 0.0 110.776 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -84.33 31.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.856 -1.152 . . . . 0.0 110.054 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.01 20.75 54.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.49 154.97 19.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 109.36 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' E' ' 23' ' ' LEU . 1.5 t -107.85 147.63 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -151.21 78.02 1.27 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.49 138.6 37.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.44 169.46 16.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 1.0 OUTLIER -120.81 126.45 50.14 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -146.17 102.27 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.204 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.533 ' HD3' ' CG ' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -149.45 128.24 6.1 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.29 -0.881 . . . . 0.0 109.066 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.13 167.69 22.98 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.45 2.1 . . . . 0.0 110.446 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.564 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.3 OUTLIER -102.84 159.86 28.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.339 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.725 ' HB3' HG13 ' D' ' 25' ' ' VAL . 36.1 Cg_endo -79.7 -178.34 23.09 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.269 -1.555 . . . . 0.0 110.504 -0.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.7 t -84.37 86.91 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.381 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.87 112.02 16.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.697 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.09 150.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 109.398 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 131.56 51.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.05 -26.71 7.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 5.9 m -111.18 130.05 55.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.425 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -137.97 67.17 1.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.605 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.415 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -84.94 67.52 10.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.99 . . . . 0.0 109.499 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 1.043 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.9 OUTLIER -114.65 124.27 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.228 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 1.043 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.1 OUTLIER -146.43 157.19 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.067 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 2.6 m -79.3 147.35 32.51 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' D' ' 42' ' ' LEU . 59.2 tp -53.96 -19.13 4.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 109.656 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -90.49 -29.53 17.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 110.339 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.509 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 77.6 m-20 -82.51 -24.56 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.087 -1.008 . . . . 0.0 109.756 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.628 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.5 t80 -83.26 -30.5 27.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 1.017 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -85.94 -31.2 22.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 110.072 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 1.6 tpt -90.65 -31.17 16.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.044 -1.035 . . . . 0.0 109.732 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' D' ' 9' ' ' ASP . 53.3 mtp85 -90.16 -36.79 14.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.986 -1.071 . . . . 0.0 110.417 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 5.4 m-85 -104.0 -30.45 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.933 -1.104 . . . . 0.0 109.737 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.21 133.31 3.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 1.017 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.9 OUTLIER -75.45 -9.66 58.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 10.6 m -79.83 -37.04 35.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -85.16 -24.91 27.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.628 HG23 ' HD2' ' D' ' 10' ' ' TYR . 87.9 m -75.35 -40.33 58.36 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.8 ' HB2' HD13 ' D' ' 30' ' ' ILE . . . -74.17 -29.62 61.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.077 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -76.13 -30.7 58.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.076 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.851 ' HB3' HG21 ' D' ' 50' ' ' VAL . 23.3 m-20 -77.85 -32.81 52.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.504 HD12 ' O ' ' D' ' 19' ' ' THR . 2.4 mt -90.03 -16.96 28.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.452 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.43 -21.59 24.55 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.572 HG23 HD11 ' D' ' 30' ' ' ILE . 2.0 m -66.99 -176.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -1.133 . . . . 0.0 109.762 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.653 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -110.19 170.96 7.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.245 -0.909 . . . . 0.0 109.735 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' D' ' 31' ' ' ASN . 1.5 mt-30 -67.04 -19.04 65.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -22.25 58.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.639 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.74 -36.53 17.29 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.235 -0.915 . . . . 0.0 108.548 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' D' ' 20' ' ' ALA . 2.2 mp -76.84 -24.65 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 35.8 t-20 -80.02 -43.03 22.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.467 -0.77 . . . . 0.0 109.241 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -69.88 -30.79 68.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 109.176 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.2 70.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.114 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.76 -29.45 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.461 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 0.2 OUTLIER -71.15 -37.91 72.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.413 -0.804 . . . . 0.0 109.693 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -77.64 -5.81 51.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.53 38.37 14.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.445 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 0.0 OUTLIER -80.21 -178.15 6.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -1.091 . . . . 0.0 109.462 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.2 mptp? -86.5 75.5 9.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.432 HD11 ' OE2' ' D' ' 54' ' ' GLU . 6.9 mm -102.06 103.44 14.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 1.7 m-30 -98.18 160.67 14.14 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.295 -0.878 . . . . 0.0 109.722 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.1 tp -129.61 95.65 4.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.0 109.776 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.686 HG23 ' NE ' ' D' ' 4' ' ' ARG . 31.1 m -87.51 100.28 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.531 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.8 mp -95.59 129.7 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.203 -0.935 . . . . 0.0 110.189 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' D' ' 47' ' ' ASP . 0.7 OUTLIER -91.0 150.84 21.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.74 -26.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.764 -0.585 . . . . 0.0 110.421 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.66 34.48 0.59 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.7 33.79 9.61 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.21 104.73 17.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -1.122 . . . . 0.0 109.311 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.851 HG21 ' HB3' ' D' ' 22' ' ' ASP . 1.5 t -79.32 117.64 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.927 -1.108 . . . . 0.0 109.681 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.588 ' CE2' ' OE2' ' D' ' 53' ' ' GLU . 2.4 t80 -123.65 84.96 2.34 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.64 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -78.68 142.36 37.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 110.415 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.588 ' OE2' ' CE2' ' D' ' 51' ' ' TYR . 98.6 mt-10 -123.36 162.47 22.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 11.1 tt0 -126.93 113.15 16.15 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -135.37 88.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.114 -0.991 . . . . 0.0 109.685 -178.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' D' ' 56' ' ' LYS . 0.0 OUTLIER -135.64 134.91 21.2 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 36.1 Cg_endo -77.54 113.21 3.48 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.473 2.115 . . . . 0.0 110.64 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.866 ' HZ ' HG11 ' E' ' 25' ' ' VAL . 6.6 t80 -97.77 142.11 24.05 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.262 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' E' ' 23' ' ' LEU . 36.5 Cg_endo -81.92 -157.39 1.42 Allowed 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.446 -1.481 . . . . 0.0 110.211 -0.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 70.4 m -60.51 -164.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 109.386 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -80.97 168.77 18.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -137.99 125.04 21.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.11 87.95 2.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.414 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -107.66 106.8 17.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.602 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -151.47 26.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 109.504 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.48 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 29.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 54.71 26.56 7.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.289 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.41 ' HB3' HD11 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -56.9 113.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.464 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -106.77 122.0 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.514 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.605 ' N ' HD12 ' E' ' 5' ' ' ILE . 1.1 mp -146.71 153.86 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.3 m -78.89 143.9 35.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 108.86 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' E' ' 19' ' ' THR . 40.4 tp -57.24 -18.93 18.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.563 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.479 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 5.5 ptmt -82.84 -33.17 27.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 84.8 m-20 -80.59 -26.02 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 109.318 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' E' ' 14' ' ' PHE . 33.2 t80 -86.17 -29.85 22.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.319 -0.863 . . . . 0.0 109.209 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.01 -22.75 27.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.439 ' CE ' HG21 ' E' ' 34' ' ' ILE . 2.4 mmt -90.33 -35.39 15.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 110.048 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -89.43 -26.96 20.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 110.065 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.2 m-85 -108.17 -5.25 17.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 109.548 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.07 132.98 5.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -62.36 -24.67 67.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -1.092 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' E' ' 21' ' ' LYS . 2.5 t -67.53 -36.54 81.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -76.89 -49.71 15.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.766 HG21 ' CD1' ' E' ' 7' ' ' LEU . 99.4 m -55.54 -30.54 60.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.722 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.78 -32.76 46.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.923 . . . . 0.0 109.598 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' E' ' 17' ' ' THR . 14.0 mtpp -72.82 -26.04 61.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.88 -31.99 21.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.117 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.674 HD12 ' O ' ' E' ' 19' ' ' THR . 3.0 mt -89.3 -7.94 54.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.395 -0.815 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.74 31.26 80.32 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.866 HG11 ' HZ ' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -110.22 -171.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.56 149.67 23.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.194 -0.941 . . . . 0.0 109.434 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -64.27 -20.88 66.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' E' ' 32' ' ' LYS . 0.3 OUTLIER -79.93 -20.84 44.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 109.496 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 -35.47 22.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 108.9 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' E' ' 20' ' ' ALA . 12.4 mt -79.36 -29.82 13.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.559 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 50.7 t30 -74.68 -37.96 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 36.0 pttt -73.92 -30.39 62.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.208 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.816 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.01 -44.38 76.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.89 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.444 HD12 ' O ' ' E' ' 30' ' ' ILE . 9.6 mt -70.77 -31.14 44.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 6.4 m170 -61.62 -36.03 79.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.2 -18.07 59.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.416 -0.803 . . . . 0.0 109.351 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.36 54.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' E' ' 40' ' ' ILE . 2.1 ptp85 -89.03 -169.61 2.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 0.1 OUTLIER -87.65 80.56 7.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.172 -179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.816 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 4.9 mt -106.36 99.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.83 167.62 13.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.782 . . . . 0.0 110.038 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' E' ' 7' ' ' LEU . 2.0 tp -134.86 126.42 28.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.865 . . . . 0.0 109.78 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' E' ' 51' ' ' TYR . 23.6 m -120.65 95.9 4.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.987 . . . . 0.0 109.182 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.2 mt -80.82 126.98 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' E' ' 47' ' ' ASP . 86.1 m-20 -80.42 142.38 34.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.05 -25.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.67 -0.644 . . . . 0.0 110.444 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' E' ' 45' ' ' ASN . 5.3 m-20 -83.18 29.51 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 0.0 110.209 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.98 26.61 58.47 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.9 OUTLIER -90.44 155.82 18.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -1.167 . . . . 0.0 109.138 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.64 HG11 ' HG ' ' E' ' 23' ' ' LEU . 0.9 OUTLIER -113.6 113.38 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.623 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB ' ' E' ' 43' ' ' THR . 46.1 t80 -122.7 83.05 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -79.64 155.86 27.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 0.0 110.4 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 10.3 mt-10 -124.25 155.61 38.3 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 9.7 tt0 -123.71 113.0 18.02 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 55' ' ' VAL . 0.2 OUTLIER -134.64 89.59 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.709 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 4.2 tptt -153.13 138.75 11.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.562 -0.711 . . . . 0.0 109.327 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -79.95 140.13 14.14 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.528 2.152 . . . . 0.0 110.23 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -111.79 149.89 41.47 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.994 . . . . 0.0 109.576 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.44 175.96 43.64 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.136 -0.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -66.72 -149.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.44 113.21 21.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.087 -1.008 . . . . 0.0 109.349 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.65 110.8 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -91.54 -146.89 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.265 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.93 123.05 20.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.388 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 20.0 m -154.33 88.77 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.477 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.408 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.79 138.29 31.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.665 ' HB3' HD11 ' D' ' 5' ' ' ILE . 2.0 mt-30 -83.11 117.66 23.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 109.7 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.621 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.2 OUTLIER -106.67 116.69 32.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.042 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.712 HD12 ' N ' ' D' ' 5' ' ' ILE . 3.6 mp -145.4 146.57 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.221 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 3.7 m -75.36 157.41 34.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.0 109.58 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.534 HD12 HG21 ' D' ' 19' ' ' THR . 28.6 tp -61.12 -15.44 33.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.492 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 0.8 OUTLIER -89.29 -29.33 19.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -82.6 -29.27 30.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.689 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' D' ' 19' ' ' THR . 14.2 t80 -82.06 -34.01 29.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.94 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -82.33 -26.58 32.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -0.838 . . . . 0.0 109.916 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.2 mmt -90.68 -41.49 11.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.194 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.458 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 0.0 OUTLIER -79.63 -26.92 41.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.8 m-85 -115.73 -13.96 11.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.127 -0.983 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 103.59 145.42 14.94 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.94 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 6.8 mp0 -71.53 -22.02 61.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -1.081 . . . . 0.0 109.487 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.47 -28.55 62.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -80.91 -37.61 29.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.228 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.76 ' O ' HD12 ' D' ' 23' ' ' LEU . 71.4 m -69.64 -29.09 66.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.149 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.729 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -85.29 -30.21 23.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -30.6 62.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.09 -41.18 22.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.351 -0.843 . . . . 0.0 109.171 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.76 HD12 ' O ' ' D' ' 19' ' ' THR . 1.2 mt -77.7 -11.46 59.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 109.525 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.17 81.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' D' ' 23' ' ' LEU . 2.6 m -91.67 -174.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -1.165 . . . . 0.0 109.286 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -99.44 158.91 15.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.154 -0.966 . . . . 0.0 109.346 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -19.39 63.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.93 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.0 t -78.58 -21.66 48.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.32 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.72 16.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.161 -0.962 . . . . 0.0 108.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' D' ' 20' ' ' ALA . 35.3 mt -71.29 -30.06 38.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.481 ' OD1' ' CE1' ' D' ' 35' ' ' HIS . 20.9 t-20 -70.97 -40.67 71.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 108.994 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -69.85 -33.33 72.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 109.191 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.92 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -65.87 -35.99 82.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mm -81.0 -27.69 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.387 -0.82 . . . . 0.0 109.083 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.481 ' CE1' ' OD1' ' D' ' 31' ' ' ASN . 17.0 m170 -71.26 -17.77 62.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.07 -17.6 34.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.529 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.99 29.07 73.8 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 mmt85 -82.78 169.97 15.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.141 . . . . 0.0 109.417 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.3 OUTLIER -83.61 72.24 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.143 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.92 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 32.2 mt -95.21 103.72 15.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.647 ' CE2' HG23 ' D' ' 55' ' ' VAL . 4.2 m-85 -93.13 160.38 14.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 109.751 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -126.39 113.54 17.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.486 HG22 ' O ' ' D' ' 43' ' ' THR . 5.6 m -98.37 90.74 4.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 109.026 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' D' ' 49' ' ' SER . 2.7 mt -82.43 108.96 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.537 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.1 m-20 -65.41 141.17 58.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.559 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.8 -21.8 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.665 -0.647 . . . . 0.0 110.492 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -86.0 32.93 0.6 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.032 -1.042 . . . . 0.0 109.702 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.23 24.4 58.77 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -90.21 156.17 18.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -1.118 . . . . 0.0 109.304 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.749 HG11 ' HG ' ' D' ' 23' ' ' LEU . 2.5 t -120.94 130.76 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.846 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 75.3 t80 -137.34 80.12 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' E' ' 58' ' ' PHE . . . -79.05 141.32 37.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.88 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.597 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.9 mm-40 -134.15 156.02 49.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 5.9 tp10 -110.58 125.62 53.57 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.451 -0.781 . . . . 0.0 108.957 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.647 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -145.83 94.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.45 ' HD2' ' HD2' ' D' ' 57' ' ' PRO . 5.2 tptt -136.17 129.26 17.85 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.483 -0.761 . . . . 0.0 109.039 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.45 ' HD2' ' HD2' ' D' ' 56' ' ' LYS . 35.9 Cg_endo -77.73 165.22 27.08 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.48 2.12 . . . . 0.0 110.251 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.768 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 39.3 t80 -148.85 140.4 14.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.6 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -81.4 -173.21 11.86 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.453 -1.478 . . . . 0.0 110.201 -1.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 2.56 36.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.54 76.73 1.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.236 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.17 68.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.905 . . . . 0.0 109.401 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 102.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.06 -172.02 2.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 109.408 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.61 101.36 13.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.47 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.472 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.351 0.596 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 173.06 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 109.128 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.49 ' O ' HG12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER -72.61 111.57 7.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.153 -0.967 . . . . 0.0 109.639 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -109.38 109.84 20.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.826 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' E' ' 9' ' ' ASP . 1.9 mp -140.35 152.87 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.143 -0.973 . . . . 0.0 109.157 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 11.9 m -77.68 151.04 34.42 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' E' ' 42' ' ' LEU . 62.8 tp -53.64 -19.68 4.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 109.376 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.499 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 17.3 ptmt -84.88 -36.33 21.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.702 ' HB2' HG22 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -75.58 -25.67 57.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.567 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.763 ' HD2' HG23 ' E' ' 19' ' ' THR . 14.4 t80 -83.67 -33.06 25.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.316 -0.865 . . . . 0.0 109.508 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.81 -21.97 29.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.06 -40.17 12.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 109.565 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.1 mtt180 -84.48 -22.17 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.267 -0.895 . . . . 0.0 109.782 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -120.66 6.02 10.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.715 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.79 150.98 4.63 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -73.3 -28.03 61.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.126 . . . . 0.0 109.377 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -41.98 98.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.541 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' E' ' 14' ' ' PHE . 10.0 mttt -71.43 -44.73 64.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.763 HG23 ' HD2' ' E' ' 10' ' ' TYR . 27.0 m -62.05 -24.94 67.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.263 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.629 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -86.47 -27.03 24.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 0.0 109.636 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -36.79 65.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.941 ' OD2' HG21 ' E' ' 50' ' ' VAL . 5.5 p-10 -77.54 -46.01 23.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.096 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.638 HD12 ' O ' ' E' ' 19' ' ' THR . 1.3 mt -79.43 -11.86 59.9 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.635 -0.666 . . . . 0.0 109.25 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.24 38.03 94.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.768 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.0 OUTLIER -110.43 -170.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.067 -1.255 . . . . 0.0 109.313 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.58 152.23 20.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 109.328 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -65.59 -17.78 64.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.431 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.53 -20.98 38.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.462 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.14 -30.4 22.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.944 . . . . 0.0 108.567 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.675 ' O ' HD12 ' E' ' 34' ' ' ILE . 59.1 mt -79.63 -35.91 17.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -75.4 -34.63 61.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.435 -0.791 . . . . 0.0 109.153 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.66 -34.69 60.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.867 . . . . 0.0 109.085 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' E' ' 40' ' ' ILE . . . -63.99 -41.46 97.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.857 . . . . 0.0 109.034 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.675 HD12 ' O ' ' E' ' 30' ' ' ILE . 5.8 mt -75.63 -32.12 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.047 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -64.26 -31.55 72.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.865 . . . . 0.0 109.247 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.24 -24.65 61.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.245 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.51 23.8 68.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -156.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -1.191 . . . . 0.0 109.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -111.95 72.36 0.77 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' E' ' 33' ' ' ALA . 26.7 mt -97.14 99.81 9.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' E' ' 55' ' ' VAL . 17.4 m-85 -86.9 162.48 17.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.465 -0.772 . . . . 0.0 109.894 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' E' ' 52' ' ' ALA . 1.2 tp -129.33 120.06 24.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.886 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.839 ' O ' HD13 ' E' ' 44' ' ' ILE . 16.6 m -101.93 138.41 38.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.95 . . . . 0.0 108.712 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.839 HD13 ' O ' ' E' ' 43' ' ' THR . 2.3 mm -133.64 122.03 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 5.5 m120 -90.24 146.55 24.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -22.35 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.783 -0.573 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -84.8 33.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.923 -1.111 . . . . 0.0 109.705 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.91 29.69 27.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -90.54 146.62 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -1.075 . . . . 0.0 109.346 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.941 HG21 ' OD2' ' E' ' 22' ' ' ASP . 18.8 t -120.65 149.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.076 -1.015 . . . . 0.0 109.69 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -159.63 81.27 0.73 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' HD12 ' E' ' 42' ' ' LEU . . . -79.47 147.44 32.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 109.603 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.93 167.69 20.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.346 -0.846 . . . . 0.0 109.966 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.51 126.22 46.32 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.2 OUTLIER -146.95 101.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.467 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' D' ' 54' ' ' GLU . 2.9 tptt -150.51 125.69 4.8 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 109.111 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 168.09 22.31 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.522 2.148 . . . . 0.0 110.995 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.622 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.4 OUTLIER -89.12 171.76 8.49 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.035 179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.622 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 34.6 Cg_endo -76.83 -179.32 26.91 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.581 -1.425 . . . . 0.0 110.797 0.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -89.62 139.7 30.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.814 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 142.95 36.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 0.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.49 27.31 16.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.45 58.6 2.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.491 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 72.8 p -99.44 74.66 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.45 ' O ' HG22 ' E' ' 65' ' ' THR . 66.6 m -112.27 62.47 0.63 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.318 -0.864 . . . . 0.0 109.545 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.495 179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.406 ' O ' ' OE1' ' D' ' 2' ' ' GLU . 2.0 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' D' ' 1' ' ' MET . 2.7 tp10 -163.9 -74.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.45 ' O ' HD12 ' D' ' 44' ' ' ILE . 1.9 mp0 -86.56 73.62 10.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.73 ' C ' HD12 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -105.22 122.89 46.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.607 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.73 HD12 ' C ' ' D' ' 4' ' ' ARG . 5.2 mp -147.0 122.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.15 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.1 m -49.4 152.67 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.883 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.4 tp -59.95 -24.46 64.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.191 -0.943 . . . . 0.0 109.108 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.495 ' CB ' HG12 ' D' ' 34' ' ' ILE . 1.3 pttt -82.11 -31.73 30.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.437 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' D' ' 13' ' ' ARG . 7.4 m-20 -74.09 -34.39 63.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 24.3 t80 -79.67 -30.02 41.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 109.617 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' D' ' 16' ' ' GLN . . . -87.82 -16.75 33.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 109.879 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -41.72 9.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 108.773 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.639 ' CG ' ' CE1' ' D' ' 14' ' ' PHE . 4.7 tpt180 -81.1 -25.28 37.1 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' D' ' 13' ' ' ARG . 2.0 m-85 -117.91 3.09 12.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.05 -1.031 . . . . 0.0 109.909 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 142.85 7.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' D' ' 11' ' ' ALA . 4.9 mp0 -67.18 -28.16 67.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' D' ' 21' ' ' LYS . 6.9 t -69.16 -29.18 67.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.164 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.43 ' CG ' ' O ' ' D' ' 14' ' ' PHE . 12.0 mttt -76.12 -35.68 59.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.687 HG21 ' CD1' ' D' ' 7' ' ' LEU . 30.4 m -73.91 -28.77 61.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.854 . . . . 0.0 108.731 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.719 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -86.08 -14.58 43.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.408 -0.808 . . . . 0.0 109.142 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' D' ' 17' ' ' THR . 0.0 OUTLIER -84.57 -39.62 18.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.286 -0.884 . . . . 0.0 108.973 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -77.3 -37.84 51.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.821 . . . . 0.0 108.851 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.499 ' HG ' HG11 ' D' ' 50' ' ' VAL . 3.7 mt -90.11 -21.25 22.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.507 -0.746 . . . . 0.0 109.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 30.42 43.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.719 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -98.09 -173.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -1.19 . . . . 0.0 109.306 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.469 ' O ' HG12 ' D' ' 30' ' ' ILE . 0.1 OUTLIER -106.78 166.89 10.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . 0.495 ' O ' ' ND2' ' D' ' 31' ' ' ASN . 23.9 mt-30 -68.54 -22.04 64.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.98 -15.23 52.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.406 ' HB2' ' HD1' ' D' ' 26' ' ' TYR . . . -85.54 -32.3 22.24 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.496 ' O ' HD12 ' D' ' 34' ' ' ILE . 11.9 mm -78.01 -38.41 24.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' D' ' 27' ' ' GLN . 80.8 m-20 -70.98 -29.04 64.91 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -75.81 -34.09 60.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -69.44 -42.11 75.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.496 HD12 ' O ' ' D' ' 30' ' ' ILE . 5.0 mt -77.63 -28.19 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -71.72 -30.09 65.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -84.5 -11.84 55.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 44.65 30.85 2.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.704 ' CD ' HD11 ' D' ' 40' ' ' ILE . 3.3 ptp180 -77.07 -154.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -1.142 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 9.2 mmtt -107.72 84.44 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.053 -1.029 . . . . 0.0 109.745 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' D' ' 33' ' ' ALA . 17.5 mt -118.73 107.88 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 5.0 m-85 -105.95 151.66 24.31 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.569 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.883 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.8 OUTLIER -114.25 113.7 24.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.917 . . . . 0.0 109.75 -179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 42.4 m -103.08 108.22 19.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.228 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.563 ' CD1' HD13 ' D' ' 5' ' ' ILE . 1.1 mp -100.08 122.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.2 m-20 -73.31 148.28 43.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.734 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.26 -20.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 122.056 -0.402 . . . . 0.0 110.952 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 34.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.864 -1.147 . . . . 0.0 109.327 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.34 23.93 28.16 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.559 ' HB2' ' HB2' ' D' ' 45' ' ' ASN . 31.8 m -91.16 154.49 19.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.312 -1.11 . . . . 0.0 109.354 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.499 HG11 ' HG ' ' D' ' 23' ' ' LEU . 15.3 t -109.48 148.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.982 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' D' ' 43' ' ' THR . 14.0 t80 -152.76 79.47 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -78.29 143.52 36.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.681 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 1.2 mt-10 -140.27 157.81 45.0 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.36 -0.838 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.0 OUTLIER -108.47 151.08 26.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -156.9 111.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.958 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.433 ' HE2' ' HD2' ' D' ' 57' ' ' PRO . 2.2 tptm -152.51 134.35 8.51 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.433 ' HD2' ' HE2' ' D' ' 56' ' ' LYS . 34.5 Cg_endo -76.66 158.35 35.66 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.481 2.121 . . . . 0.0 111.077 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -134.74 148.21 66.26 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -82.12 -87.77 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.316 -1.535 . . . . 0.0 110.624 -0.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.29 155.57 19.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.629 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.41 ' C ' ' HE3' ' D' ' 62' ' ' LYS . 50.8 m-80 -155.33 167.56 29.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.534 ' HE3' ' N ' ' D' ' 62' ' ' LYS . 0.0 OUTLIER -139.31 81.15 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.393 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.51 173.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.486 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.71 60.63 2.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.409 HG22 ' H ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -120.41 -164.32 1.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.414 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.409 ' H ' HG22 ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' E' ' 1' ' ' MET . 2.1 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 62.43 108.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 45.9 mt-30 -79.28 79.5 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.565 ' HE ' HG23 ' E' ' 43' ' ' THR . 4.3 mmt85 -133.25 108.89 9.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.112 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.682 HG22 ' HB2' ' E' ' 9' ' ' ASP . 3.2 mp -142.88 150.93 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 1.4 m -72.92 149.16 43.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.704 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' E' ' 42' ' ' LEU . 24.7 tp -54.22 -21.53 9.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.484 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 10.0 pttt -86.06 -32.07 21.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.308 -0.87 . . . . 0.0 110.054 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.682 ' HB2' HG22 ' E' ' 5' ' ' ILE . 2.7 m-20 -78.27 -25.86 46.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.819 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 2.5 t80 -82.27 -32.78 29.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.563 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.461 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -81.5 -29.91 33.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 110.008 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.529 ' HG3' ' HG2' ' E' ' 13' ' ' ARG . 5.5 ptm -90.65 -36.82 14.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.009 -1.057 . . . . 0.0 110.511 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.529 ' HG2' ' HG3' ' E' ' 12' ' ' MET . 0.4 OUTLIER -82.72 -29.69 29.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.074 -1.016 . . . . 0.0 110.007 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.9 m-85 -111.41 -30.86 7.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 0.0 109.558 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 138.57 4.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.461 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 1.5 mt-30 -70.35 -18.19 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.454 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' E' ' 21' ' ' LYS . 45.1 m -73.77 -32.87 64.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 2.0 mttp -81.15 -33.56 33.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.476 ' O ' HD12 ' E' ' 23' ' ' LEU . 21.1 m -70.97 -38.8 72.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.932 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.929 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -80.54 -26.44 38.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.376 -0.828 . . . . 0.0 108.807 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' E' ' 17' ' ' THR . 3.2 mmmt -74.95 -29.67 61.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.85 -37.29 27.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.096 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.583 ' CB ' HG23 ' E' ' 25' ' ' VAL . 6.2 mt -90.37 -3.95 57.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.437 -0.789 . . . . 0.0 109.359 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.44 22.29 69.38 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.759 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.1 t -94.64 159.21 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -1.184 . . . . 0.0 109.359 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' E' ' 29' ' ' ALA . 0.8 OUTLIER -75.44 163.72 27.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -68.43 -37.61 80.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.297 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -14.35 61.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' E' ' 25' ' ' VAL . . . -80.24 -48.29 13.32 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.929 HD12 ' HB2' ' E' ' 20' ' ' ALA . 2.8 mt -70.76 -26.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.59 -40.76 80.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.362 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 1.0 OUTLIER -70.91 -35.23 72.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' E' ' 32' ' ' LYS . . . -65.06 -38.43 90.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.072 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.38 -31.38 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.437 -0.79 . . . . 0.0 108.926 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -65.7 -28.64 69.21 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.463 -0.773 . . . . 0.0 109.495 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -78.17 -15.55 58.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 45.78 41.76 10.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -90.07 -170.84 2.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -1.082 . . . . 0.0 109.677 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.496 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 11.6 mmtt -91.86 77.08 5.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -0.87 . . . . 0.0 109.794 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.44 99.58 8.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.7 m-30 -88.8 161.38 16.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.399 -0.813 . . . . 0.0 109.628 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.4 tp -126.4 105.96 9.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 109.882 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.565 HG23 ' HE ' ' E' ' 4' ' ' ARG . 5.8 m -95.18 103.42 15.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 0.0 108.821 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' E' ' 49' ' ' SER . 0.8 OUTLIER -95.27 128.58 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.113 -0.992 . . . . 0.0 109.73 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' E' ' 47' ' ' ASP . 19.2 m-20 -86.37 147.21 26.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.521 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.45 -23.86 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.679 -0.638 . . . . 0.0 110.702 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -84.57 31.61 0.52 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.148 . . . . 0.0 109.95 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.41 29.75 47.6 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -88.02 141.47 28.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -1.099 . . . . 0.0 108.992 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.544 ' CG1' HD21 ' E' ' 23' ' ' LEU . 2.7 t -109.66 116.82 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.895 -1.128 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -125.62 82.83 2.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.15 145.49 33.67 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.347 -0.846 . . . . 0.0 109.118 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.5 156.35 46.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.785 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 8.9 tp10 -108.0 134.08 51.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' D' ' 54' ' ' GLU . 0.0 OUTLIER -152.64 112.63 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' E' ' 39' ' ' LYS . 0.0 OUTLIER -155.42 129.06 4.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.347 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.3 Cg_endo -79.21 143.32 17.56 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.586 2.19 . . . . 0.0 110.722 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.7 p90 -115.5 147.2 38.26 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 34.9 Cg_endo -77.39 175.21 48.89 Favored 'Cis proline' 0 C--N 1.308 -1.588 0 C-N-CA 123.069 -1.638 . . . . 0.0 110.536 -0.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -82.52 -14.21 55.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.68 -179.21 4.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.545 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 123.84 12.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.772 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -148.29 63.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.52 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 2.0 p -103.88 37.32 2.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.04 -159.72 0.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.598 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.392 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.295 0.569 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.1 112.28 19.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.456 ' O ' HG13 ' D' ' 44' ' ' ILE . 0.0 OUTLIER -74.06 94.93 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.232 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 1.014 ' O ' HD13 ' D' ' 5' ' ' ILE . 1.5 mmt85 -82.2 143.89 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.792 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 1.014 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.6 OUTLIER -145.93 -179.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 108.645 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.405 ' H ' HG22 ' D' ' 5' ' ' ILE . 0.7 OUTLIER -121.15 142.0 50.29 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.68 HD11 HG23 ' D' ' 30' ' ' ILE . 63.0 tp -51.39 -19.95 1.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -89.89 -33.27 16.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 110.198 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' D' ' 8' ' ' LYS . 11.6 m-20 -73.85 -36.42 64.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.618 ' HD2' HG23 ' D' ' 19' ' ' THR . 11.8 t80 -76.76 -32.04 57.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.683 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -84.85 -25.12 28.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.255 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 13.8 mtt -88.99 -35.7 16.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.032 -1.043 . . . . 0.0 109.836 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -87.79 -22.98 24.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.896 . . . . 0.0 109.612 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 2.0 m-85 -122.44 -0.01 9.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 82.49 138.29 2.92 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.683 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 0.5 OUTLIER -61.75 -19.57 62.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -1.134 . . . . 0.0 109.178 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -58.67 5.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -61.15 -26.84 67.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.672 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.618 HG23 ' HD2' ' D' ' 10' ' ' TYR . 66.3 m -73.67 -32.24 63.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.083 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.61 32.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.374 -0.829 . . . . 0.0 109.191 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' D' ' 21' ' ' LYS . 3.9 mmtp -83.96 -30.02 26.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -83.8 -34.84 24.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 109.025 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.593 HD12 ' O ' ' D' ' 19' ' ' THR . 2.3 mt -87.99 -24.06 23.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 109.226 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 87.72 -25.02 8.93 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.6 OUTLIER -52.81 -173.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.235 . . . . 0.0 109.656 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -98.78 156.1 17.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.551 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -69.32 -37.01 77.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.857 . . . . 0.0 109.179 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -7.65 49.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 0.0 109.46 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.64 -48.66 7.39 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.68 HG23 HD11 ' D' ' 7' ' ' LEU . 97.7 mt -63.77 -31.95 55.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -68.71 -54.99 12.84 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -53.56 -26.19 20.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.205 -0.934 . . . . 0.0 109.147 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' D' ' 38' ' ' ARG . . . -69.19 -45.9 68.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 3.7 mt -68.34 -27.51 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.142 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.93 -26.46 59.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.322 -0.861 . . . . 0.0 109.676 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.71 -10.55 42.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.38 45.61 95.86 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' D' ' 7' ' ' LEU . 0.1 OUTLIER -80.67 -164.95 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -1.094 . . . . 0.0 109.997 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.556 ' CD ' ' HD3' ' D' ' 56' ' ' LYS . 0.3 OUTLIER -127.11 68.47 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 109.216 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' E' ' 58' ' ' PHE . 63.7 mt -98.39 102.84 13.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' D' ' 55' ' ' VAL . 12.0 m-85 -88.47 132.53 34.45 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.451 -0.78 . . . . 0.0 109.455 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.7 mp -88.95 102.57 15.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.09 -1.006 . . . . 0.0 110.016 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 5.6 m -93.67 111.08 22.69 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.801 HD11 HG13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -89.18 102.02 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.167 -0.958 . . . . 0.0 109.488 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 12.1 m120 -46.54 140.01 4.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.351 -0.843 . . . . 0.0 109.736 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -23.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.784 -0.572 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.7 OUTLIER -84.82 33.66 0.53 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.948 -1.095 . . . . 0.0 109.692 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.46 20.01 28.61 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.47 154.36 19.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.503 -0.999 . . . . 0.0 109.133 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' D' ' 23' ' ' LEU . 46.2 t -100.77 145.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.535 ' CE1' ' HG3' ' D' ' 53' ' ' GLU . 1.2 t80 -149.64 83.11 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 108.994 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.5 126.79 31.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' D' ' 51' ' ' TYR . 6.2 mt-10 -122.95 161.24 24.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.439 -0.788 . . . . 0.0 109.472 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 30.7 tt0 -114.8 129.64 56.73 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.71 HG23 ' CE1' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -144.58 102.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.543 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.556 ' HD3' ' CD ' ' D' ' 39' ' ' LYS . 0.0 OUTLIER -151.87 126.39 4.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.008 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.46 160.27 32.13 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.329 2.02 . . . . 0.0 110.888 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.647 ' CE1' HD22 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -115.72 164.16 18.42 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 109.243 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 34.9 Cg_endo -76.62 -160.31 2.27 Favored 'Cis proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.295 -1.544 . . . . 0.0 110.564 0.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t -64.0 167.93 5.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' D' ' 62' ' ' LYS . 14.3 p30 -97.51 -158.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.397 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' D' ' 61' ' ' ASN . 1.6 mttp -86.84 140.73 29.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.26 141.83 21.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.947 . . . . 0.0 109.634 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -146.13 -87.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.458 HG22 ' O ' ' D' ' 65' ' ' THR . 21.8 m -115.24 43.78 1.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.53 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -110.8 173.47 6.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.428 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.481 ' O ' HD12 ' E' ' 44' ' ' ILE . 9.3 mt-30 -79.81 111.4 16.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -110.66 108.53 18.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 0.0 109.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.1 mp -130.74 137.17 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.325 -0.86 . . . . 0.0 108.982 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.05 156.04 32.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 109.558 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.868 ' CD1' HG21 ' E' ' 19' ' ' THR . 38.2 tp -62.9 -19.63 64.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.327 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 0.0 OUTLIER -87.75 -23.75 24.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -0.847 . . . . 0.0 109.769 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.489 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.8 OUTLIER -86.65 -32.93 20.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 13.2 t80 -83.07 -31.33 27.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.549 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -82.48 -29.96 30.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 109.864 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 7.9 mtt -90.57 -38.24 13.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.0 110.175 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.509 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 0.0 OUTLIER -82.08 -26.21 33.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.099 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.4 m-85 -116.26 -9.26 11.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.933 -1.104 . . . . 0.0 109.824 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.3 133.51 7.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.549 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 33.8 mt-30 -64.46 -17.77 64.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.038 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.599 HG23 ' N ' ' E' ' 18' ' ' LYS . 10.1 t -72.32 -46.26 56.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.599 ' N ' HG23 ' E' ' 17' ' ' THR . 63.5 mttt -64.72 -31.56 72.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.868 HG21 ' CD1' ' E' ' 7' ' ' LEU . 32.6 m -75.75 -30.13 59.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.303 -0.873 . . . . 0.0 109.079 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -84.33 -15.59 45.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 -34.98 22.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.37 -0.831 . . . . 0.0 109.286 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.831 ' HB3' HG21 ' E' ' 50' ' ' VAL . 4.8 t0 -81.81 -34.04 30.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.12 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.784 ' HG ' HG11 ' E' ' 50' ' ' VAL . 2.0 mt -88.55 -20.2 25.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.5 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.87 -35.85 3.92 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.72 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.6 OUTLIER -53.2 168.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -1.114 . . . . 0.0 109.419 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.76 167.69 10.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.031 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . 0.476 ' NE2' ' HB ' ' E' ' 17' ' ' THR . 65.4 mt-30 -68.11 -11.88 59.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -77.7 -28.41 50.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.204 -0.935 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.09 -36.94 20.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mt -71.68 -22.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.455 ' OD1' ' OE1' ' E' ' 16' ' ' GLN . 1.6 m120 -77.81 -52.71 8.46 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -26.95 68.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -0.962 . . . . 0.0 108.82 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.41 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -69.91 -45.17 68.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.879 . . . . 0.0 108.738 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 HG21 ' E' ' 34' ' ' ILE . 12.3 mt -71.74 -21.89 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -75.99 -16.8 59.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.248 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -18.18 30.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.316 -0.865 . . . . 0.0 109.228 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.17 21.85 62.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.4 172.31 9.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -1.166 . . . . 0.0 109.64 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.557 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -88.34 74.26 8.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.41 HD13 ' HB1' ' E' ' 33' ' ' ALA . 10.7 mt -97.89 107.16 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.735 ' CD2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -98.52 155.56 17.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.272 -0.893 . . . . 0.0 109.641 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.573 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 mp -119.53 103.75 9.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 29.9 m -88.94 99.74 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 108.882 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.481 HD12 ' O ' ' E' ' 3' ' ' GLN . 1.0 OUTLIER -90.04 122.36 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.916 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' CB ' ' E' ' 49' ' ' SER . 2.5 m120 -77.67 146.89 35.79 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.34 -19.26 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.64 33.65 0.65 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.984 -1.072 . . . . 0.0 109.476 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.01 26.5 55.68 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.58 152.54 20.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.494 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' E' ' 22' ' ' ASP . 3.8 t -118.15 128.82 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 44.4 t80 -133.78 77.18 1.7 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.225 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.47 131.82 37.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.902 . . . . 0.0 109.443 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.4 152.98 46.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 0.6 OUTLIER -96.21 131.36 42.76 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' E' ' 41' ' ' PHE . 0.1 OUTLIER -146.14 105.37 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.02 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 2.5 tptt -148.55 136.76 11.42 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' E' ' 59' ' ' PRO . 36.4 Cg_endo -78.57 165.48 25.0 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.615 2.21 . . . . 0.0 110.73 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -86.2 147.28 44.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.126 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.596 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.5 Cg_endo -78.86 -162.01 2.87 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.28 -1.55 . . . . 0.0 110.431 0.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.1 t -90.02 -13.52 35.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -90.36 -170.69 2.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.59 139.92 30.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.82 -159.25 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 109.212 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.61 142.34 29.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.473 ' O ' HG23 ' E' ' 65' ' ' THR . 15.3 t -115.38 129.81 56.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.373 179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.4 mp0 -61.91 170.68 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.071 -1.018 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.828 ' O ' HD12 ' D' ' 44' ' ' ILE . 2.2 mt-30 -83.31 73.67 10.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.883 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.544 ' C ' HD12 ' D' ' 5' ' ' ILE . 9.1 mmt85 -89.6 119.14 29.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.57 HD12 ' N ' ' D' ' 5' ' ' ILE . 4.7 mp -146.64 151.2 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.337 -0.852 . . . . 0.0 109.185 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.475 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.0 m -75.68 156.11 35.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.542 ' HA ' HD22 ' D' ' 42' ' ' LEU . 18.8 tp -59.04 -19.43 43.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.668 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.482 ' O ' ' CE ' ' D' ' 12' ' ' MET . 0.4 OUTLIER -84.04 -37.07 22.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.112 -0.992 . . . . 0.0 110.066 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.7 OUTLIER -77.91 -24.46 48.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.937 . . . . 0.0 109.396 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' D' ' 19' ' ' THR . 7.3 t80 -85.01 -31.26 23.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 109.066 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.22 -27.72 27.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.388 -0.82 . . . . 0.0 109.974 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' D' ' 13' ' ' ARG . 21.1 ptp -88.72 -37.99 15.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' D' ' 12' ' ' MET . 0.2 OUTLIER -80.86 -31.65 35.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.535 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 32.8 m-85 -108.73 -6.21 16.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 86.23 148.94 12.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.78 -18.09 62.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -1.091 . . . . 0.0 109.202 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 26.0 m -70.02 -33.99 72.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.304 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -86.38 -27.46 24.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 0.0 109.274 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.845 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.2 m -76.91 -26.27 53.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 108.774 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -85.39 -36.35 20.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.395 -0.815 . . . . 0.0 109.308 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -70.55 -37.45 74.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.94 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.827 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.1 OUTLIER -73.49 -41.17 63.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 0.0 109.348 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.845 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -85.76 -6.21 59.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.373 -0.829 . . . . 0.0 109.557 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.94 28.88 69.38 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' D' ' 23' ' ' LEU . 1.6 m -107.49 -172.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -1.209 . . . . 0.0 109.384 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.2 159.16 15.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 0.0 109.927 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -71.13 -29.56 65.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.845 . . . . 0.0 109.121 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.05 -16.02 61.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.452 -0.78 . . . . 0.0 109.296 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -86.94 -33.74 19.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.548 ' O ' ' CD1' ' D' ' 34' ' ' ILE . 57.0 mt -75.31 -32.9 26.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -71.86 -45.65 60.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 0.0 OUTLIER -67.23 -25.83 66.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -69.94 -43.07 72.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 108.972 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' D' ' 30' ' ' ILE . 1.7 mp -72.94 -26.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.215 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.48 -13.08 44.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.85 24.53 13.72 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.79 174.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -1.09 . . . . 0.0 109.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.494 ' HG3' ' CZ ' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -84.01 76.73 10.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 109.32 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.401 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 62.6 mt -109.37 97.73 6.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' D' ' 55' ' ' VAL . 2.5 m-85 -89.13 163.46 15.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.444 -0.785 . . . . 0.0 109.749 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.1 mp -124.96 124.33 41.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.634 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 11.4 m -116.15 100.42 7.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.828 HD12 ' O ' ' D' ' 3' ' ' GLN . 1.0 OUTLIER -99.51 115.76 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.797 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' D' ' 47' ' ' ASP . 6.8 m-80 -76.12 147.39 38.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.97 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.021 -0.425 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' D' ' 45' ' ' ASN . 4.4 m-20 -84.2 35.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.64 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 47.87 28.22 5.39 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.4 OUTLIER -90.36 130.81 36.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 109.214 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' D' ' 23' ' ' LEU . 6.4 t -90.18 138.51 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.834 -1.166 . . . . 0.0 109.567 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.478 ' O ' ' HB ' ' D' ' 43' ' ' THR . 4.2 t80 -145.83 76.53 1.47 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 109.079 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.58 147.49 32.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 3.7 mt-10 -140.15 161.25 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.743 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 13.6 tt0 -115.72 139.4 50.18 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -156.8 113.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.043 -1.036 . . . . 0.0 109.83 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.74 130.53 6.06 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.373 -0.829 . . . . 0.0 108.823 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.14 140.92 22.92 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.441 2.094 . . . . 0.0 111.074 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' D' ' 58' ' ' PHE . 0.8 OUTLIER -138.43 147.56 55.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.535 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 36.7 Cg_endo -82.76 -6.74 48.83 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.349 -1.521 . . . . 0.0 110.387 -0.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -53.49 154.36 3.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -146.55 -156.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -107.87 178.66 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 109.386 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -81.97 -70.16 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.472 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 41.63 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.529 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.43 149.19 23.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.401 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 131.93 45.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.73 93.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 109.551 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.475 ' O ' HG13 ' E' ' 5' ' ' ILE . 0.5 OUTLIER -94.03 114.78 27.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 4.4 mp -146.8 134.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.491 -0.756 . . . . 0.0 109.047 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -70.02 152.68 44.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 109.213 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' E' ' 19' ' ' THR . 55.6 tp -56.3 -16.31 5.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.675 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.2 OUTLIER -90.24 -34.7 15.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.266 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 0.5 OUTLIER -79.85 -24.77 41.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.6 t80 -84.22 -37.54 21.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.107 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.698 ' HB1' ' HG2' ' E' ' 16' ' ' GLN . . . -78.73 -23.79 45.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.788 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.98 -39.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 110.623 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 4.9 mtp180 -87.99 -12.89 43.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.04 -1.037 . . . . 0.0 110.248 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.3 m-85 -127.23 -2.11 6.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 109.806 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.15 135.63 7.0 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.698 ' HG2' ' HB1' ' E' ' 11' ' ' ALA . 29.8 mt-30 -63.97 -21.78 66.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -1.089 . . . . 0.0 109.314 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.0 m -72.79 -28.16 62.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.352 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.434 ' CD ' ' O ' ' E' ' 14' ' ' PHE . 55.0 mttt -78.95 -38.58 36.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.361 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.742 HG21 ' CD1' ' E' ' 7' ' ' LEU . 26.9 m -71.04 -32.09 68.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 108.869 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -83.69 -14.38 51.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.173 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -86.84 -32.9 20.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 108.927 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 -34.17 31.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 108.915 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.5 ' CB ' HG22 ' E' ' 25' ' ' VAL . 13.8 mt -86.48 -25.33 25.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.57 -0.706 . . . . 0.0 109.116 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.47 -19.39 36.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.5 HG22 ' CB ' ' E' ' 23' ' ' LEU . 1.5 m -58.59 175.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -1.093 . . . . 0.0 109.467 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -85.18 150.26 24.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 109.324 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -64.87 -29.09 70.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.109 -0.994 . . . . 0.0 108.907 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' E' ' 32' ' ' LYS . 0.7 OUTLIER -75.86 -18.38 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.15 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.36 39.46 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 2.7 mt -75.96 -29.83 20.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -69.46 -42.95 74.23 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' E' ' 28' ' ' SER . 27.2 mttt -65.96 -41.42 91.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.219 -0.925 . . . . 0.0 108.942 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -57.19 -41.1 78.68 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' E' ' 8' ' ' LYS . 22.6 mm -74.05 -25.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.044 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -74.63 -16.8 60.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.46 -0.775 . . . . 0.0 109.383 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -18.38 32.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.48 85.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.76 166.3 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -1.047 . . . . 0.0 109.512 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.575 ' HB3' ' CE1' ' E' ' 41' ' ' PHE . 5.7 mttt -82.6 74.49 9.57 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.223 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' HB1' ' E' ' 33' ' ' ALA . 1.6 mt -98.63 99.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.684 ' CE1' HG23 ' E' ' 55' ' ' VAL . 7.1 m-85 -87.8 158.18 18.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.774 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' E' ' 7' ' ' LEU . 1.2 mp -127.32 105.16 8.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -92.77 109.3 20.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.025 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' E' ' 49' ' ' SER . 4.3 mt -99.76 88.27 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.043 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' E' ' 49' ' ' SER . 70.6 m-20 -42.66 140.27 1.34 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 109.578 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.4 -23.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.802 -0.561 . . . . 0.0 110.901 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' E' ' 45' ' ' ASN . 26.2 m-20 -82.96 30.46 0.44 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 110.024 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.87 22.64 48.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.95 119.35 31.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -1.107 . . . . 0.0 109.374 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.61 142.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.962 -1.086 . . . . 0.0 109.562 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.461 ' CZ ' ' HG3' ' E' ' 53' ' ' GLU . 7.8 t80 -148.33 78.77 1.43 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 58' ' ' PHE . . . -78.21 143.64 36.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.365 -0.835 . . . . 0.0 109.976 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' CZ ' ' E' ' 51' ' ' TYR . 0.9 OUTLIER -137.5 161.25 36.87 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.546 -0.721 . . . . 0.0 109.09 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 29.2 tt0 -113.73 135.41 53.98 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.81 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -155.47 106.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.66 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.37 131.55 7.74 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 109.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -77.91 163.91 28.07 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.884 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.676 ' CZ ' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -151.64 147.4 20.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.447 -0.783 . . . . 0.0 108.916 179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' E' ' 58' ' ' PHE . 35.4 Cg_endo -76.83 -160.22 2.26 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.223 -1.574 . . . . 0.0 110.617 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 28.5 p -46.56 -27.37 1.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -116.86 141.09 48.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.63 26.81 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.159 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . 0.468 ' O ' HG23 ' E' ' 64' ' ' THR . 0.3 OUTLIER -176.59 -72.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.376 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . 0.468 HG23 ' O ' ' E' ' 63' ' ' LYS . 44.8 p -157.16 -171.77 3.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.547 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.407 ' O ' ' O ' ' E' ' 66' ' ' ALA . 1.8 m -85.51 75.36 10.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.516 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.297 0.57 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -117.08 103.97 10.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.218 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' D' ' 44' ' ' ILE . 64.8 mt-30 -84.78 109.29 17.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 1.025 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.4 OUTLIER -108.14 114.83 29.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 108.804 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 1.025 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -143.36 141.97 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.94 . . . . 0.0 109.462 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 1.7 m -69.15 145.91 52.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.351 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 1.003 ' HB2' HD13 ' D' ' 42' ' ' LEU . 15.2 tp -57.29 -15.97 7.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.586 ' HA ' HD11 ' D' ' 34' ' ' ILE . 8.7 pttp -89.09 -30.34 18.72 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 110.037 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 73.2 m-20 -82.43 -31.44 29.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.173 -0.955 . . . . 0.0 110.124 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 4.2 t80 -80.71 -30.66 36.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.002 . . . . 0.0 109.198 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.62 -31.9 36.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 4.3 tpt -90.47 -31.1 16.93 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 120.923 -1.111 . . . . 0.0 109.981 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.5 mtm180 -82.55 -38.92 23.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.023 -1.048 . . . . 0.0 109.736 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 60.0 m-85 -97.0 -38.12 9.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.287 -0.883 . . . . 0.0 109.739 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.81 133.73 3.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.466 HE21 HG22 ' D' ' 30' ' ' ILE . 17.6 mt-30 -67.18 -28.6 68.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 85.0 m -70.23 -36.46 74.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.776 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -73.9 -34.01 64.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.421 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.659 ' O ' HD12 ' D' ' 23' ' ' LEU . 26.0 m -66.76 -40.61 88.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.347 -0.845 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -72.07 -24.21 61.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.405 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -79.02 -26.94 43.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' D' ' 50' ' ' VAL . 4.7 t0 -83.76 -37.59 22.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -0.854 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.659 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -84.98 -12.81 52.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.14 36.71 80.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.32 177.36 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -1.21 . . . . 0.0 109.337 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 157.9 20.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.235 -0.916 . . . . 0.0 109.284 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -24.75 64.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 0.0 109.275 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' D' ' 32' ' ' LYS . 0.1 OUTLIER -73.42 -22.08 60.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.33 28.2 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' D' ' 20' ' ' ALA . 21.0 mm -79.76 -35.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -74.96 -35.74 62.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.0 109.259 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' D' ' 28' ' ' SER . 0.3 OUTLIER -71.87 -33.92 68.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.316 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.23 78.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.255 -0.903 . . . . 0.0 109.129 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' D' ' 8' ' ' LYS . 20.1 mm -68.16 -34.49 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.837 . . . . 0.0 108.949 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -29.66 70.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.506 -0.746 . . . . 0.0 109.5 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' D' ' 38' ' ' ARG . . . -77.57 -20.46 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.347 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 39.75 10.0 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.845 ' HD2' ' HB1' ' D' ' 36' ' ' ALA . 1.2 mtt180 -89.97 -167.36 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 1.1 mmmt -85.13 79.67 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.758 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.42 93.69 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' D' ' 41' ' ' PHE . 2.0 m-85 -81.5 160.88 23.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.505 -0.747 . . . . 0.0 109.961 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.7 tp -133.13 99.89 4.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.59 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 73.7 m -93.84 114.1 26.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.079 -1.013 . . . . 0.0 109.284 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' D' ' 3' ' ' GLN . 0.9 OUTLIER -102.82 128.91 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.942 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' D' ' 49' ' ' SER . 9.3 m120 -83.91 139.54 32.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.389 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.89 -18.95 0.2 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.674 -0.641 . . . . 0.0 110.829 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.97 32.6 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.988 -1.07 . . . . 0.0 109.617 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.82 21.39 55.27 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' D' ' 45' ' ' ASN . 0.2 OUTLIER -90.9 160.05 15.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.734 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.565 HG11 ' HG ' ' D' ' 23' ' ' LEU . 41.2 t -123.18 145.85 29.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 109.155 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' D' ' 51' ' ' TYR . 27.2 t80 -157.42 77.52 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -80.03 154.75 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.18 161.77 32.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.341 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' E' ' 56' ' ' LYS . 1.6 tp10 -123.65 119.73 30.7 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.555 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.2 OUTLIER -139.75 100.93 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.773 -178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 0.0 OUTLIER -153.81 132.41 6.77 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.493 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 34.9 Cg_endo -76.82 145.27 25.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 0.0 111.013 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.745 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.4 OUTLIER -87.69 172.0 8.69 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 35.2 Cg_endo -77.13 -179.3 26.85 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.674 -1.386 . . . . 0.0 110.65 0.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 31.5 m -89.99 173.04 8.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' D' ' 61' ' ' ASN . 35.7 p30 -139.15 26.06 2.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.682 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.13 151.64 28.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.444 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 95.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.673 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -89.73 161.28 16.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.274 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -171.18 2.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.308 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.261 0.553 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.61 93.54 3.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.251 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -90.31 117.83 29.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.84 . . . . 0.0 110.031 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.471 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.2 mmt-85 -114.16 120.34 40.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 108.906 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.496 ' CG2' ' HB3' ' E' ' 9' ' ' ASP . 4.7 mp -147.03 148.15 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.132 -0.98 . . . . 0.0 109.585 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.643 HG23 ' O ' ' E' ' 40' ' ' ILE . 25.1 m -71.7 142.39 49.82 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.071 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.949 ' HB2' HD13 ' E' ' 42' ' ' LEU . 20.3 tp -52.66 -19.08 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' E' ' 34' ' ' ILE . 0.0 OUTLIER -82.45 -36.0 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.827 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -76.93 -28.19 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.728 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' E' ' 19' ' ' THR . 5.0 t80 -80.86 -32.06 35.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -86.31 -27.66 24.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -31.94 16.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.8 OUTLIER -90.15 -31.06 17.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.154 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.4 m-85 -107.97 -39.21 5.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.036 -1.04 . . . . 0.0 109.6 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.39 138.78 3.64 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.52 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 4.3 mt-30 -79.71 -21.25 44.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.352 -1.087 . . . . 0.0 109.405 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -49.54 61.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' E' ' 14' ' ' PHE . 0.1 OUTLIER -72.24 -26.65 62.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.239 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.672 HG21 ' CD1' ' E' ' 7' ' ' LEU . 73.0 m -70.38 -36.02 73.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 109.251 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' E' ' 25' ' ' VAL . . . -79.71 -19.84 47.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -77.36 -40.1 45.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.263 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.17 -30.4 49.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.859 . . . . 0.0 109.351 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.745 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 5.1 mt -86.46 -18.28 32.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.82 22.75 63.31 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 0.1 OUTLIER -109.77 -178.5 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -1.181 . . . . 0.0 109.438 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -103.81 167.84 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' E' ' 31' ' ' ASN . 0.0 OUTLIER -70.69 -9.32 56.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.949 . . . . 0.0 109.429 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t -85.49 -26.45 26.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -86.55 -26.38 24.55 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' E' ' 20' ' ' ALA . 13.2 mm -80.19 -33.26 14.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' E' ' 27' ' ' GLN . 1.3 m-20 -79.25 -31.42 43.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.551 -0.718 . . . . 0.0 109.351 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.0 OUTLIER -78.44 -28.26 46.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.157 -0.964 . . . . 0.0 109.375 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.633 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -77.28 -38.16 51.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' E' ' 8' ' ' LYS . 72.1 mt -80.48 -32.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.11 -14.64 63.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 0.0 109.649 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.01 -19.08 27.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.87 91.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -87.67 170.92 10.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -1.138 . . . . 0.0 109.649 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.592 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.5 OUTLIER -85.83 73.2 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.86 . . . . 0.0 109.51 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.643 ' O ' HG23 ' E' ' 6' ' ' THR . 9.8 mt -100.31 97.05 5.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.664 ' CE2' HG23 ' E' ' 55' ' ' VAL . 3.1 m-30 -81.75 161.65 23.23 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.357 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 1.13 HD12 ' HB2' ' E' ' 52' ' ' ALA . 2.6 tp -137.19 109.88 7.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.121 -0.987 . . . . 0.0 110.554 -178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -84.63 140.82 31.08 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' E' ' 49' ' ' SER . 3.3 mt -129.09 113.18 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.969 -1.082 . . . . 0.0 110.139 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' E' ' 49' ' ' SER . 1.5 t-20 -90.7 153.82 20.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.514 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.62 -18.34 1.71 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.815 -0.553 . . . . 0.0 110.421 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -88.26 35.59 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.026 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.79 35.84 31.93 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' CB ' ' E' ' 45' ' ' ASN . 1.5 m -89.75 141.69 28.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.511 -0.994 . . . . 0.0 109.405 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.12 98.03 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -107.58 83.07 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.399 -0.813 . . . . 0.0 109.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 1.13 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -81.11 148.38 29.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.876 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -141.02 149.32 41.58 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.406 -0.809 . . . . 0.0 109.304 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 30.8 tt0 -98.16 126.2 43.52 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.664 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -140.65 98.09 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.411 -0.805 . . . . 0.0 109.565 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -146.45 134.57 10.68 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.809 . . . . 0.0 109.199 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 36.4 Cg_endo -79.45 173.16 13.5 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.514 2.143 . . . . 0.0 110.733 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.593 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 0.1 OUTLIER -98.65 150.27 36.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.212 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.593 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -79.53 -158.99 1.86 Allowed 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.368 -1.513 . . . . 0.0 110.399 -0.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 16.7 m -83.49 -147.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.311 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' E' ' 62' ' ' LYS . 8.3 p-10 -104.68 173.76 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . 0.464 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 0.1 OUTLIER -83.78 175.38 9.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . 0.46 ' O ' HG23 ' E' ' 64' ' ' THR . 0.0 OUTLIER -178.54 175.14 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.372 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . 0.46 HG23 ' O ' ' E' ' 63' ' ' LYS . 1.1 p -154.82 123.97 6.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -138.57 82.6 1.91 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.196 -0.94 . . . . 0.0 109.38 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.271 0.558 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' D' ' 2' ' ' GLU . 1.2 mp0 -103.4 136.17 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -90.13 122.67 33.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 109.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.434 ' C ' HG13 ' D' ' 5' ' ' ILE . 1.7 mmt-85 -99.5 132.98 44.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.673 HG22 ' H ' ' D' ' 6' ' ' THR . 0.7 OUTLIER -145.04 -177.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 0.0 108.846 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.673 ' H ' HG22 ' D' ' 5' ' ' ILE . 1.0 OUTLIER -106.29 152.96 22.86 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.634 HD11 HG23 ' D' ' 30' ' ' ILE . 11.2 tp -63.75 -25.41 68.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.108 -0.995 . . . . 0.0 109.047 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -84.52 -33.23 23.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 4.8 m-20 -77.68 -23.61 49.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.195 -0.941 . . . . 0.0 109.393 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.578 ' CD1' HG23 ' D' ' 19' ' ' THR . 8.0 t80 -86.96 -33.3 19.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.023 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.569 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -82.14 -24.66 34.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mmt -89.92 -48.5 7.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 3.8 mtt-85 -72.07 -27.02 62.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.503 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' D' ' 10' ' ' TYR . 6.7 m-85 -119.03 9.11 11.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.19 -0.943 . . . . 0.0 109.598 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 69.32 138.42 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.569 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 2.2 mt-30 -59.92 -15.31 20.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 29.0 m -70.17 -46.97 63.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -71.88 -26.18 62.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.61 HG22 HD12 ' D' ' 23' ' ' LEU . 2.3 m -72.31 -42.15 65.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -78.36 -17.0 57.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.79 -38.52 21.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.567 ' HB3' HG21 ' D' ' 50' ' ' VAL . 26.4 m-20 -81.67 -30.23 32.76 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.414 -0.804 . . . . 0.0 109.15 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.703 ' HG ' HG11 ' D' ' 50' ' ' VAL . 7.9 mt -86.34 -22.81 26.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.895 . . . . 0.0 109.39 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 96.74 -37.81 3.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' D' ' 24' ' ' GLY . 0.1 OUTLIER -53.47 -170.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 109.467 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -113.17 172.02 7.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.652 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -71.31 -24.99 62.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.604 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.04 -20.94 59.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.41 18.97 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' D' ' 20' ' ' ALA . 6.5 mt -72.13 -24.8 22.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.67 -47.06 50.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.713 . . . . 0.0 109.186 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -71.57 -21.47 61.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.086 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -76.27 -37.12 57.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 108.858 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 23.6 mt -81.56 -24.23 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -74.01 -38.37 64.09 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.386 -0.821 . . . . 0.0 109.051 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.62 -18.56 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.05 34.61 84.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -84.17 -177.23 6.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.167 -1.196 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -91.88 80.68 5.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.778 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 96.0 mt -108.61 113.21 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.583 ' CD2' HG21 ' D' ' 55' ' ' VAL . 7.6 m-30 -110.64 145.42 37.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.521 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' D' ' 7' ' ' LEU . 2.5 mp -98.08 133.68 42.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 2.6 m -118.65 118.87 32.81 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' D' ' 49' ' ' SER . 2.5 mm -105.6 129.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.139 -0.975 . . . . 0.0 110.552 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' D' ' 47' ' ' ASP . 9.7 m120 -83.4 144.57 29.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.326 -0.859 . . . . 0.0 109.128 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.78 -24.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.722 -0.611 . . . . 0.0 110.905 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.8 OUTLIER -82.87 30.72 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.722 -1.236 . . . . 0.0 110.165 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.27 24.7 45.74 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.532 ' O ' ' CG2' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -90.52 155.85 18.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -1.123 . . . . 0.0 109.192 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.703 HG11 ' HG ' ' D' ' 23' ' ' LEU . 4.0 t -106.49 155.01 7.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' E' ' 57' ' ' PRO . 4.2 t80 -156.18 76.71 0.92 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 108.989 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.55 133.41 37.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.247 -0.908 . . . . 0.0 109.359 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' D' ' 51' ' ' TYR . 9.8 mt-10 -140.44 148.7 41.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.344 -0.848 . . . . 0.0 110.081 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.54 ' HG2' ' N ' ' D' ' 55' ' ' VAL . 24.1 tt0 -84.06 153.49 23.77 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 1.047 ' CG1' HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -149.36 124.88 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 118.509 -1.277 . . . . 0.0 109.845 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -159.97 138.58 7.7 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.552 -0.718 . . . . 0.0 109.516 -178.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.511 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.1 Cg_endo -76.88 146.77 26.49 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.459 2.106 . . . . 0.0 110.758 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' E' ' 52' ' ' ALA . 0.7 OUTLIER -118.37 155.99 51.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.4 Cg_endo -80.16 176.82 39.36 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.24 -1.567 . . . . 0.0 110.33 -0.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.6 t -89.96 -66.92 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.176 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.88 149.91 20.83 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.312 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -100.55 42.05 1.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.03 34.51 0.82 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.404 HG22 ' O ' ' D' ' 64' ' ' THR . 19.9 m -98.0 48.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.505 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.77 90.37 3.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.428 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.67 166.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.44 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.2 110.24 18.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.26 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 1.064 ' O ' HD13 ' E' ' 5' ' ' ILE . 5.9 mmt-85 -102.4 123.94 47.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 1.064 HD13 ' O ' ' E' ' 4' ' ' ARG . 1.6 mm -139.95 129.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.202 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 19.2 m -66.01 153.54 41.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 109.241 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' E' ' 42' ' ' LEU . 35.0 tp -58.4 -16.89 16.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HA ' HD11 ' E' ' 34' ' ' ILE . 0.9 OUTLIER -90.66 -33.43 15.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 76.4 m-20 -79.08 -25.56 43.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 109.559 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' E' ' 14' ' ' PHE . 10.9 t80 -80.45 -36.0 34.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -83.02 -24.7 32.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.076 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 39.5 mtt -89.98 -36.32 15.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.042 -1.036 . . . . 0.0 110.224 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 3.2 mmt180 -86.6 -22.09 26.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 109.844 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 2.7 m-85 -115.62 -33.91 5.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.977 . . . . 0.0 109.603 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.53 147.34 7.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.523 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.04 -26.89 65.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -1.152 . . . . 0.0 109.264 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.45 ' H ' HG22 ' E' ' 17' ' ' THR . 0.5 OUTLIER -70.2 -24.27 63.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.27 -0.894 . . . . 0.0 109.152 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' E' ' 14' ' ' PHE . 12.8 mttm -82.7 -54.51 5.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.264 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.677 ' O ' HD12 ' E' ' 23' ' ' LEU . 55.1 m -60.09 -28.6 67.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.528 -0.733 . . . . 0.0 109.446 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.649 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -83.24 -25.34 31.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.865 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -26.6 58.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.118 -0.989 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -88.55 -35.87 16.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.094 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.677 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -89.15 -9.81 49.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.38 44.81 89.84 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.549 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.6 OUTLIER -111.82 -169.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -1.175 . . . . 0.0 109.45 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.549 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.3 OUTLIER -97.38 156.57 16.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.478 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -65.76 -34.02 77.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -76.25 -10.62 59.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.835 . . . . 0.0 109.425 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' E' ' 32' ' ' LYS . . . -84.87 -36.29 21.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.649 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.2 mp -78.88 -35.18 17.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -35.03 70.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 108.925 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' E' ' 29' ' ' ALA . 2.0 pttt -77.12 -35.45 56.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.242 -0.911 . . . . 0.0 109.047 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.14 -38.6 89.58 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' E' ' 8' ' ' LYS . 59.0 mt -78.36 -30.96 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -67.06 -26.0 66.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.433 -0.792 . . . . 0.0 109.064 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.0 -18.03 35.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 27.98 61.8 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -72.63 177.19 4.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -1.232 . . . . 0.0 109.461 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 2.2 mptp? -88.87 79.35 7.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.468 HD13 ' HB1' ' E' ' 33' ' ' ALA . 9.5 mt -113.42 103.59 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 2.2 m-30 -96.49 160.93 14.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.806 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 mp -126.04 102.74 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 109.735 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.741 HG22 ' O ' ' E' ' 51' ' ' TYR . 2.7 t -87.19 115.47 24.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 109.288 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.692 HD11 HG13 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -104.67 106.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.945 -1.097 . . . . 0.0 109.481 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' E' ' 47' ' ' ASP . 3.6 m120 -64.51 145.69 55.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 109.831 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.83 -25.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.905 -0.497 . . . . 0.0 110.555 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.8 OUTLIER -85.05 32.56 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.609 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.3 31.85 28.29 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' E' ' 45' ' ' ASN . 1.1 p -90.43 111.61 22.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -1.171 . . . . 0.0 109.39 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.61 121.47 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.941 -1.099 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.741 ' O ' HG22 ' E' ' 43' ' ' THR . 39.9 t80 -136.14 95.12 3.14 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.646 ' CB ' ' CE2' ' D' ' 58' ' ' PHE . . . -78.87 151.64 31.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.107 -0.995 . . . . 0.0 110.49 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 2.2 mt-10 -138.8 160.28 40.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.588 -0.695 . . . . 0.0 109.267 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.5 ' O ' HG12 ' D' ' 55' ' ' VAL . 6.7 tp10 -111.57 145.08 39.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 1.047 HG13 ' CG1' ' D' ' 55' ' ' VAL . 0.0 OUTLIER -159.01 107.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.493 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -132.89 142.8 46.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 108.907 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.537 ' HB3' ' CZ ' ' D' ' 51' ' ' TYR . 34.0 Cg_endo -75.9 164.1 32.27 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.463 2.108 . . . . 0.0 111.721 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' E' ' 59' ' ' PRO . 1.6 m-85 -80.05 164.43 52.7 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.617 -0.677 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -80.26 150.33 81.08 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.131 -1.612 . . . . 0.0 110.161 -0.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -90.2 25.04 2.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 0.0 109.797 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -98.61 166.43 11.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' E' ' 63' ' ' LYS . 5.9 mtpp -82.55 170.71 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' E' ' 62' ' ' LYS . 25.0 tptt 65.62 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -111.82 118.01 34.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.37 -0.831 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.56 158.89 16.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.551 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.519 179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -119.71 136.01 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -88.68 98.33 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.775 ' O ' HD13 ' D' ' 5' ' ' ILE . 0.3 OUTLIER -90.21 110.89 21.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.313 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.775 HD13 ' O ' ' D' ' 4' ' ' ARG . 1.5 mm -134.34 139.3 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 108.921 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.408 HG22 ' O ' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -74.64 151.69 39.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.533 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.655 HD11 HD12 ' D' ' 30' ' ' ILE . 18.1 tp -58.77 -20.65 51.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 109.149 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.1 OUTLIER -88.86 -25.0 22.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 0.3 OUTLIER -83.34 -36.63 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.107 -0.995 . . . . 0.0 109.963 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.567 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 3.3 t80 -80.04 -34.56 38.16 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 108.85 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -78.58 -30.54 46.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.43 -0.794 . . . . 0.0 110.512 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 2.0 mmt -90.43 -37.52 13.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 110.526 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.499 ' HB2' ' CE1' ' D' ' 14' ' ' PHE . 57.4 mtt-85 -81.99 -19.84 39.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 110.269 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.8 m-85 -118.48 -35.22 3.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.0 -1.063 . . . . 0.0 110.027 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.5 130.11 2.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.456 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 3.6 mt-30 -66.4 -32.56 74.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -67.8 -31.41 71.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 24.2 mttp -75.72 -34.91 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.373 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.643 HG21 ' CD1' ' D' ' 7' ' ' LEU . 92.8 m -66.5 -40.25 89.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.336 -0.853 . . . . 0.0 109.349 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -74.45 -19.58 60.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.96 . . . . 0.0 109.47 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' D' ' 21' ' ' LYS . 0.0 OUTLIER -77.95 -34.35 51.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.15 -31.77 30.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.525 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' E' ' 58' ' ' PHE . 1.3 mt -90.23 -12.61 37.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.337 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.06 79.75 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -90.52 -172.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.211 . . . . 0.0 109.607 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.02 171.15 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -69.43 -21.95 63.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.25 -19.31 39.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.33 -37.84 16.78 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.655 HD12 HD11 ' D' ' 7' ' ' LEU . 19.6 mm -72.68 -33.62 44.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 38.2 t30 -73.79 -40.66 63.26 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -63.88 -39.06 93.31 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -61.51 -42.49 98.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -0.804 . . . . 0.0 108.907 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' D' ' 34' ' ' ILE . 14.3 mm -72.93 -22.49 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.415 -0.803 . . . . 0.0 109.11 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 26.3 m170 -75.03 -33.94 61.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.443 -0.786 . . . . 0.0 109.26 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.62 -13.58 60.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.323 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.28 28.96 3.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.508 ' CG ' HG13 ' D' ' 40' ' ' ILE . 6.0 ptm180 -80.89 -179.34 7.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -1.139 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 12.8 mptt -84.04 79.0 9.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.908 . . . . 0.0 109.726 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.762 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 26.6 mt -98.69 106.47 18.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.645 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 7.4 m-85 -97.55 159.23 15.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.776 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.3 tp -127.39 95.38 4.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.762 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 3.0 m -85.88 104.39 15.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 108.916 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.533 HG23 ' O ' ' D' ' 49' ' ' SER . 2.2 mt -94.1 113.56 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.945 . . . . 0.0 109.88 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 49' ' ' SER . 2.3 m-80 -59.17 146.59 38.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.7 -19.87 0.4 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.011 0.434 . . . . 0.0 110.522 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -84.86 31.56 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.916 -1.115 . . . . 0.0 109.737 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.07 22.63 55.82 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.533 ' O ' HG23 ' D' ' 44' ' ' ILE . 0.1 OUTLIER -91.11 147.39 23.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -1.093 . . . . 0.0 109.183 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.42 136.59 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.276 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 1.0 OUTLIER -142.53 76.97 1.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.643 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.19 143.46 37.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.427 -0.796 . . . . 0.0 110.478 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -131.67 152.27 50.99 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 2.3 tt0 -106.91 124.3 49.43 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 108.731 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -139.98 92.7 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.12 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 1.6 tptp -141.79 139.09 17.82 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.196 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.479 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -76.8 141.87 22.04 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.451 2.101 . . . . 0.0 110.805 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.1 OUTLIER -93.49 167.55 13.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 108.997 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -79.04 175.23 47.19 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.586 -1.422 . . . . 0.0 110.674 -0.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 18.9 t -81.08 166.01 21.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.235 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -141.94 168.04 20.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.23 33.87 16.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.239 -0.913 . . . . 0.0 109.568 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 64' ' ' THR . 10.3 ptmt -81.39 -34.7 31.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.519 ' N ' ' HG3' ' D' ' 63' ' ' LYS . 0.2 OUTLIER -103.27 85.29 2.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 109.494 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -94.25 130.49 40.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.514 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.536 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -114.32 177.87 4.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 109.569 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 107.03 6.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.188 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.924 ' C ' HD13 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -111.8 100.74 9.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.162 -0.961 . . . . 0.0 109.969 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.924 HD13 ' C ' ' E' ' 4' ' ' ARG . 0.4 OUTLIER -127.18 130.66 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.291 -0.881 . . . . 0.0 108.704 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' E' ' 8' ' ' LYS . 0.4 OUTLIER -53.78 152.69 5.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.121 -0.987 . . . . 0.0 109.763 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.926 HD11 HD12 ' E' ' 30' ' ' ILE . 15.9 tp -57.06 -16.75 8.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.502 ' HG3' ' HB ' ' E' ' 6' ' ' THR . 0.0 OUTLIER -90.4 -30.08 17.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 110.051 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.598 ' CB ' HG22 ' E' ' 5' ' ' ILE . 30.3 m-20 -80.75 -30.32 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 109.75 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.568 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 19.1 t80 -83.24 -30.56 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.033 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.56 -30.68 46.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.776 . . . . 0.0 109.55 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -29.72 17.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.147 -0.97 . . . . 0.0 109.561 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' CE1' ' E' ' 14' ' ' PHE . 15.1 mmt85 -89.95 -13.49 36.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.122 -0.986 . . . . 0.0 110.059 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.4 m-85 -128.1 -34.9 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.69 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.07 142.45 4.27 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.6 -34.98 23.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -1.172 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.487 ' OG1' ' NE2' ' E' ' 27' ' ' GLN . 75.3 m -65.66 -35.12 79.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.514 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' E' ' 19' ' ' THR . 10.7 ptpt -79.65 -30.92 41.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.807 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.696 ' O ' HD12 ' E' ' 23' ' ' LEU . 83.3 m -68.57 -33.1 73.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 108.949 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.15 -30.66 34.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.93 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -76.69 -18.09 58.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.114 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.975 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.7 OUTLIER -88.69 -38.28 14.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.2 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.696 HD12 ' O ' ' E' ' 19' ' ' THR . 2.8 mt -90.06 -9.95 46.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.35 16.29 69.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' E' ' 23' ' ' LEU . 0.0 OUTLIER -93.89 -170.97 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.176 -1.191 . . . . 0.0 109.396 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.0 OUTLIER -111.13 168.65 9.34 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.308 -0.87 . . . . 0.0 109.38 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . 0.487 ' NE2' ' OG1' ' E' ' 17' ' ' THR . 7.2 mt-30 -67.05 -41.29 86.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . 0.517 ' O ' ' CD ' ' E' ' 32' ' ' LYS . 13.3 m -69.1 -8.18 42.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.375 -0.828 . . . . 0.0 109.413 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.05 -34.17 16.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.926 HD12 HD11 ' E' ' 7' ' ' LEU . 29.5 mm -72.78 -41.22 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -70.5 -44.98 66.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' E' ' 28' ' ' SER . 2.9 mtpp -61.29 -34.46 75.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.226 -0.921 . . . . 0.0 108.808 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.558 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -62.34 -41.62 98.73 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 7.1 mt -72.6 -21.35 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -77.48 -29.87 52.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 109.457 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.95 -13.58 47.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.51 19.44 13.18 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 166.32 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -1.166 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -82.03 78.76 8.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.558 HD13 ' HB1' ' E' ' 33' ' ' ALA . 1.9 mt -110.3 96.17 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.5 m-30 -87.85 158.74 18.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.33 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -122.29 111.09 16.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.071 -1.018 . . . . 0.0 110.013 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.47 ' OG1' ' HD3' ' E' ' 4' ' ' ARG . 51.8 m -94.94 89.23 5.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.056 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.533 HD12 HG12 ' E' ' 5' ' ' ILE . 1.1 mt -83.89 100.01 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.624 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' E' ' 47' ' ' ASP . 5.3 m-20 -67.89 146.59 53.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.02 -22.97 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.041 -0.412 . . . . 0.0 110.761 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -85.15 34.21 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.873 -1.142 . . . . 0.0 109.473 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.34 29.02 9.94 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.01 108.27 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -1.057 . . . . 0.0 109.616 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.975 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.9 t -79.72 112.47 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.897 -1.127 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 18.7 t80 -119.92 83.93 2.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 108.896 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -78.69 143.47 36.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 3.3 mt-10 -136.82 160.68 38.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -115.27 132.99 56.44 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.733 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -142.89 106.31 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.878 -178.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 0.6 OUTLIER -155.87 140.37 11.86 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.497 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.83 141.85 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.456 2.104 . . . . 0.0 110.732 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.705 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.1 OUTLIER -98.69 165.65 14.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.017 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -78.53 169.58 72.25 Favored 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.412 -0.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 99.9 p -89.66 -161.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 76.21 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.564 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -134.62 138.88 44.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 90.03 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 13.4 t -127.64 161.29 29.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.922 . . . . 0.0 109.311 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.678 ' O ' ' HB2' ' E' ' 66' ' ' ALA . 7.8 t -123.57 159.0 30.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.644 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.394 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.327 0.584 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -47.97 114.67 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.705 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' D' ' 5' ' ' ILE . 9.6 mp0 -67.43 90.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.623 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.473 ' O ' HG13 ' D' ' 5' ' ' ILE . 4.6 mmt85 -94.33 110.46 22.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' D' ' 42' ' ' LEU . 3.0 mp -144.28 150.65 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 108.783 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.1 148.53 37.82 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 109.711 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' D' ' 42' ' ' LEU . 27.6 tp -52.99 -22.92 6.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.507 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 49.8 pttt -79.64 -35.65 39.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -77.61 -30.29 52.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 -179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' D' ' 19' ' ' THR . 12.6 t80 -78.36 -35.96 46.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.003 -1.061 . . . . 0.0 109.845 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.63 -27.15 40.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.492 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -89.35 -39.1 13.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.924 -1.11 . . . . 0.0 110.744 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 0.5 OUTLIER -83.29 -23.78 32.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 109.941 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.1 m-85 -113.89 -37.18 4.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.626 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.5 136.31 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.536 ' HB3' HG21 ' D' ' 30' ' ' ILE . 0.8 OUTLIER -78.99 -19.61 51.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.361 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . 0.486 HG23 ' N ' ' D' ' 18' ' ' LYS . 5.0 t -71.4 -41.35 69.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.905 . . . . 0.0 109.702 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.4 OUTLIER -80.36 -24.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.952 . . . . 0.0 109.537 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.992 ' O ' HD12 ' D' ' 23' ' ' LEU . 85.6 m -73.36 -31.42 63.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.967 . . . . 0.0 109.005 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.98 ' HB2' HG13 ' D' ' 30' ' ' ILE . . . -79.65 -36.61 37.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.357 -0.84 . . . . 0.0 109.518 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -71.17 -32.08 68.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -35.39 56.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 109.604 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.992 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -81.04 -21.91 39.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 109.633 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.01 14.03 53.04 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' E' ' 59' ' ' PRO . 0.0 OUTLIER -107.01 -178.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.304 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.74 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 1.3 p90 -101.3 169.01 9.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.139 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -40.54 96.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.499 -0.751 . . . . 0.0 109.905 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' D' ' 32' ' ' LYS . 3.9 m -59.18 -17.8 30.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.79 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.74 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -88.61 -30.94 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 108.669 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.98 HG13 ' HB2' ' D' ' 20' ' ' ALA . 14.4 mm -76.83 -27.95 16.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.553 -0.717 . . . . 0.0 109.226 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 45.7 t30 -81.76 -43.13 18.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.051 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' D' ' 28' ' ' SER . 1.3 pttp -71.2 -22.99 61.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.331 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.76 -39.88 30.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.319 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.54 HD11 ' HG ' ' D' ' 7' ' ' LEU . 23.9 mm -76.97 -26.37 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 109.234 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 31.5 m-70 -74.6 -39.23 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.43 -0.794 . . . . 0.0 109.557 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' D' ' 37' ' ' GLY . . . -72.58 -18.43 61.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' D' ' 36' ' ' ALA . . . 42.38 44.88 5.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.512 ' HG3' ' CG1' ' D' ' 40' ' ' ILE . 0.2 OUTLIER -86.45 55.65 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -1.14 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' D' ' 38' ' ' ARG . 6.5 mttt 39.33 73.32 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.792 0.806 . . . . 0.0 110.268 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.512 ' CG1' ' HG3' ' D' ' 38' ' ' ARG . 47.5 mt -109.69 103.57 15.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 3.8 m-85 -89.12 163.16 15.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.935 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.9 tp -125.46 106.89 10.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.729 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' HG22 ' D' ' 43' ' ' THR . 2.7 m -98.3 94.44 6.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.318 -0.863 . . . . 0.0 108.887 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' D' ' 49' ' ' SER . 9.3 mt -93.11 98.68 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.996 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.96 144.96 13.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.99 -20.21 0.14 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.927 -0.483 . . . . 0.0 110.765 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 31.88 0.51 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.894 -1.129 . . . . 0.0 109.683 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.12 25.17 53.49 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.2 OUTLIER -91.11 111.73 23.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -1.121 . . . . 0.0 109.623 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.519 HG12 HD21 ' D' ' 23' ' ' LEU . 28.0 t -79.79 124.38 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.495 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 69.1 t80 -136.47 80.98 1.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.388 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -79.07 146.9 33.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.721 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 1.4 mt-10 -140.41 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.066 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 17.1 tt0 -109.22 138.42 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -148.84 106.67 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.075 -1.015 . . . . 0.0 109.761 -179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 1.3 ttpt -152.7 134.23 8.38 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.408 -0.807 . . . . 0.0 108.964 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.4 Cg_endo -77.37 161.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.352 2.034 . . . . 0.0 110.74 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' E' ' 52' ' ' ALA . 0.2 OUTLIER -115.0 165.76 13.32 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.377 -0.827 . . . . 0.0 109.198 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' D' ' 58' ' ' PHE . 33.7 Cg_endo -75.87 156.29 98.87 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.266 -1.556 . . . . 0.0 110.623 0.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 41.7 t -73.88 118.9 17.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -141.82 -173.47 3.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.226 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' D' ' 63' ' ' LYS . 2.2 mtmt -96.06 82.99 3.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' D' ' 62' ' ' LYS . 2.3 mttt 42.96 50.68 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.88 127.87 39.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.986 . . . . 0.0 109.314 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -154.98 101.19 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.532 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . 0.408 ' HG2' ' CG ' ' E' ' 4' ' ' ARG . 10.2 tt0 -144.99 84.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.497 ' HB3' ' HB ' ' E' ' 44' ' ' ILE . 0.0 OUTLIER -86.4 81.71 8.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.902 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.55 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.4 OUTLIER -107.42 124.25 49.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.205 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.55 HD12 ' C ' ' E' ' 4' ' ' ARG . 3.2 mp -153.94 157.03 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 109.032 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.45 ' N ' HG22 ' E' ' 5' ' ' ILE . 1.1 m -81.89 150.19 27.88 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.222 -0.924 . . . . 0.0 108.885 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.704 ' HB2' HD13 ' E' ' 42' ' ' LEU . 22.5 tp -55.01 -17.89 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.495 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.473 ' C ' ' CD ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -87.86 -34.29 18.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 110.117 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -82.42 -19.12 39.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.964 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.603 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.8 t80 -88.0 -31.89 19.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.34 -0.85 . . . . 0.0 109.229 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.99 -26.25 23.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -33.04 16.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 0.2 OUTLIER -90.26 -33.37 16.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.517 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 8.1 m-85 -102.17 -50.18 3.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.985 -1.072 . . . . 0.0 109.74 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.43 144.86 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.89 -21.75 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -1.102 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.446 HG23 ' N ' ' E' ' 18' ' ' LYS . 8.2 t -72.68 -38.59 67.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 109.346 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' E' ' 14' ' ' PHE . 0.2 OUTLIER -79.57 -36.64 37.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -0.883 . . . . 0.0 109.294 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.603 HG23 ' CD2' ' E' ' 10' ' ' TYR . 50.2 m -65.8 -38.39 88.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.254 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.768 ' HB2' HD13 ' E' ' 30' ' ' ILE . . . -74.18 -33.21 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -76.07 -21.86 56.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.942 ' HB3' HG21 ' E' ' 50' ' ' VAL . 3.4 t0 -89.26 -29.77 18.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.672 HD22 ' CE1' ' D' ' 58' ' ' PHE . 5.4 mt -89.71 -18.01 27.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.99 16.13 63.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.28 -170.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.548 ' O ' HD12 ' E' ' 30' ' ' ILE . 0.6 OUTLIER -103.07 159.87 15.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.2 -28.42 68.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -12.86 60.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.935 . . . . 0.0 109.084 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.19 -35.23 23.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.768 HD13 ' HB2' ' E' ' 20' ' ' ALA . 1.5 mp -74.32 -36.12 41.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.404 ' OD1' ' CE1' ' E' ' 35' ' ' HIS . 46.8 t-20 -66.49 -44.13 83.47 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -68.62 -32.12 71.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.09 91.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' E' ' 8' ' ' LYS . 5.8 mt -76.87 -26.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.404 ' CE1' ' OD1' ' E' ' 31' ' ' ASN . 0.4 OUTLIER -70.96 -22.75 62.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.494 -0.754 . . . . 0.0 109.362 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.03 -12.24 44.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.75 19.63 49.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -64.15 165.34 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.435 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.465 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 7.0 mttp -86.35 74.34 10.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.935 . . . . 0.0 109.636 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 74.1 mt -103.05 92.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 1.6 m-30 -79.53 164.69 23.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.704 HD13 ' HB2' ' E' ' 7' ' ' LEU . 0.8 OUTLIER -127.56 122.21 32.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 10.4 m -114.1 104.78 12.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.171 -0.955 . . . . 0.0 108.61 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' E' ' 49' ' ' SER . 1.6 mt -90.33 131.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 110.346 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' E' ' 47' ' ' ASP . 6.3 m-20 -90.54 148.89 22.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.367 -0.833 . . . . 0.0 109.634 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.63 -24.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.756 -0.59 . . . . 0.0 110.855 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' E' ' 45' ' ' ASN . 87.3 m-20 -84.92 34.58 0.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.81 30.31 8.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.21 154.01 20.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.291 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.6 t -113.5 126.1 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -130.24 80.7 1.97 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 108.984 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' D' ' 58' ' ' PHE . . . -79.16 151.18 31.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.724 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.71 157.72 45.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.515 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 45.8 tt0 -109.98 139.49 45.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.788 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -153.26 108.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 1.9 ttpt -149.18 136.37 10.93 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.427 -0.796 . . . . 0.0 109.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 34.8 Cg_endo -76.22 150.05 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.292 1.995 . . . . 0.0 110.62 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' D' ' 52' ' ' ALA . 0.1 OUTLIER -98.64 163.42 19.0 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 35.8 Cg_endo -78.3 162.21 89.09 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.351 -1.52 . . . . 0.0 110.429 0.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 5.8 t -75.24 134.76 41.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.388 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.427 ' O ' ' HD3' ' E' ' 62' ' ' LYS . 0.4 OUTLIER -113.01 120.9 42.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.613 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' E' ' 61' ' ' ASN . 1.1 tptt -153.26 130.03 10.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.88 144.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . 0.439 ' O ' HG23 ' E' ' 64' ' ' THR . 1.3 t -151.36 98.96 2.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.522 HG22 ' N ' ' E' ' 66' ' ' ALA . 16.7 m -133.47 162.02 33.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.384 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.522 ' N ' HG22 ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.541 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -153.21 19.49 0.57 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.28 85.93 7.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -124.56 115.85 21.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.481 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 4.3 mp -137.94 144.73 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -59.89 158.64 10.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.894 . . . . 0.0 109.514 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.835 ' HA ' HD22 ' D' ' 42' ' ' LEU . 13.5 tp -66.13 -19.75 65.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.336 -0.852 . . . . 0.0 109.618 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 3.5 pttm -85.59 -33.11 21.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 0.0 109.746 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.535 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 4.1 m-20 -80.92 -24.42 38.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.0 t80 -85.44 -36.39 20.66 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.517 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.64 -22.42 46.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.04 -1.037 . . . . 0.0 109.454 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' D' ' 8' ' ' LYS . 2.8 ttt -88.8 -51.86 5.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.145 -0.972 . . . . 0.0 109.416 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.8 mmm180 -69.24 -37.02 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 39.2 m-85 -101.61 -6.37 23.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.531 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 85.57 137.63 4.33 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.517 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 17.3 mt-30 -62.41 -14.44 40.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -1.2 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . 0.522 HG23 HE21 ' D' ' 27' ' ' GLN . 0.2 OUTLIER -71.18 -43.98 66.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.434 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -75.1 -24.8 58.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.95 ' O ' HD12 ' D' ' 23' ' ' LEU . 4.9 m -74.1 -35.5 64.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.604 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.906 ' HB2' ' CD1' ' D' ' 30' ' ' ILE . . . -82.82 -24.73 33.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 109.68 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -76.2 -40.23 52.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.562 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.595 ' HB3' HG21 ' D' ' 50' ' ' VAL . 41.3 m-20 -76.62 -35.12 58.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.487 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.95 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -82.87 -15.22 52.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.47 3.09 61.32 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' E' ' 58' ' ' PHE . 1.9 m -84.6 -179.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.136 -1.214 . . . . 0.0 109.576 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.403 ' O ' HD12 ' D' ' 30' ' ' ILE . 0.0 OUTLIER -91.17 156.43 17.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.952 . . . . 0.0 109.057 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . 0.522 HE21 HG23 ' D' ' 17' ' ' THR . 0.5 OUTLIER -67.02 -34.37 77.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.085 -1.009 . . . . 0.0 109.157 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -18.94 65.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.272 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.44 18.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.906 ' CD1' ' HB2' ' D' ' 20' ' ' ALA . 2.4 mt -61.99 -31.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -49.57 67.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.0 109.252 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -59.36 -31.47 69.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.894 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -68.6 -37.26 79.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.902 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.447 HD12 ' O ' ' D' ' 30' ' ' ILE . 4.5 mt -80.68 -23.5 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.292 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -24.5 50.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.404 -0.81 . . . . 0.0 109.311 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.21 -11.9 42.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.302 -0.873 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 52.89 28.9 33.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.28 171.38 13.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -1.124 . . . . 0.0 109.293 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -84.31 72.32 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.077 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.894 HD12 ' HB1' ' D' ' 33' ' ' ALA . 69.4 mt -96.9 98.83 7.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 12.3 m-85 -88.44 155.25 19.78 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.457 -0.777 . . . . 0.0 109.768 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.835 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.4 mp -119.96 110.36 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.823 . . . . 0.0 109.176 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 1.2 m -102.21 112.56 25.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.376 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.9 OUTLIER -111.34 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.495 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.7 m-20 -55.03 146.24 18.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 110.053 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.79 -22.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.019 -0.426 . . . . 0.0 110.67 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' D' ' 45' ' ' ASN . 16.9 t0 -83.34 32.77 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.107 . . . . 0.0 109.639 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.05 25.14 16.6 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.6 OUTLIER -90.85 116.22 28.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -1.119 . . . . 0.0 109.455 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.79 HG11 ' HG ' ' D' ' 23' ' ' LEU . 34.4 t -79.44 150.06 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.96 -1.087 . . . . 0.0 109.018 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.519 ' HB3' ' HB ' ' D' ' 43' ' ' THR . 0.6 OUTLIER -155.84 72.96 0.81 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.341 -0.849 . . . . 0.0 108.869 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' E' ' 58' ' ' PHE . . . -79.66 138.89 37.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.404 -0.81 . . . . 0.0 109.786 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.16 164.35 27.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.485 -0.759 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.424 ' C ' ' CG2' ' D' ' 55' ' ' VAL . 3.8 tt0 -119.1 130.2 55.46 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 39' ' ' LYS . 0.2 OUTLIER -151.86 100.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.844 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.487 ' C ' ' CD ' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -151.18 129.77 6.17 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 33.6 Cg_endo -76.0 106.11 2.2 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.225 1.95 . . . . 0.0 110.893 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -86.82 145.82 39.64 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.701 ' HG3' HG22 ' E' ' 25' ' ' VAL . 36.6 Cg_endo -81.21 -84.79 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.414 -1.494 . . . . 0.0 110.219 -0.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.99 174.06 8.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.086 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.452 ' HB2' ' HG2' ' D' ' 57' ' ' PRO . 4.2 t30 -139.14 151.26 46.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.291 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.36 165.45 23.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -0.88 . . . . 0.0 109.297 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.07 -159.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 8.3 t -90.37 12.21 19.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.552 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -100.31 94.03 5.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.602 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.585 179.899 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -171.23 -175.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.379 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.522 ' HG3' ' NH1' ' E' ' 4' ' ' ARG . 6.6 pt20 -87.64 58.49 4.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.13 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.808 ' C ' HD12 ' E' ' 5' ' ' ILE . 57.4 mmt-85 -145.5 113.99 6.72 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.813 HD13 HD11 ' E' ' 44' ' ' ILE . 4.4 mp -146.37 155.69 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.341 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -75.49 155.62 35.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.234 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.643 ' HA ' HD22 ' E' ' 42' ' ' LEU . 21.7 tp -60.7 -20.98 62.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 109.327 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' E' ' 12' ' ' MET . 0.5 OUTLIER -89.3 -24.56 22.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.689 ' HB2' HG22 ' E' ' 5' ' ' ILE . 99.8 m-20 -85.65 -24.01 27.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 109.55 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.506 ' HA ' ' CD1' ' E' ' 14' ' ' PHE . 22.3 t80 -85.72 -32.72 21.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.922 . . . . 0.0 109.092 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.958 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.63 -27.63 27.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' E' ' 8' ' ' LYS . 1.6 mmm -90.31 -36.46 14.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.692 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' E' ' 9' ' ' ASP . 12.8 mmt85 -81.79 -28.51 33.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.693 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 5.4 m-85 -113.12 -46.97 3.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.556 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.72 142.26 3.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.958 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 40.8 mt-30 -77.86 -17.89 56.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -1.112 . . . . 0.0 109.377 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 -42.88 66.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.527 ' HD3' ' CB ' ' E' ' 14' ' ' PHE . 1.0 OUTLIER -79.0 -26.96 43.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.137 -0.977 . . . . 0.0 109.417 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.903 ' O ' HD12 ' E' ' 23' ' ' LEU . 85.9 m -71.71 -31.34 66.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.944 . . . . 0.0 109.147 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.679 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -85.0 -36.74 21.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.328 -0.858 . . . . 0.0 109.339 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -26.65 61.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.85 ' HB3' HG21 ' E' ' 50' ' ' VAL . 9.0 t0 -85.7 -33.47 21.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.251 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.903 HD12 ' O ' ' E' ' 19' ' ' THR . 4.1 mt -83.4 -17.0 43.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.829 . . . . 0.0 109.45 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.67 65.8 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.701 HG22 ' HG3' ' D' ' 59' ' ' PRO . 0.0 OUTLIER -100.68 -175.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -1.214 . . . . 0.0 109.233 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.42 167.69 10.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 109.02 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.78 -21.44 61.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -80.26 -21.08 43.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.466 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.59 -30.59 21.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.91 . . . . 0.0 108.605 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.702 ' O ' HD12 ' E' ' 34' ' ' ILE . 16.7 mm -77.68 -30.5 16.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -76.2 -43.92 40.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.469 -0.769 . . . . 0.0 109.361 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.8 ptmm? -70.43 -29.94 66.67 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.092 -1.005 . . . . 0.0 109.215 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -67.79 -40.94 83.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.982 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.702 HD12 ' O ' ' E' ' 30' ' ' ILE . 7.4 mt -76.81 -22.95 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 0.0 109.063 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.12 -23.95 59.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.434 -0.791 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HD3' ' E' ' 38' ' ' ARG . . . -85.61 -14.74 44.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.422 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 51.47 24.74 11.83 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.47 ' HD3' ' HB1' ' E' ' 36' ' ' ALA . 3.7 mtp180 -64.33 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -1.17 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -102.03 73.62 1.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.239 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 39.2 mt -108.62 100.57 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.713 ' CE1' HG23 ' E' ' 55' ' ' VAL . 14.5 m-85 -87.42 165.53 15.5 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.569 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -128.12 131.0 49.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.96 . . . . 0.0 110.127 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' E' ' 51' ' ' TYR . 24.1 m -120.65 119.28 32.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 108.755 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.813 HD11 HD13 ' E' ' 5' ' ' ILE . 0.6 OUTLIER -94.78 101.07 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.983 -1.073 . . . . 0.0 109.811 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' E' ' 47' ' ' ASP . 23.8 m-80 -52.58 141.85 19.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.16 -24.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.89 -0.506 . . . . 0.0 110.827 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' E' ' 45' ' ' ASN . 13.9 m-20 -85.06 35.19 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.92 -1.112 . . . . 0.0 109.574 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.01 22.66 9.85 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.1 OUTLIER -90.44 154.43 19.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.417 -1.049 . . . . 0.0 109.089 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.85 HG21 ' HB3' ' E' ' 22' ' ' ASP . 2.3 t -98.56 148.4 6.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.269 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.48 ' HB3' ' HB ' ' E' ' 43' ' ' THR . 66.9 t80 -151.27 78.66 1.28 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.82 144.32 35.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.795 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 1.0 OUTLIER -129.67 157.94 40.74 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.469 -0.77 . . . . 0.0 109.331 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 0.7 OUTLIER -113.29 130.7 56.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.713 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -151.25 104.77 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.81 128.99 7.64 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 108.925 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.07 179.74 6.22 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.594 2.196 . . . . 0.0 110.945 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' D' ' 25' ' ' VAL . 1.1 t80 -132.85 143.26 47.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 109.318 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.6 Cg_endo -80.62 -162.8 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.488 0 C-N-CA 123.413 -1.494 . . . . 0.0 110.472 -0.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 3.1 m -82.81 -25.17 32.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.905 . . . . 0.0 109.116 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.47 100.42 10.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 109.064 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -110.02 119.7 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.898 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 160.93 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.113 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -115.58 75.78 0.97 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.075 -1.016 . . . . 0.0 109.631 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.459 ' O ' HG22 ' E' ' 65' ' ' THR . 17.9 m -142.18 39.99 1.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.421 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -98.07 85.6 3.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -86.9 100.74 12.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -110.75 109.74 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' D' ' 42' ' ' LEU . 3.3 mp -138.57 145.09 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.323 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -70.95 155.58 40.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' D' ' 42' ' ' LEU . 17.3 tp -57.4 -19.8 25.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.413 -0.804 . . . . 0.0 109.706 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.483 ' O ' ' CG ' ' D' ' 12' ' ' MET . 14.2 pttt -80.21 -41.15 25.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.607 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' CG2' ' D' ' 5' ' ' ILE . 0.6 OUTLIER -76.45 -21.29 56.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' D' ' 19' ' ' THR . 6.6 t80 -87.17 -35.1 18.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.434 -0.791 . . . . 0.0 109.396 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -85.54 -20.85 29.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' D' ' 8' ' ' LYS . 6.6 mmm -90.17 -39.97 12.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.955 . . . . 0.0 109.83 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -83.72 -29.54 27.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.804 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.502 ' O ' ' CD ' ' D' ' 18' ' ' LYS . 5.8 m-30 -105.66 -35.72 7.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.938 . . . . 0.0 109.604 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.12 143.72 5.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 7.5 mt-30 -81.62 -14.71 56.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.5 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . 0.57 HG23 ' NE2' ' D' ' 27' ' ' GLN . 9.6 m -76.75 -47.13 22.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.789 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' D' ' 19' ' ' THR . 0.1 OUTLIER -76.24 -27.65 56.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.806 ' O ' HD12 ' D' ' 23' ' ' LEU . 18.8 m -69.22 -43.2 74.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.083 -1.011 . . . . 0.0 109.165 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.81 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -73.55 -34.77 65.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.389 -0.819 . . . . 0.0 109.422 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -71.91 -27.83 63.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' D' ' 18' ' ' LYS . 0.6 OUTLIER -77.36 -37.9 51.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.812 HD21 ' CG1' ' D' ' 50' ' ' VAL . 1.6 mt -90.21 -4.72 57.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.379 -0.825 . . . . 0.0 109.437 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 91.12 -33.13 4.83 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' D' ' 20' ' ' ALA . 0.0 OUTLIER -52.04 -173.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -1.131 . . . . 0.0 109.356 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.0 OUTLIER -117.83 173.42 6.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.201 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . 0.57 ' NE2' HG23 ' D' ' 17' ' ' THR . 67.3 mt-30 -65.99 -18.8 65.58 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 108.989 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t -80.38 -19.94 45.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 0.0 109.128 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' D' ' 25' ' ' VAL . . . -84.53 -25.17 28.97 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.714 ' CG1' ' HB2' ' D' ' 20' ' ' ALA . 9.3 mm -81.21 -40.26 18.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' D' ' 35' ' ' HIS . 4.3 t-20 -71.37 -32.83 68.96 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.416 -0.802 . . . . 0.0 108.852 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -78.65 -36.75 43.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.474 -0.766 . . . . 0.0 109.223 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.576 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -67.71 -31.75 71.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.791 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -83.21 -30.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' D' ' 31' ' ' ASN . 7.4 m170 -73.71 -25.75 60.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.491 -0.756 . . . . 0.0 109.41 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.76 -21.11 44.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.524 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.0 26.9 56.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -72.73 -162.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -1.185 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.532 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 0.7 OUTLIER -108.18 75.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.576 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 10.1 mt -108.28 99.9 9.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.65 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.0 m-30 -88.79 163.13 15.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.454 -0.779 . . . . 0.0 109.765 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' D' ' 7' ' ' LEU . 1.0 OUTLIER -126.39 104.21 8.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.179 -0.951 . . . . 0.0 110.083 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' D' ' 51' ' ' TYR . 40.6 m -93.06 103.9 16.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.447 ' H ' HD12 ' D' ' 44' ' ' ILE . 0.7 OUTLIER -108.3 116.27 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.196 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' D' ' 45' ' ' ASN . 1.2 m-20 -79.88 144.12 33.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.402 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.55 -23.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.717 -0.614 . . . . 0.0 110.778 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' D' ' 45' ' ' ASN . 15.0 m-20 -81.81 29.29 0.39 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.806 -1.184 . . . . 0.0 110.207 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.54 26.86 46.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.53 106.2 18.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.272 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.812 ' CG1' HD21 ' D' ' 23' ' ' LEU . 78.0 t -78.79 136.46 23.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.815 -1.178 . . . . 0.0 109.395 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 73.7 t80 -144.12 78.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.433 -0.792 . . . . 0.0 108.874 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' CE1' ' E' ' 58' ' ' PHE . . . -78.98 137.16 37.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.827 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.55 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.8 OUTLIER -126.55 156.48 40.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.462 -0.774 . . . . 0.0 109.249 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.1 tp10 -108.93 134.4 51.65 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.65 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -148.66 104.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.199 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.465 ' HG3' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -136.98 141.41 34.66 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.465 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 32.1 Cg_endo -72.41 166.21 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.371 2.047 . . . . 0.0 111.14 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.588 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 4.7 t80 -128.38 145.38 55.55 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.0 Cg_endo -80.51 153.01 83.65 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.574 -1.427 . . . . 0.0 110.657 -0.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.01 167.59 7.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.593 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' D' ' 62' ' ' LYS . 10.3 t30 -94.17 119.47 33.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.324 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' D' ' 61' ' ' ASN . 0.3 OUTLIER 172.24 117.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.662 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -113.08 -176.94 3.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.472 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.31 83.96 0.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 109.568 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.64 151.1 26.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.403 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.264 0.554 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.43 99.2 6.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' E' ' 4' ' ' ARG . 0.1 OUTLIER -82.09 118.23 22.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' E' ' 3' ' ' GLN . 12.4 mmt85 -128.93 107.31 9.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.0 mp -140.38 146.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.449 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 12.4 m -73.16 151.84 41.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.592 ' CD1' HG21 ' E' ' 19' ' ' THR . 28.4 tp -57.54 -18.6 20.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.478 -0.763 . . . . 0.0 109.634 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 22.8 pttt -81.66 -42.49 19.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.955 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 8.0 m-20 -79.13 -17.76 54.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.777 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.588 ' HA ' ' CD2' ' E' ' 14' ' ' PHE . 7.5 t80 -88.74 -33.82 17.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.164 -0.96 . . . . 0.0 109.177 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.521 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -82.83 -27.91 30.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 1.7 mtm -90.3 -36.47 14.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 110.294 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 8.9 mtm180 -82.69 -30.64 29.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' E' ' 10' ' ' TYR . 30.0 m-85 -109.36 -9.39 14.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 109.566 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.21 146.86 19.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.521 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 4.4 mt-30 -75.83 -28.7 58.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -1.133 . . . . 0.0 109.378 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -65.37 -44.4 87.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 109.301 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -66.64 -37.04 84.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.285 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.928 ' O ' HD12 ' E' ' 23' ' ' LEU . 10.4 m -63.54 -31.88 73.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.136 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.624 ' HB3' HE22 ' E' ' 27' ' ' GLN . . . -85.49 -21.73 28.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 -33.6 61.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.147 -0.971 . . . . 0.0 108.987 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' E' ' 50' ' ' VAL . 4.8 m-20 -82.44 -38.03 24.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.103 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.928 HD12 ' O ' ' E' ' 19' ' ' THR . 3.3 mt -85.47 -9.47 57.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.495 -0.753 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.53 36.5 93.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.589 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.8 OUTLIER -113.87 -170.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.243 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.759 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -109.05 161.13 15.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.636 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . 0.624 HE22 ' HB3' ' E' ' 20' ' ' ALA . 35.7 mm-40 -65.26 -23.74 67.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.1 -20.45 62.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.88 . . . . 0.0 109.435 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -87.65 -33.07 18.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.17 -23.8 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -42.64 18.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.024 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 0.1 OUTLIER -72.75 -25.33 61.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.91 -43.11 46.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.344 -0.848 . . . . 0.0 109.075 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' E' ' 34' ' ' ILE . 29.7 mm -72.81 -27.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 108.998 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -72.16 -38.36 69.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.477 -0.764 . . . . 0.0 109.436 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.31 -14.33 62.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -0.913 . . . . 0.0 109.277 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 45.96 35.51 6.32 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.8 170.13 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.127 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' E' ' 55' ' ' VAL . 4.6 mmmt -71.61 83.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 41.7 mt -115.63 101.17 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.808 ' CE1' HG23 ' E' ' 55' ' ' VAL . 26.1 m-85 -92.43 163.75 13.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.555 -0.716 . . . . 0.0 110.036 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.707 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.1 tp -126.22 100.0 6.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.847 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -91.12 104.81 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 108.991 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' E' ' 49' ' ' SER . 2.4 mt -95.97 132.77 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' E' ' 47' ' ' ASP . 4.3 m120 -90.29 151.39 21.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.4 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.62 -26.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.817 -0.552 . . . . 0.0 110.466 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -87.0 34.64 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.945 -1.097 . . . . 0.0 109.401 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.25 34.31 12.58 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.3 OUTLIER -89.28 105.7 17.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -1.115 . . . . 0.0 109.053 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' E' ' 22' ' ' ASP . 48.7 t -79.01 113.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.968 -1.083 . . . . 0.0 110.25 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -123.05 89.87 3.19 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.707 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.95 143.26 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.962 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -130.22 174.01 10.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.859 0.837 . . . . 0.0 109.712 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -122.94 139.12 54.4 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.808 HG23 ' CE1' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -153.64 110.43 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.507 ' HE2' ' CB ' ' E' ' 60' ' ' SER . 22.9 tptt -151.18 127.85 5.31 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 108.949 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.37 125.62 7.12 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.425 2.084 . . . . 0.0 110.66 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.751 ' HE2' HG11 ' D' ' 25' ' ' VAL . 0.0 OUTLIER -92.62 158.87 37.58 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.373 -0.829 . . . . 0.0 109.078 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.71 122.75 8.81 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.351 -0.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . 0.507 ' CB ' ' HE2' ' E' ' 56' ' ' LYS . 74.9 p -58.93 177.32 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 24.9 p30 -111.93 151.36 29.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 59.34 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -117.14 28.46 8.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.72 120.5 38.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.507 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.581 ' O ' ' HB3' ' E' ' 66' ' ' ALA . 27.6 m -121.77 35.04 4.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.51 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.513 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.243 0.544 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' D' ' 1' ' ' MET . 1.2 pt-20 164.78 86.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.677 ' O ' HD12 ' D' ' 44' ' ' ILE . 6.2 tt0 -84.65 84.15 7.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.91 . . . . 0.0 109.55 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.936 ' O ' HD13 ' D' ' 5' ' ' ILE . 19.5 mmt85 -104.86 118.95 37.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.936 HD13 ' O ' ' D' ' 4' ' ' ARG . 0.0 OUTLIER -144.24 150.11 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.011 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -75.41 154.76 36.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.513 ' HA ' HD22 ' D' ' 42' ' ' LEU . 46.5 tp -57.37 -14.59 4.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 109.767 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.28 -34.72 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 110.259 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -79.54 -30.13 41.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.133 -0.979 . . . . 0.0 110.097 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' D' ' 14' ' ' PHE . 25.6 t80 -80.46 -35.63 34.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -79.62 -24.14 42.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 109.698 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mmt -89.71 -35.89 15.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.082 -1.011 . . . . 0.0 110.214 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -90.61 -20.91 22.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 110.238 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 3.3 m-85 -117.49 -5.46 11.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.993 -1.067 . . . . 0.0 109.764 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.85 133.24 8.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.736 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 3.4 mt-30 -77.39 -32.89 55.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . 0.52 ' HB ' ' NE2' ' D' ' 27' ' ' GLN . 0.1 OUTLIER -60.23 -33.35 72.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.883 . . . . 0.0 109.647 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' D' ' 19' ' ' THR . 0.0 OUTLIER -84.69 -24.52 28.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.895 ' O ' HD12 ' D' ' 23' ' ' LEU . 93.9 m -71.8 -34.26 69.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 108.782 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.678 ' HA ' HG23 ' D' ' 25' ' ' VAL . . . -80.93 -28.15 35.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.832 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -74.18 -30.23 62.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.044 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -37.22 29.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 109.433 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.895 HD12 ' O ' ' D' ' 19' ' ' THR . 1.0 OUTLIER -83.99 -10.94 57.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.385 179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.41 -30.34 6.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' D' ' 20' ' ' ALA . 1.1 m -55.84 -171.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.316 -1.108 . . . . 0.0 109.539 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' D' ' 17' ' ' THR . 3.9 mt-30 -69.78 -32.33 70.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.471 -0.768 . . . . 0.0 109.381 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' D' ' 32' ' ' LYS . 1.1 m -72.05 -13.77 61.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' CD ' ' D' ' 32' ' ' LYS . . . -89.92 -32.3 16.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.24 -0.912 . . . . 0.0 108.605 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' D' ' 20' ' ' ALA . 18.5 mm -79.35 -28.56 13.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -78.85 -42.74 26.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.764 . . . . 0.0 109.124 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.476 ' CD ' ' HA ' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -70.8 -26.53 63.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.008 . . . . 0.0 109.183 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.669 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -71.96 -42.3 66.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.946 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.412 HD13 HG21 ' D' ' 34' ' ' ILE . 17.9 mt -73.76 -26.93 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 108.908 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -70.42 -19.14 63.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.79 . . . . 0.0 109.337 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.18 -16.77 32.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.17 48.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.842 ' HD3' HD11 ' D' ' 40' ' ' ILE . 6.1 ptm180 -78.42 -165.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.069 -1.253 . . . . 0.0 109.64 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 1.3 mttm -98.54 83.72 3.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.842 HD11 ' HD3' ' D' ' 38' ' ' ARG . 1.8 mt -112.23 99.21 8.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.64 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.1 m-85 -92.34 161.39 14.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' D' ' 52' ' ' ALA . 1.2 tp -126.37 133.05 51.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' D' ' 51' ' ' TYR . 4.4 m -124.09 100.21 6.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.372 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.677 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.47 127.31 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.872 . . . . 0.0 109.611 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.7 m120 -90.3 149.31 22.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.623 -0.673 . . . . 0.0 110.509 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 45' ' ' ASN . 48.8 t0 -84.85 32.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.075 . . . . 0.0 109.773 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.64 32.23 39.02 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.3 OUTLIER -90.38 100.09 12.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.417 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' D' ' 23' ' ' LEU . 67.9 t -79.01 130.52 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 109.798 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB ' ' D' ' 43' ' ' THR . 14.6 t80 -143.07 84.13 1.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.633 ' CB ' ' CE2' ' E' ' 58' ' ' PHE . . . -79.56 145.84 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 5.6 mt-10 -126.91 152.08 47.57 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.442 ' OE1' HG23 ' D' ' 40' ' ' ILE . 0.2 OUTLIER -112.7 123.78 51.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.64 ' CG2' ' CE2' ' D' ' 41' ' ' PHE . 0.0 OUTLIER -138.64 102.48 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.599 -178.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' E' ' 54' ' ' GLU . 0.4 OUTLIER -155.3 134.65 7.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 109.327 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' D' ' 56' ' ' LYS . 35.0 Cg_endo -76.83 157.52 35.1 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.259 1.973 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' E' ' 23' ' ' LEU . 0.0 OUTLIER -103.95 165.87 12.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.952 . . . . 0.0 109.219 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 35.1 Cg_endo -77.33 -179.22 26.54 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 123.098 -1.626 . . . . 0.0 110.609 0.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 6.1 p -54.02 174.56 0.05 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 0.0 109.641 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -125.29 138.36 54.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.35 100.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.851 . . . . 0.0 109.433 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.94 42.06 2.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -113.9 157.19 22.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.18 36.72 4.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 109.494 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.463 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.4 ' HG2' ' HG3' ' E' ' 2' ' ' GLU . 1.9 ttp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' E' ' 1' ' ' MET . 9.5 mt-10 -119.64 81.4 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' E' ' 5' ' ' ILE . 0.3 OUTLIER -86.25 113.55 22.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.79 111.88 23.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' E' ' 42' ' ' LEU . 3.1 mp -135.9 144.87 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.0 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.439 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 9.9 m -76.49 145.29 39.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.286 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.935 HD12 HG21 ' E' ' 19' ' ' THR . 27.4 tp -52.42 -19.95 2.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.44 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.1 pttt -85.73 -34.76 21.14 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.453 -0.779 . . . . 0.0 110.319 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' E' ' 5' ' ' ILE . 28.9 m-20 -78.6 -25.32 45.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 0.0 109.5 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' E' ' 10' ' ' TYR . 1.8 t80 -84.04 -34.41 24.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 0.0 109.456 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.578 ' HB1' ' CG ' ' E' ' 16' ' ' GLN . . . -84.91 -21.14 29.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 6.4 mmt -90.57 -44.02 9.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 42.2 mtp180 -83.02 -30.87 27.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 110.346 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.3 m-85 -107.31 -22.24 12.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 109.536 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' E' ' 11' ' ' ALA . . . 112.77 147.31 10.1 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.578 ' CG ' ' HB1' ' E' ' 11' ' ' ALA . 61.6 mt-30 -71.88 -22.8 61.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 109.41 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 65.5 m -71.67 -28.32 63.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -81.91 -42.98 18.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.377 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.935 HG21 HD12 ' E' ' 7' ' ' LEU . 24.6 m -64.85 -37.13 86.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.369 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.96 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -76.68 -23.95 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -76.98 -33.51 57.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' E' ' 50' ' ' VAL . 0.1 OUTLIER -79.1 -38.68 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.31 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' D' ' 58' ' ' PHE . 1.3 mt -78.53 -24.66 45.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.835 . . . . 0.0 109.375 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 26.69 55.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.442 HG12 ' H ' ' E' ' 26' ' ' TYR . 0.2 OUTLIER -101.69 -172.31 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.306 -1.114 . . . . 0.0 109.149 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.442 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.1 OUTLIER -100.77 164.9 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.241 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -67.79 -23.2 65.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.233 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -77.75 -16.85 58.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.18 -32.98 19.54 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.96 HG13 ' HB2' ' E' ' 20' ' ' ALA . 11.4 mm -77.72 -27.87 15.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' E' ' 35' ' ' HIS . 1.6 t30 -77.91 -38.86 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.526 -0.734 . . . . 0.0 109.156 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 0.5 OUTLIER -69.66 -33.07 72.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.697 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.529 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -72.73 -41.19 65.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.72 -19.64 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.905 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 31' ' ' ASN . 18.1 m170 -75.46 -23.48 56.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.042 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.64 -19.27 33.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.0 109.383 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.24 25.83 48.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -174.9 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -1.179 . . . . 0.0 109.46 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 1.8 mptp? -98.14 73.38 2.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.833 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.47 96.08 5.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.677 ' CE2' HG23 ' E' ' 55' ' ' VAL . 2.3 m-30 -80.94 158.51 25.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.446 -0.784 . . . . 0.0 110.045 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.789 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.4 tp -123.91 111.97 16.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 60.8 m -97.07 91.57 5.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.07 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.09 123.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.273 -0.892 . . . . 0.0 110.192 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 2.1 m-20 -91.15 147.0 23.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.353 -0.842 . . . . 0.0 109.185 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -40.88 -26.5 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 110.241 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -87.07 34.54 0.68 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.083 -1.011 . . . . 0.0 109.579 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 34.08 34.29 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.2 OUTLIER -90.19 96.99 10.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -1.173 . . . . 0.0 109.631 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.576 HG11 ' HG ' ' E' ' 23' ' ' LEU . 21.2 t -79.19 103.68 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.014 -1.054 . . . . 0.0 109.574 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -112.81 85.27 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.789 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.28 142.18 36.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.501 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.75 144.68 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' D' ' 56' ' ' LYS . 62.4 tt0 -94.68 127.88 40.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 108.78 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.677 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.37 96.91 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.481 -0.762 . . . . 0.0 109.211 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.56 ' HB2' ' HB2' ' E' ' 39' ' ' LYS . 0.1 OUTLIER -150.06 127.05 5.4 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' D' ' 53' ' ' GLU . 36.2 Cg_endo -78.83 145.37 19.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.267 1.978 . . . . 0.0 110.094 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' D' ' 23' ' ' LEU . 0.4 OUTLIER -121.58 151.03 56.27 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.413 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' E' ' 60' ' ' SER . 35.4 Cg_endo -78.57 -168.75 7.24 Favored 'Cis proline' 0 C--N 1.309 -1.506 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.385 0.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . 0.456 ' O ' ' O ' ' E' ' 59' ' ' PRO . 92.5 p -57.48 -160.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.357 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.59 64.61 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -51.03 161.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.346 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 2.8 tptt 57.51 34.81 25.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -80.74 158.93 25.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 109.488 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.572 ' O ' HG23 ' E' ' 65' ' ' THR . 13.2 t -93.22 48.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.51 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.461 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tmm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.94 -178.55 0.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.385 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.724 ' O ' HD12 ' D' ' 44' ' ' ILE . 18.2 mm-40 -86.17 73.55 10.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.825 ' C ' HD12 ' D' ' 5' ' ' ILE . 3.2 mmm180 -108.39 119.51 39.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 109.606 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.825 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.6 mp -153.21 140.26 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.116 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.492 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 2.4 m -62.4 155.95 23.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' D' ' 42' ' ' LEU . 29.8 tp -60.05 -15.15 20.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.544 ' CB ' HG12 ' D' ' 34' ' ' ILE . 13.8 ptpt -90.6 -34.7 15.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -79.85 -24.13 41.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.978 . . . . 0.0 109.439 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.602 ' CD2' HG23 ' D' ' 19' ' ' THR . 18.8 t80 -83.65 -33.26 25.29 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.282 -0.887 . . . . 0.0 109.23 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' D' ' 16' ' ' GLN . . . -77.57 -32.91 54.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.459 -0.776 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.31 -44.38 10.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 109.986 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 0.3 OUTLIER -70.18 -24.77 63.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 109.747 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 6.3 m-85 -118.38 -38.58 3.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.672 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 136.27 139.94 4.05 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.803 ' HG2' ' HB1' ' D' ' 11' ' ' ALA . 10.7 mt-30 -80.22 -22.74 41.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -1.108 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.02 76.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.238 -0.914 . . . . 0.0 109.301 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' CB ' ' D' ' 14' ' ' PHE . 12.8 ptpt -82.2 -29.69 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.623 HG21 ' CD1' ' D' ' 7' ' ' LEU . 29.7 m -73.05 -30.02 63.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.168 -0.957 . . . . 0.0 109.008 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 -28.27 42.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.32 -0.862 . . . . 0.0 109.064 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -35.69 54.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.056 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.58 ' HB3' HG21 ' D' ' 50' ' ' VAL . 48.7 m-20 -72.76 -35.08 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.0 109.408 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.75 ' HG ' HG11 ' D' ' 50' ' ' VAL . 2.9 mt -90.63 -15.46 30.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.697 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.39 20.5 78.71 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.502 HG23 ' CB ' ' D' ' 23' ' ' LEU . 0.2 OUTLIER -99.03 172.39 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -1.112 . . . . 0.0 109.152 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -86.28 162.22 18.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 109.501 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -65.47 -37.99 88.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.211 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -9.23 53.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' D' ' 32' ' ' LYS . . . -88.52 -31.94 18.44 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.573 ' O ' HD12 ' D' ' 34' ' ' ILE . 37.3 mm -78.05 -34.65 19.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.9 -40.76 62.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.512 -0.743 . . . . 0.0 109.268 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' D' ' 33' ' ' ALA . 10.9 pttt -67.5 -32.48 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' D' ' 32' ' ' LYS . . . -68.27 -38.93 82.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.573 HD12 ' O ' ' D' ' 30' ' ' ILE . 6.4 mt -79.44 -21.68 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.26 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.32 -22.11 52.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 109.352 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.65 -14.76 36.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.375 -0.828 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.86 17.62 43.72 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -61.79 165.7 5.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 2.2 mmmm -85.08 75.19 10.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.341 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.424 HD12 ' HB1' ' D' ' 33' ' ' ALA . 9.3 mt -108.6 93.13 2.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.606 ' CE2' HG23 ' D' ' 55' ' ' VAL . 1.3 m-85 -80.51 163.02 24.05 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' D' ' 7' ' ' LEU . 2.4 tp -129.71 104.34 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.139 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 12.7 m -97.6 100.58 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.206 -0.934 . . . . 0.0 109.24 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.724 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.4 OUTLIER -87.18 107.53 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.631 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.8 m-80 -58.38 141.98 49.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.004 . . . . 0.0 109.555 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.63 -21.66 0.21 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.804 -0.56 . . . . 0.0 110.466 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.64 32.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.81 51.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.544 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -90.6 149.1 22.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.423 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.75 HG11 ' HG ' ' D' ' 23' ' ' LEU . 29.1 t -106.41 126.79 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.374 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' D' ' 53' ' ' GLU . 66.4 t80 -134.01 74.95 1.57 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.258 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.642 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.58 147.59 32.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.627 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' D' ' 51' ' ' TYR . 0.1 OUTLIER -140.44 165.68 26.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.366 -0.834 . . . . 0.0 109.617 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -119.87 138.01 53.66 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' D' ' 41' ' ' PHE . 0.1 OUTLIER -157.16 108.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.3 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' D' ' 39' ' ' LYS . 14.1 tptm -153.86 128.44 4.73 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.375 -0.828 . . . . 0.0 109.049 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 160.19 31.48 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.49 2.127 . . . . 0.0 110.901 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.504 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.2 OUTLIER -85.25 155.22 60.31 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.485 -0.76 . . . . 0.0 109.289 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.2 Cg_endo -78.66 174.65 50.24 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.246 -1.564 . . . . 0.0 110.401 -0.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -89.87 42.86 1.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.336 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -126.08 59.0 1.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.63 168.46 0.15 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -138.92 178.62 7.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.5 p -115.11 119.76 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -111.53 146.24 37.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' E' ' 2' ' ' GLU . 1.5 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.295 0.569 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' E' ' 1' ' ' MET . 6.7 mt-10 -149.54 129.5 13.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.099 -1.001 . . . . 0.0 109.765 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.484 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.0 OUTLIER -76.48 110.69 11.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.138 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.442 ' O ' HG13 ' E' ' 5' ' ' ILE . 2.8 mmm180 -103.51 122.53 45.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.083 -1.011 . . . . 0.0 109.754 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.721 ' N ' HD12 ' E' ' 5' ' ' ILE . 0.2 OUTLIER -148.62 146.6 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.056 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -76.53 154.58 34.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' E' ' 42' ' ' LEU . 25.8 tp -57.62 -18.79 22.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.449 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.509 ' HG2' ' HB ' ' E' ' 6' ' ' THR . 0.1 OUTLIER -87.91 -32.87 18.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.957 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 5' ' ' ILE . 0.8 OUTLIER -75.31 -27.26 59.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 109.376 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.663 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 2.6 t80 -81.17 -38.52 26.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.106 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.483 ' HA ' ' OG1' ' E' ' 19' ' ' THR . . . -78.01 -22.19 49.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 4.8 mtm -90.44 -44.1 9.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.0 . . . . 0.0 110.268 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -80.37 -31.61 37.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' E' ' 10' ' ' TYR . 16.2 m-85 -103.57 -22.07 13.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.605 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.72 125.64 5.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -26.25 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -1.113 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -46.68 71.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.645 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -64.88 -43.0 94.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.663 ' HG1' ' HD1' ' E' ' 10' ' ' TYR . 3.2 m -58.22 -41.62 84.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.518 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.857 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -78.56 -13.71 59.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.02 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -36.37 23.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.978 -1.076 . . . . 0.0 109.73 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.455 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.1 m-20 -84.03 -28.23 27.79 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' E' ' 50' ' ' VAL . 5.1 mt -90.47 -18.06 26.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.238 -0.913 . . . . 0.0 109.515 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' E' ' 25' ' ' VAL . . . 88.91 -32.92 4.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' E' ' 24' ' ' GLY . 1.6 m -52.8 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -1.16 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' E' ' 29' ' ' ALA . 0.2 OUTLIER -113.37 164.6 13.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.13 -21.05 66.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.01 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.91 -23.99 55.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.567 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' E' ' 26' ' ' TYR . . . -84.32 -33.96 23.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.598 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' E' ' 20' ' ' ALA . 14.5 mt -74.36 -29.11 23.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -45.41 45.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.336 -0.853 . . . . 0.0 109.285 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 1.3 pttt -69.69 -30.69 68.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.245 -0.909 . . . . 0.0 109.582 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -70.16 -39.18 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.543 HD12 ' O ' ' E' ' 30' ' ' ILE . 21.2 mt -78.1 -25.03 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 109.139 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.8 -25.02 56.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.423 -0.798 . . . . 0.0 109.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.33 -12.6 58.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.8 45.05 86.86 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' E' ' 40' ' ' ILE . 0.5 OUTLIER -88.73 -156.09 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -1.098 . . . . 0.0 109.332 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -119.73 73.98 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' E' ' 38' ' ' ARG . 43.5 mt -104.73 101.24 12.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.621 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.5 m-30 -88.57 158.65 18.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.676 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.4 mp -123.27 105.61 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.95 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.62 ' C ' HD13 ' E' ' 44' ' ' ILE . 97.6 m -99.66 111.82 24.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 108.964 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.79 ' N ' HD13 ' E' ' 44' ' ' ILE . 0.5 OUTLIER -96.92 112.92 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.923 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.1 m-20 -61.02 140.82 57.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.84 -22.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.763 -0.586 . . . . 0.0 110.758 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.5 OUTLIER -82.41 30.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.985 -1.072 . . . . 0.0 110.078 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.4 20.98 53.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.4 OUTLIER -90.54 146.07 24.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 0.0 109.347 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' E' ' 23' ' ' LEU . 42.2 t -103.27 143.17 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 109.161 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -150.0 83.32 1.39 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.162 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.83 136.88 37.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.276 -0.89 . . . . 0.0 109.223 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 155.17 39.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.309 -0.869 . . . . 0.0 109.483 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 3.9 tt0 -108.5 129.17 55.29 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.621 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -147.04 106.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.295 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' D' ' 54' ' ' GLU . 4.2 tptt -152.48 138.07 11.43 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.379 -0.826 . . . . 0.0 109.229 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.459 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 32.9 Cg_endo -75.33 173.76 13.95 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.371 2.048 . . . . 0.0 110.736 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.559 ' CG ' ' HA ' ' E' ' 59' ' ' PRO . 6.6 t80 -129.42 144.93 54.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.677 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.2 Cg_endo -81.0 -86.1 0.0 OUTLIER 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.465 -0.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 165.83 23.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -124.84 131.76 53.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 158.88 5.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 109.561 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.28 98.08 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 61.9 m -99.53 151.42 21.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.26 163.74 15.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.504 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.471 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.479 ' O ' ' CB ' ' D' ' 2' ' ' GLU . 32.3 mtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.327 0.584 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.564 ' HB3' ' NE ' ' D' ' 4' ' ' ARG . 0.2 OUTLIER 74.73 140.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 109.245 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.06 74.84 4.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.564 ' NE ' ' HB3' ' D' ' 2' ' ' GLU . 0.1 OUTLIER -78.7 124.21 27.95 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.937 -1.102 . . . . 0.0 109.565 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.557 HG23 ' CB ' ' D' ' 9' ' ' ASP . 1.6 mp -148.77 143.05 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.98 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.534 HG21 ' HE3' ' D' ' 8' ' ' LYS . 2.7 m -70.79 152.51 43.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.392 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.691 ' HA ' HD22 ' D' ' 42' ' ' LEU . 15.6 tp -55.66 -17.75 6.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' D' ' 6' ' ' THR . 15.4 ptpt -88.96 -32.24 17.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.557 ' CB ' HG23 ' D' ' 5' ' ' ILE . 1.4 m-20 -78.52 -31.0 47.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.807 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 5.9 t80 -85.24 -32.04 22.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 108.904 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -80.8 -24.64 38.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mmt -90.7 -46.0 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -71.75 -37.09 70.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.836 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.535 ' CD2' ' CD2' ' D' ' 10' ' ' TYR . 50.8 m-85 -100.2 -17.92 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.73 142.38 11.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.6 -18.17 64.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -1.105 . . . . 0.0 109.17 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 53.7 m -71.44 -39.45 71.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' D' ' 14' ' ' PHE . 29.3 mttt -72.93 -39.01 66.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.334 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.764 ' O ' HD12 ' D' ' 23' ' ' LEU . 2.8 m -67.56 -26.18 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.352 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' D' ' 25' ' ' VAL . . . -83.0 -34.47 26.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.35 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' D' ' 50' ' ' VAL . 6.1 m-20 -81.5 -45.38 16.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 109.137 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.764 HD12 ' O ' ' D' ' 19' ' ' THR . 0.8 OUTLIER -83.73 -5.98 59.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.468 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.21 73.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 1.5 t -102.32 167.26 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -1.18 . . . . 0.0 109.302 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.08 159.74 28.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -67.48 -30.52 70.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.171 -0.955 . . . . 0.0 109.24 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . 0.465 ' O ' ' CG ' ' D' ' 32' ' ' LYS . 1.1 m -75.69 -11.53 60.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.294 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.426 ' HB3' HG12 ' D' ' 25' ' ' VAL . . . -89.41 -31.32 17.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' D' ' 20' ' ' ALA . 42.9 mm -76.75 -37.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -77.26 -33.02 56.03 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' D' ' 28' ' ' SER . 15.5 mttm -77.04 -28.76 54.95 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.04 66.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 108.843 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -69.57 -31.99 51.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -66.99 -21.9 65.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -0.829 . . . . 0.0 109.243 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.96 -25.42 48.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.269 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.13 35.89 92.16 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 172.57 8.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -1.234 . . . . 0.0 109.375 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' D' ' 56' ' ' LYS . 2.8 mmtm -77.18 81.23 3.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.519 HG23 ' CD2' ' E' ' 58' ' ' PHE . 5.5 mt -115.35 104.01 16.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.519 ' CD2' HG23 ' D' ' 55' ' ' VAL . 32.6 m-85 -95.94 161.55 13.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.813 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.3 tp -133.86 106.98 7.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.9 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . . . . . . . . . 7.5 m -98.35 124.2 42.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.383 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.82 133.09 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.497 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.5 m-80 -90.65 148.04 22.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.74 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' D' ' 45' ' ' ASN . . . -39.98 -26.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.707 -0.621 . . . . 0.0 110.459 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.9 OUTLIER -87.13 34.23 0.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 109.578 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.39 32.42 30.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.497 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -85.65 105.13 15.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.214 -1.168 . . . . 0.0 109.108 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.645 HG21 ' HB3' ' D' ' 22' ' ' ASP . 69.3 t -79.0 139.41 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.776 -1.202 . . . . 0.0 109.827 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' D' ' 53' ' ' GLU . 8.6 t80 -153.17 83.46 1.2 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.591 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -79.4 151.83 30.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 109.913 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.601 ' HG3' ' CZ ' ' D' ' 51' ' ' TYR . 0.0 OUTLIER -140.38 165.31 27.76 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.512 -0.743 . . . . 0.0 109.64 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' E' ' 56' ' ' LYS . 38.4 tt0 -124.5 138.6 54.33 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.576 HG13 HG13 ' E' ' 55' ' ' VAL . 0.2 OUTLIER -147.93 104.06 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 118.784 -1.166 . . . . 0.0 110.201 -178.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 2.5 tptt -149.07 141.1 14.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.488 ' N ' ' HG3' ' D' ' 56' ' ' LYS . 33.9 Cg_endo -74.32 143.07 31.01 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.447 2.098 . . . . 0.0 111.14 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.55 ' CB ' ' HA ' ' D' ' 59' ' ' PRO . 0.1 OUTLIER -87.86 171.89 8.8 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -80.22 -22.22 16.31 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.89 -1.296 . . . . 0.0 110.667 -0.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 5.8 p -43.46 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 0.0 110.234 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' D' ' 59' ' ' PRO . 2.0 m120 -160.73 28.29 0.15 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.13 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.1 -175.03 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.849 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.36 -161.24 1.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.544 HG22 ' N ' ' D' ' 65' ' ' THR . 19.3 m -104.58 -88.38 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.544 ' N ' HG22 ' D' ' 64' ' ' THR . 0.7 OUTLIER -93.97 38.4 1.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.298 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.416 -179.882 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' E' ' 1' ' ' MET . 13.3 ptt? . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.309 0.576 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.3 115.46 6.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.465 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.421 ' HB3' HD12 ' E' ' 44' ' ' ILE . 5.1 mt-30 -78.52 78.97 4.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.591 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.0 OUTLIER -105.62 119.79 40.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.938 . . . . 0.0 109.664 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.591 HD12 ' C ' ' E' ' 4' ' ' ARG . 5.2 mp -145.17 144.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.225 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -65.71 161.3 20.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.723 ' HA ' HD22 ' E' ' 42' ' ' LEU . 13.9 tp -68.52 -19.36 64.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.908 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' E' ' 12' ' ' MET . 0.3 OUTLIER -89.93 -27.7 19.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.025 . . . . 0.0 110.068 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 13' ' ' ARG . 25.9 m-20 -85.78 -32.26 21.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 3.7 t80 -80.55 -31.52 36.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' E' ' 16' ' ' GLN . . . -85.98 -28.57 24.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.3 OUTLIER -90.08 -28.76 18.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 0.0 110.058 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' E' ' 9' ' ' ASP . 0.1 OUTLIER -88.67 -39.6 13.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 109.681 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.547 ' CB ' ' HD2' ' E' ' 18' ' ' LYS . 35.3 m-85 -94.23 -46.61 7.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' E' ' 18' ' ' LYS . . . 152.18 133.31 1.94 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' E' ' 11' ' ' ALA . 2.7 mt-30 -72.86 -27.61 62.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.494 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 22.4 m -72.87 -36.43 67.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.78 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.547 ' HD2' ' CB ' ' E' ' 14' ' ' PHE . 1.2 ptpt -77.64 -27.98 51.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.68 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.607 HG22 HD12 ' E' ' 23' ' ' LEU . 18.0 m -71.9 -37.0 70.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.13 -0.981 . . . . 0.0 108.977 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.692 ' HB2' ' CG1' ' E' ' 30' ' ' ILE . . . -77.76 -35.91 51.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.896 . . . . 0.0 109.145 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -29.73 65.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.609 ' CB ' HG21 ' E' ' 50' ' ' VAL . 53.2 m-20 -83.12 -27.95 29.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.232 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.607 HD12 HG22 ' E' ' 19' ' ' THR . 9.0 mt -89.38 -10.46 46.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.422 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.01 17.31 79.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' E' ' 23' ' ' LEU . 0.2 OUTLIER -102.37 179.2 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -1.116 . . . . 0.0 109.292 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.25 160.67 17.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -64.07 -43.1 96.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.69 -8.45 42.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.355 -0.84 . . . . 0.0 109.251 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' E' ' 32' ' ' LYS . . . -88.31 -32.76 18.29 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 108.639 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.692 ' CG1' ' HB2' ' E' ' 20' ' ' ALA . 12.6 mm -75.79 -38.0 36.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -73.4 -41.09 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.34 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' E' ' 29' ' ' ALA . 6.8 pttm -68.2 -26.8 65.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 108.84 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.33 72.51 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.83 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -68.84 -19.28 64.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.54 -0.725 . . . . 0.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.25 -15.47 56.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 53.62 21.06 13.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.03 172.3 12.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -1.189 . . . . 0.0 109.573 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' CD ' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -89.5 75.42 7.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.243 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 8.5 mt -108.5 97.79 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' E' ' 55' ' ' VAL . 1.8 m-30 -86.7 161.09 18.62 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.619 -0.675 . . . . 0.0 109.484 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.723 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.0 OUTLIER -120.56 109.83 15.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 11.6 m -98.4 104.11 16.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.533 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' E' ' 49' ' ' SER . 7.0 mt -85.12 126.81 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.891 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' E' ' 47' ' ' ASP . 55.1 m-80 -85.32 147.86 26.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.442 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.55 -24.66 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.809 -0.557 . . . . 0.0 110.835 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' E' ' 45' ' ' ASN . 4.7 m-20 -84.14 32.83 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 0.0 109.6 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.44 28.02 9.09 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 8.7 m -90.66 152.32 20.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -1.098 . . . . 0.0 109.309 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' E' ' 22' ' ' ASP . 1.4 t -110.55 116.33 52.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -119.49 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.3 141.14 37.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 109.767 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -139.98 152.3 46.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 109.084 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.403 ' OE1' ' OE2' ' D' ' 54' ' ' GLU . 3.9 tt0 -100.89 127.82 47.19 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.342 -0.849 . . . . 0.0 108.915 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.879 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -142.43 108.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.057 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' E' ' 57' ' ' PRO . 1.8 tptp -152.84 141.79 14.32 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.52 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 35.5 Cg_endo -78.17 150.07 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.6 2.2 . . . . 0.0 110.335 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 0.9 OUTLIER -114.89 160.5 33.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.898 . . . . 0.0 109.276 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' E' ' 58' ' ' PHE . 36.1 Cg_endo -78.63 144.81 75.38 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.339 -1.525 . . . . 0.0 110.578 -0.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . 0.482 ' HB3' ' HE3' ' E' ' 56' ' ' LYS . 0.9 OUTLIER -89.73 -65.61 1.0 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' E' ' 61' ' ' ASN . 6.8 p30 -146.57 69.51 1.19 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.895 . . . . 0.0 109.565 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 117.24 28.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.08 71.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.31 76.9 1.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.97 106.83 13.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.5 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.839 ' HG3' ' HB2' ' D' ' 46' ' ' ALA . 11.5 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 1' ' ' MET . 1.9 pt-20 177.06 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' D' ' 5' ' ' ILE . 11.3 mm-40 -77.23 95.99 4.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.027 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.52 ' NE ' HG23 ' D' ' 43' ' ' THR . 3.7 mmt85 -107.53 102.85 12.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.672 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.607 HD11 ' OE1' ' D' ' 3' ' ' GLN . 1.7 mp -125.56 148.45 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 108.719 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.9 OUTLIER -67.32 147.84 52.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.065 -1.022 . . . . 0.0 109.957 -179.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.614 ' HA ' HD22 ' D' ' 42' ' ' LEU . 36.5 tp -57.14 -26.12 60.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.647 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' D' ' 9' ' ' ASP . 24.1 pttt -74.66 -43.74 53.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 109.949 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.514 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 1.0 OUTLIER -74.31 -22.0 59.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 10' ' ' TYR . 6.9 t80 -84.27 -37.03 22.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.033 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.798 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -78.93 -27.64 43.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.673 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -46.81 8.19 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.469 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' D' ' 9' ' ' ASP . 2.2 mmm180 -70.06 -24.81 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.255 -0.903 . . . . 0.0 109.789 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.461 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 19.9 m-85 -116.38 -35.6 4.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' D' ' 11' ' ' ALA . . . 127.69 131.84 3.52 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.798 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 0.2 OUTLIER -71.71 -21.77 61.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -1.187 . . . . 0.0 109.723 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -36.5 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.553 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 14' ' ' PHE . 0.3 OUTLIER -86.25 -21.18 27.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.299 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.602 HG22 HD12 ' D' ' 23' ' ' LEU . 17.7 m -74.83 -29.83 61.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -86.79 -26.01 24.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 109.432 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -81.55 -31.0 32.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 108.991 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -83.2 -34.49 25.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.422 -0.799 . . . . 0.0 109.237 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.626 HD21 ' CG1' ' D' ' 50' ' ' VAL . 10.6 mt -85.06 -20.83 29.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.345 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.99 26.25 41.86 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.442 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.1 OUTLIER -108.46 171.89 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 0.0 109.059 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.4 159.1 18.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.183 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.34 -29.21 69.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.135 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 3.4 m -78.5 -12.09 59.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' D' ' 32' ' ' LYS . . . -84.25 -44.43 13.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' D' ' 20' ' ' ALA . 19.4 mt -70.59 -25.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.499 ' OD1' ' NE2' ' D' ' 35' ' ' HIS . 41.9 t30 -76.44 -37.94 56.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.466 -0.771 . . . . 0.0 109.422 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' D' ' 29' ' ' ALA . 5.6 ptpt -73.18 -25.49 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.329 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.879 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -74.92 -41.95 58.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.219 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 21.9 mt -74.97 -29.83 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.499 ' NE2' ' OD1' ' D' ' 31' ' ' ASN . 6.4 m170 -69.69 -34.75 74.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.415 -0.803 . . . . 0.0 109.322 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CD ' ' D' ' 38' ' ' ARG . . . -80.15 -18.47 49.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.348 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.54 26.86 62.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.604 ' CD ' ' HB1' ' D' ' 36' ' ' ALA . 6.0 mpt_? -66.21 -175.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -1.231 . . . . 0.0 109.386 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.504 ' CE ' ' HD3' ' D' ' 56' ' ' LYS . 0.1 OUTLIER -94.05 75.14 4.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.879 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 60.5 mt -104.98 96.9 4.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -85.53 161.32 19.4 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.479 -0.763 . . . . 0.0 109.499 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.65 ' CD1' ' HB2' ' D' ' 52' ' ' ALA . 1.6 tp -122.62 119.7 31.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.447 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.52 HG23 ' NE ' ' D' ' 4' ' ' ARG . 23.3 m -113.39 116.42 29.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 108.909 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.681 HD13 ' N ' ' D' ' 44' ' ' ILE . 1.5 mm -90.79 107.56 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.085 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 5.1 m120 -50.59 140.9 13.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.521 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.839 ' HB2' ' HG3' ' D' ' 1' ' ' MET . . . -43.47 -23.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 0.0 110.621 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' D' ' 45' ' ' ASN . 5.4 m-20 -86.02 33.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.941 -1.099 . . . . 0.0 109.784 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.93 19.13 43.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.0 OUTLIER -90.56 162.72 14.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.402 -1.058 . . . . 0.0 109.126 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.626 ' CG1' HD21 ' D' ' 23' ' ' LEU . 2.7 t -103.9 152.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -0.809 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' D' ' 43' ' ' THR . 45.6 t80 -154.12 75.8 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 108.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.65 ' HB2' ' CD1' ' D' ' 42' ' ' LEU . . . -78.76 142.47 36.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.328 -0.858 . . . . 0.0 109.582 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.98 168.81 18.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.411 -0.805 . . . . 0.0 109.702 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -120.85 128.66 53.03 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.32 106.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.156 -0.965 . . . . 0.0 109.565 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' E' ' 54' ' ' GLU . 9.1 tptp -153.57 125.24 3.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 34.8 Cg_endo -76.72 166.74 26.6 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.249 1.966 . . . . 0.0 110.606 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 1.06 ' CZ ' HG11 ' E' ' 25' ' ' VAL . 0.2 OUTLIER -165.08 146.69 6.42 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.424 -0.797 . . . . 0.0 109.178 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' D' ' 58' ' ' PHE . 35.9 Cg_endo -80.07 172.14 59.08 Favored 'Cis proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.085 -1.631 . . . . 0.0 110.308 -0.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -49.6 -23.32 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.533 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.45 167.32 20.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 109.665 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' D' ' 63' ' ' LYS . 46.3 mttt -137.64 109.04 6.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.669 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' D' ' 62' ' ' LYS . 0.7 OUTLIER 43.05 -149.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -140.48 146.72 38.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.455 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.427 ' O ' ' O ' ' D' ' 66' ' ' ALA . 6.7 m -128.86 116.34 19.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' D' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.423 ' O ' ' N ' ' E' ' 3' ' ' GLN . 2.9 mtm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -58.03 89.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.965 . . . . 0.0 109.567 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.664 ' O ' HD12 ' E' ' 44' ' ' ILE . 0.0 OUTLIER -69.64 100.82 1.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 1.013 ' O ' HD13 ' E' ' 5' ' ' ILE . 7.0 mmt85 -102.51 108.96 20.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 1.013 HD13 ' O ' ' E' ' 4' ' ' ARG . 3.7 mm -134.63 142.51 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 8.4 m -69.08 152.11 45.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' E' ' 19' ' ' THR . 50.2 tp -57.33 -15.4 6.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.625 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.625 ' HB3' HD12 ' E' ' 34' ' ' ILE . 0.0 OUTLIER -89.11 -31.16 18.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' E' ' 5' ' ' ILE . 3.8 m-20 -81.88 -31.78 31.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.555 ' CD2' HG23 ' E' ' 19' ' ' THR . 25.2 t80 -79.58 -30.94 41.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.567 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.41 -28.02 29.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' E' ' 8' ' ' LYS . 22.3 ptm -89.89 -32.22 16.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.027 -1.046 . . . . 0.0 109.977 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 5.6 mtp180 -87.3 -24.28 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 109.79 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.1 m-85 -113.78 -23.96 9.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.037 -1.04 . . . . 0.0 109.693 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.33 133.5 4.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.443 ' O ' HD12 ' E' ' 30' ' ' ILE . 16.7 mt-30 -67.37 -25.14 65.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -1.088 . . . . 0.0 109.46 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 4.5 t -71.97 -35.07 69.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.249 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -72.12 -43.91 63.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.146 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.7 HG21 ' CD1' ' E' ' 7' ' ' LEU . 14.9 m -65.64 -32.8 74.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.4 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.863 ' HA ' HG23 ' E' ' 25' ' ' VAL . . . -80.71 -25.86 37.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.375 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -81.77 -23.54 36.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.873 . . . . 0.0 109.264 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.6 -39.14 17.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 109.228 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 1.01 HD21 HG12 ' E' ' 50' ' ' VAL . 5.8 mt -90.45 -9.01 49.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.66 -34.09 4.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 1.06 HG11 ' CZ ' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -46.18 164.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -1.129 . . . . 0.0 109.453 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.3 OUTLIER -95.07 168.68 10.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 109.476 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -65.96 -31.22 72.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.367 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.18 -18.4 57.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -85.47 -28.64 24.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' E' ' 20' ' ' ALA . 9.7 mt -80.81 -28.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -76.69 -41.42 45.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 0.0 109.074 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' E' ' 33' ' ' ALA . 8.5 pttt -72.04 -29.76 64.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.952 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' E' ' 32' ' ' LYS . . . -68.71 -39.65 80.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 108.93 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' E' ' 8' ' ' LYS . 24.0 mm -75.66 -29.51 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -0.795 . . . . 0.0 108.975 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -72.96 -14.59 61.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.523 -0.736 . . . . 0.0 109.484 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.9 -13.16 36.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.857 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.77 13.87 41.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.437 ' HB3' HG13 ' E' ' 40' ' ' ILE . 0.1 OUTLIER -58.74 160.17 5.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -1.08 . . . . 0.0 109.768 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.514 ' CD ' ' HD3' ' E' ' 56' ' ' LYS . 0.0 OUTLIER -81.97 75.4 8.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' E' ' 38' ' ' ARG . 65.5 mt -107.91 96.18 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.699 ' CE2' HG23 ' E' ' 55' ' ' VAL . 5.8 m-85 -86.67 159.41 19.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.503 -0.748 . . . . 0.0 109.514 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.703 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -122.22 104.61 9.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 110.155 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . 0.746 HG23 ' NE ' ' E' ' 4' ' ' ARG . 91.9 m -89.16 84.42 6.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 108.807 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.664 HD12 ' O ' ' E' ' 3' ' ' GLN . 0.3 OUTLIER -88.07 121.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.593 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' E' ' 47' ' ' ASP . 0.6 OUTLIER -87.37 151.11 23.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.54 -22.61 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.816 -0.552 . . . . 0.0 110.383 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' E' ' 45' ' ' ASN . 0.6 OUTLIER -85.63 33.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.947 -1.095 . . . . 0.0 109.64 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.67 32.28 31.97 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' E' ' 44' ' ' ILE . 0.7 OUTLIER -90.25 95.1 10.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -1.144 . . . . 0.0 109.468 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 1.01 HG12 HD21 ' E' ' 23' ' ' LEU . 88.1 t -79.14 107.02 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.074 -1.016 . . . . 0.0 109.568 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -119.57 86.62 2.59 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.342 -0.849 . . . . 0.0 108.863 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.703 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -78.87 143.84 35.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.709 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 29.9 mt-10 -140.02 156.81 46.44 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.337 -0.852 . . . . 0.0 109.669 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' D' ' 56' ' ' LYS . 73.0 tt0 -107.74 128.05 54.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.699 HG23 ' CE2' ' E' ' 41' ' ' PHE . 0.0 OUTLIER -148.8 97.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.514 ' HD3' ' CD ' ' E' ' 39' ' ' LYS . 2.5 ttpt -138.36 132.09 16.56 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 166.71 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.427 2.085 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' E' ' 59' ' ' PRO . 49.4 t80 -142.43 140.11 18.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 109.441 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' E' ' 58' ' ' PHE . 35.1 Cg_endo -79.64 175.55 44.88 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 110.345 -0.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -62.07 -173.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' E' ' 62' ' ' LYS . 10.7 p30 -91.56 158.39 16.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' E' ' 61' ' ' ASN . 0.0 OUTLIER -43.35 122.93 2.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.48 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -137.53 113.27 9.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.603 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.45 67.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.371 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' E' ' 66' ' ' ALA . 0.1 OUTLIER -123.13 89.24 3.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.547 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' E' ' 65' ' ' THR . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.55 100.65 5.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . 0.53 ' O ' HD12 ' D' ' 44' ' ' ILE . 9.7 mt-30 -87.85 75.44 8.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.614 ' C ' HD13 ' D' ' 5' ' ' ILE . 0.0 OUTLIER -107.94 107.63 18.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.57 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.614 HD13 ' C ' ' D' ' 4' ' ' ARG . 1.6 mm -124.38 125.85 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.462 -0.774 . . . . 0.0 109.394 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -50.56 149.26 3.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.762 HD12 ' O ' ' D' ' 7' ' ' LEU . 4.5 tp -57.07 -15.94 6.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 109.532 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' D' ' 9' ' ' ASP . 0.0 OUTLIER -86.44 -30.6 21.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.935 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' D' ' 8' ' ' LYS . 7.5 m-20 -87.35 -25.99 23.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.557 ' HD1' ' HG1' ' D' ' 19' ' ' THR . 3.8 t80 -81.98 -29.32 32.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.025 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.712 ' HB1' ' CG ' ' D' ' 16' ' ' GLN . . . -86.93 -31.28 20.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.427 -0.796 . . . . 0.0 109.711 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 8' ' ' LYS . 3.8 mtm -86.54 -30.46 21.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.968 . . . . 0.0 110.08 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' D' ' 9' ' ' ASP . 3.2 mtt180 -87.61 -40.03 14.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.107 -0.996 . . . . 0.0 109.782 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' D' ' 10' ' ' TYR . 40.7 m-85 -95.16 -32.84 12.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.05 117.83 2.4 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.712 ' CG ' ' HB1' ' D' ' 11' ' ' ALA . 1.2 mt-30 -55.61 -21.26 16.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -1.151 . . . . 0.0 109.447 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -66.81 -44.7 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.363 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.484 ' HD3' ' O ' ' D' ' 14' ' ' PHE . 1.9 mptp? -76.72 -23.43 53.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.337 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.557 ' HG1' ' HD1' ' D' ' 10' ' ' TYR . 17.6 m -74.11 -31.7 62.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 108.994 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -87.72 -22.6 24.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.29 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -81.69 -33.01 31.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.202 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.72 -36.39 23.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.871 . . . . 0.0 109.08 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.732 ' HG ' HG11 ' D' ' 50' ' ' VAL . 14.8 mt -85.35 -15.96 41.5 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.329 -0.857 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.33 33.9 55.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.403 ' O ' ' HB1' ' D' ' 20' ' ' ALA . 0.2 OUTLIER -108.09 175.65 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -1.2 . . . . 0.0 109.245 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -94.47 162.44 13.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -63.92 -40.66 96.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -7.35 53.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.529 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.51 -39.03 16.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.135 -0.978 . . . . 0.0 108.477 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' D' ' 20' ' ' ALA . 40.8 mt -78.46 -31.53 15.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -76.02 -34.75 59.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 108.964 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -40.79 65.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.083 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' D' ' 40' ' ' ILE . . . -60.5 -45.91 92.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 20.5 mm -62.68 -39.65 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -65.4 -20.45 66.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.753 -0.592 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.29 -22.4 35.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.08 23.94 60.15 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -165.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -1.124 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' D' ' 55' ' ' VAL . 7.7 mmmt -104.41 76.73 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' D' ' 33' ' ' ALA . 2.4 mt -109.36 108.31 25.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.637 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 2.7 m-85 -102.98 158.52 16.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.256 -0.902 . . . . 0.0 109.589 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.72 HD22 ' HA ' ' D' ' 7' ' ' LEU . 0.9 OUTLIER -120.21 101.28 7.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 110.119 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 2.3 m -91.92 110.76 22.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.095 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.53 HD12 ' O ' ' D' ' 3' ' ' GLN . 0.3 OUTLIER -103.24 105.96 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 -179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 20.6 m-80 -55.75 144.05 28.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.182 -0.949 . . . . 0.0 110.0 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -40.2 -23.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 122.031 -0.418 . . . . 0.0 110.959 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' ASN . 0.4 OUTLIER -82.31 30.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.782 -1.199 . . . . 0.0 109.892 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.79 23.32 29.44 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 1.3 p -90.75 123.96 34.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.377 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.732 HG11 ' HG ' ' D' ' 23' ' ' LEU . 45.9 t -79.71 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.05 -1.031 . . . . 0.0 109.595 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' D' ' 43' ' ' THR . 18.0 t80 -141.64 82.16 1.8 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.94 138.21 38.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 109.685 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -139.42 164.38 30.01 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.695 0.76 . . . . 0.0 109.422 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 3.3 tm-20 -113.44 147.17 38.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -155.6 122.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 -179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' D' ' 57' ' ' PRO . 5.1 ttpt -144.32 141.91 18.84 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.694 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.471 ' HB3' ' OH ' ' E' ' 51' ' ' TYR . 34.0 Cg_endo -75.25 154.79 41.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.324 2.016 . . . . 0.0 111.476 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.584 ' CG ' ' HA ' ' D' ' 59' ' ' PRO . 0.4 OUTLIER -67.67 165.81 27.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.565 -0.71 . . . . 0.0 109.819 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.584 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 35.8 Cg_endo -79.43 -176.61 18.8 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.129 -1.613 . . . . 0.0 110.084 -0.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 20.4 p -55.02 -58.09 9.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.196 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.37 -168.89 2.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -139.07 -159.98 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -93.59 -162.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.384 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.43 63.44 1.35 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.579 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -153.76 72.78 0.92 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.879 -1.058 . . . . 0.0 109.475 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' E' ' 1' ' ' MET . 8.4 tpt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' E' ' 4' ' ' ARG . 58.9 mt-10 -143.84 61.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.457 ' O ' HG13 ' E' ' 44' ' ' ILE . 38.8 mt-30 -44.99 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' E' ' 2' ' ' GLU . 12.8 mmm-85 -101.02 108.15 19.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.862 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.566 HD13 HD11 ' E' ' 44' ' ' ILE . 5.3 mp -127.77 144.86 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.47 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.7 m -64.76 152.52 42.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 109.673 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.735 ' HA ' HD22 ' E' ' 42' ' ' LEU . 31.4 tp -59.46 -14.21 11.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.836 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' E' ' 34' ' ' ILE . 10.1 pttp -89.74 -39.77 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.153 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.553 ' HB3' ' CG2' ' E' ' 5' ' ' ILE . 0.1 OUTLIER -67.29 -36.34 81.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.637 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.525 ' HD1' ' HG1' ' E' ' 19' ' ' THR . 9.7 t80 -80.31 -31.19 38.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 108.917 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -24.95 60.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.305 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -45.23 9.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 110.137 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . . . . . . . . . 46.0 mtp85 -78.02 -16.7 57.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.888 . . . . 0.0 109.816 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.586 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 3.0 m-85 -122.94 10.19 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.13 136.66 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -62.15 -18.39 60.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -69.11 -45.13 70.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.388 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.31 -33.56 69.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.773 ' O ' HD12 ' E' ' 23' ' ' LEU . 5.0 m -69.06 -27.77 65.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.045 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' E' ' 30' ' ' ILE . . . -85.0 -26.4 27.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -77.62 -29.47 51.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.65 -35.66 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.841 . . . . 0.0 109.135 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.773 HD12 ' O ' ' E' ' 19' ' ' THR . 1.2 mt -88.55 -14.11 38.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.365 -0.835 . . . . 0.0 109.402 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.73 -33.79 4.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' E' ' 20' ' ' ALA . 2.2 m -54.53 -175.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.182 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' E' ' 26' ' ' TYR . 0.1 OUTLIER -111.57 170.61 8.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.251 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -69.31 -26.54 64.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . . . . . . . . . 2.9 t -75.95 -22.86 55.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.154 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.02 -33.99 24.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' E' ' 20' ' ' ALA . 5.9 mt -77.33 -27.54 15.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -41.42 48.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.439 -0.788 . . . . 0.0 109.175 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -72.98 -32.1 64.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 108.898 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.553 ' HB1' HD13 ' E' ' 40' ' ' ILE . . . -68.63 -42.57 77.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' E' ' 8' ' ' LYS . 30.1 mm -73.92 -27.16 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.38 -0.825 . . . . 0.0 109.02 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -70.94 -31.42 68.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.431 -0.793 . . . . 0.0 109.019 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.25 -13.58 59.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.14 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.97 21.8 32.4 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 173.96 2.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.494 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' E' ' 39' ' ' LYS . 0.2 OUTLIER -76.42 85.58 3.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.553 HD13 ' HB1' ' E' ' 33' ' ' ALA . 36.8 mt -124.32 103.12 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 0.0 109.177 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' E' ' 55' ' ' VAL . 3.4 m-30 -101.83 165.42 11.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.465 -0.772 . . . . 0.0 109.683 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 mp -122.47 112.72 18.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.429 -0.794 . . . . 0.0 109.831 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 66.9 m -95.98 104.11 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.566 HD11 HD13 ' E' ' 5' ' ' ILE . 0.7 OUTLIER -93.27 125.99 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.8 OUTLIER -88.55 149.2 23.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -0.853 . . . . 0.0 109.554 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' E' ' 45' ' ' ASN . . . -39.97 -26.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.122 0.487 . . . . 0.0 110.613 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' E' ' 45' ' ' ASN . 34.3 t70 -85.68 33.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.958 -1.089 . . . . 0.0 109.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 49.01 34.02 15.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 1.0 OUTLIER -90.33 116.35 28.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -1.102 . . . . 0.0 109.604 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.83 120.26 35.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.68 -1.262 . . . . 0.0 109.755 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' D' ' 57' ' ' PRO . 8.4 t80 -130.12 85.95 2.35 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.04 140.26 37.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -140.3 168.06 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.9 0.857 . . . . 0.0 109.683 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 30.1 tt0 -107.64 150.84 26.42 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 1.031 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -151.62 124.29 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.773 -178.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' E' ' 61' ' ' ASN . 0.7 OUTLIER -157.59 138.31 9.27 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.487 -0.758 . . . . 0.0 109.134 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HG3' ' E' ' 56' ' ' LYS . 32.7 Cg_endo -73.74 158.78 46.52 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.481 2.121 . . . . 0.0 111.168 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.48 75.36 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.522 -0.736 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.457 ' O ' ' ND2' ' E' ' 61' ' ' ASN . 36.2 Cg_endo -79.0 3.62 30.93 Favored 'Cis proline' 0 C--N 1.307 -1.63 0 C-N-CA 123.206 -1.581 . . . . 0.0 110.309 -0.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . 0.471 ' O ' ' HE2' ' E' ' 56' ' ' LYS . 1.1 t -43.24 110.13 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . 0.487 ' HA ' ' HE2' ' E' ' 56' ' ' LYS . 78.0 m-20 -121.81 -167.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.395 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -48.58 119.15 2.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -81.62 164.15 22.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -97.73 106.33 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.487 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 11.0 t -158.99 158.24 32.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.391 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.36 -177.7 6.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.601 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -75.63 95.68 3.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -0.876 . . . . 0.0 109.467 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.661 ' C ' HD12 ' D' ' 5' ' ' ILE . 8.2 mmm-85 -124.7 124.21 41.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.321 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.661 HD12 ' C ' ' D' ' 4' ' ' ARG . 4.7 mp -150.79 152.9 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.158 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -76.88 154.29 33.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -0.951 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.633 ' HA ' HD22 ' D' ' 42' ' ' LEU . 22.4 tp -60.19 -14.11 15.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.807 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.478 ' HG2' ' HB ' ' D' ' 6' ' ' THR . 5.7 pttt -90.21 -32.53 16.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.977 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -80.31 -33.65 37.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.797 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' D' ' 19' ' ' THR . 34.9 t80 -80.37 -31.33 37.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' D' ' 19' ' ' THR . . . -84.31 -23.17 30.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.032 -1.043 . . . . 0.0 109.665 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' D' ' 8' ' ' LYS . 1.6 mtm -90.37 -35.2 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.986 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -88.01 -23.79 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.152 -0.967 . . . . 0.0 109.982 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.0 m-85 -108.38 -4.99 16.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.32 130.94 4.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.13 -14.18 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 -32.02 57.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -82.14 -35.95 27.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.899 ' O ' HD12 ' D' ' 23' ' ' LEU . 10.0 m -71.67 -32.82 68.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' D' ' 30' ' ' ILE . . . -80.54 -28.49 37.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.296 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -79.42 -28.21 41.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.617 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.3 OUTLIER -81.92 -38.14 25.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.337 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.899 HD12 ' O ' ' D' ' 19' ' ' THR . 0.9 OUTLIER -88.26 -14.75 37.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.387 -0.821 . . . . 0.0 109.616 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' D' ' 25' ' ' VAL . . . 89.31 -33.14 4.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.463 ' H ' HG22 ' D' ' 25' ' ' VAL . 0.5 OUTLIER -50.1 179.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -1.122 . . . . 0.0 109.321 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.69 162.88 12.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.194 -0.941 . . . . 0.0 109.294 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -65.4 -26.02 67.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.094 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.97 -19.46 57.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.311 -0.868 . . . . 0.0 109.026 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.22 -32.92 26.24 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' D' ' 20' ' ' ALA . 25.5 mt -80.09 -29.34 12.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -75.77 -33.4 60.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 109.122 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -74.73 -36.14 62.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 1.127 ' HB1' ' CD1' ' D' ' 40' ' ' ILE . . . -68.34 -35.38 77.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.93 -27.37 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.0 109.054 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 -27.77 62.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.445 -0.784 . . . . 0.0 109.546 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.84 -18.5 40.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.44 34.94 91.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 -173.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -1.111 . . . . 0.0 109.592 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.569 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 13.5 mmtt -95.25 74.08 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.319 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 1.127 ' CD1' ' HB1' ' D' ' 33' ' ' ALA . 69.5 mt -104.7 105.85 19.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' D' ' 39' ' ' LYS . 4.2 m-85 -98.18 160.7 14.13 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.293 -0.879 . . . . 0.0 109.515 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.633 HD22 ' HA ' ' D' ' 7' ' ' LEU . 1.2 tp -126.02 126.23 43.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.055 -1.028 . . . . 0.0 109.834 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' D' ' 51' ' ' TYR . 5.0 m -122.46 107.33 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 108.764 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' D' ' 49' ' ' SER . 0.6 OUTLIER -98.75 110.27 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.962 -1.086 . . . . 0.0 109.554 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' D' ' 47' ' ' ASP . 1.9 m-20 -54.18 141.0 30.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.221 -0.925 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -42.6 -23.62 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.82 -0.55 . . . . 0.0 110.609 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' D' ' 45' ' ' ASN . 2.9 m-20 -84.27 31.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.128 . . . . 0.0 110.007 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 58.78 24.46 57.51 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' D' ' 44' ' ' ILE . 0.1 OUTLIER -89.73 144.4 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.335 -1.097 . . . . 0.0 108.769 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' D' ' 22' ' ' ASP . 38.8 t -98.45 135.04 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.791 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' D' ' 43' ' ' THR . 13.2 t80 -145.52 78.24 1.54 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.665 ' HB1' ' CE2' ' E' ' 58' ' ' PHE . . . -79.2 153.51 29.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 0.7 OUTLIER -136.92 158.25 44.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.292 -0.88 . . . . 0.0 109.932 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 1.6 tp10 -123.42 112.81 17.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' E' ' 55' ' ' VAL . 0.1 OUTLIER -131.3 105.44 10.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.163 -178.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' D' ' 57' ' ' PRO . 0.0 OUTLIER -148.47 138.39 12.74 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 121.444 -0.785 . . . . 0.0 109.21 -179.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.486 ' HD2' ' HG2' ' D' ' 56' ' ' LYS . 36.2 Cg_endo -77.51 141.93 20.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.709 2.272 . . . . 0.0 111.18 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.599 ' HE1' HG11 ' E' ' 25' ' ' VAL . 23.2 t80 -100.69 140.92 21.76 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.304 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . 0.58 ' HA ' ' CG ' ' D' ' 58' ' ' PHE . 36.6 Cg_endo -81.37 -161.67 2.71 Favored 'Cis proline' 0 C--N 1.308 -1.563 0 C-N-CA 123.607 -1.414 . . . . 0.0 110.275 -0.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.74 158.97 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -85.79 47.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.569 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp 53.23 78.89 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.212 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -110.79 146.63 36.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.763 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 37.8 p -127.59 128.42 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.325 -0.86 . . . . 0.0 109.337 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.0 -168.54 1.63 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.432 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -91.53 159.13 16.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.441 ' HB3' HD11 ' E' ' 5' ' ' ILE . 1.7 mt-30 -84.77 118.87 24.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.247 -0.908 . . . . 0.0 109.165 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.467 ' O ' HG13 ' E' ' 5' ' ' ILE . 1.9 mmm180 -110.29 110.08 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 109.606 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.594 HD13 HD13 ' E' ' 44' ' ' ILE . 3.1 mp -143.65 145.81 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 2.5 m -77.04 153.74 34.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' E' ' 42' ' ' LEU . 30.2 tp -60.45 -16.47 36.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' E' ' 12' ' ' MET . 51.5 pttt -87.01 -37.54 17.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' E' ' 13' ' ' ARG . 1.7 m-20 -77.86 -33.98 51.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.019 . . . . 0.0 109.972 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' E' ' 10' ' ' TYR . 7.6 t80 -78.66 -30.86 46.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.56 ' CB ' HD11 ' E' ' 34' ' ' ILE . . . -84.8 -30.53 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' E' ' 8' ' ' LYS . 0.0 OUTLIER -89.78 -29.29 18.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.897 -1.127 . . . . 0.0 110.072 -179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 32.9 mtm180 -89.63 -26.93 20.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.101 -0.999 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' E' ' 10' ' ' TYR . 11.7 m-85 -115.52 8.84 15.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 109.601 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.52 131.62 2.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -1.094 . . . . 0.0 109.535 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . 0.621 HG23 HE21 ' E' ' 27' ' ' GLN . 0.2 OUTLIER -63.12 -53.26 56.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' E' ' 14' ' ' PHE . 20.7 mttt -54.02 -37.86 64.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.488 HG23 ' CD1' ' E' ' 10' ' ' TYR . 3.0 m -66.61 -32.18 73.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.931 ' HB2' HG13 ' E' ' 30' ' ' ILE . . . -78.42 -24.38 46.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -77.1 -39.64 48.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.779 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.501 ' HB3' HG21 ' E' ' 50' ' ' VAL . 1.0 OUTLIER -75.27 -32.65 61.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.272 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' E' ' 50' ' ' VAL . 16.7 mt -87.92 -17.7 30.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.346 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.93 69.58 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' D' ' 58' ' ' PHE . 0.1 OUTLIER -97.49 -169.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.438 -1.037 . . . . 0.0 109.393 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.29 163.68 12.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.173 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . 0.621 HE21 HG23 ' E' ' 17' ' ' THR . 10.7 mt-30 -68.75 -29.96 68.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.502 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 32' ' ' LYS . 42.1 t -80.99 -11.34 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.685 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' E' ' 32' ' ' LYS . . . -90.36 -33.88 15.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.09 -1.006 . . . . 0.0 108.516 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.931 HG13 ' HB2' ' E' ' 20' ' ' ALA . 29.7 mm -78.79 -37.03 19.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.428 ' O ' ' ND1' ' E' ' 35' ' ' HIS . 1.7 t30 -76.79 -37.02 56.56 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 109.101 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' E' ' 29' ' ' ALA . 49.8 pttt -73.19 -29.75 63.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.163 -0.961 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' E' ' 40' ' ' ILE . . . -68.5 -44.99 73.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 108.89 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.56 HD11 ' CB ' ' E' ' 11' ' ' ALA . 9.5 mt -70.58 -28.53 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 108.838 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.428 ' ND1' ' O ' ' E' ' 31' ' ' ASN . 8.4 m80 -67.21 -26.02 66.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.437 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' E' ' 37' ' ' GLY . . . -84.13 -10.8 57.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' E' ' 36' ' ' ALA . . . 44.36 26.76 1.04 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -169.49 0.7 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.173 -1.193 . . . . 0.0 109.582 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.516 ' HE3' ' HD2' ' E' ' 56' ' ' LYS . 0.6 OUTLIER -91.73 76.0 5.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.94 . . . . 0.0 109.358 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . 0.498 HG21 HD22 ' E' ' 7' ' ' LEU . 59.4 mt -106.54 90.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' E' ' 41' ' ' PHE . 1.1 m-85 -79.21 162.97 25.37 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.709 -0.62 . . . . 0.0 109.528 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.715 ' CD1' ' HB2' ' E' ' 52' ' ' ALA . 1.2 tp -128.02 96.09 4.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.928 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 25.8 m -90.01 89.54 7.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 108.968 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.905 HG23 ' O ' ' E' ' 49' ' ' SER . 3.1 mp -82.1 129.97 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.021 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 20.2 m-20 -81.66 147.76 29.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.863 . . . . 0.0 109.382 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.04 -19.81 0.29 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.625 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.6 31.07 0.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.895 -1.128 . . . . 0.0 109.926 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.67 62.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.905 ' O ' HG23 ' E' ' 44' ' ' ILE . 0.2 OUTLIER -90.66 155.97 18.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -1.073 . . . . 0.0 109.404 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' E' ' 23' ' ' LEU . 1.5 t -125.41 119.06 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . 0.516 ' CZ ' ' CD ' ' E' ' 53' ' ' GLU . 2.8 t80 -119.84 80.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.421 -0.799 . . . . 0.0 108.864 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.715 ' HB2' ' CD1' ' E' ' 42' ' ' LEU . . . -79.0 134.75 36.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.726 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' E' ' 51' ' ' TYR . 7.0 mt-10 -123.76 165.47 17.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' E' ' 39' ' ' LYS . 4.4 tt0 -121.08 129.84 53.5 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 55' ' ' VAL . 0.1 OUTLIER -150.61 98.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.018 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.516 ' HD2' ' HE3' ' E' ' 39' ' ' LYS . 5.1 tptp -154.32 138.94 11.52 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.796 . . . . 0.0 109.319 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.487 ' N ' ' HG3' ' E' ' 56' ' ' LYS . 36.5 Cg_endo -80.5 159.2 22.44 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.499 2.133 . . . . 0.0 110.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.665 ' CE2' ' HB1' ' D' ' 52' ' ' ALA . 3.2 p90 -134.85 135.96 24.27 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.413 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.65 -162.75 3.05 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.423 -1.491 . . . . 0.0 110.493 0.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -79.53 104.77 10.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -144.83 47.65 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' E' ' 63' ' ' LYS . 0.1 OUTLIER -138.98 166.33 24.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.59 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' E' ' 62' ' ' LYS . 0.0 OUTLIER -164.83 34.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.04 136.07 40.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -155.24 109.57 2.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.626 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.16 164.35 30.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.608 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.21 103.59 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . 0.479 ' C ' HD12 ' D' ' 5' ' ' ILE . 7.7 mmm180 -105.39 119.35 38.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 109.77 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' D' ' 9' ' ' ASP . 4.9 mp -148.94 155.5 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.199 -0.938 . . . . 0.0 109.631 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' D' ' 8' ' ' LYS . 0.2 OUTLIER -84.14 145.11 28.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 109.126 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' D' ' 42' ' ' LEU . 14.6 tp -47.14 -22.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.897 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.671 ' HA ' HD11 ' D' ' 34' ' ' ILE . 2.0 pttp -81.11 -41.92 21.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' D' ' 13' ' ' ARG . 0.8 OUTLIER -70.87 -24.68 62.55 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.107 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' TYR . . . . . 0.773 ' CD2' HG23 ' D' ' 19' ' ' THR . 11.1 t80 -79.65 -32.61 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.903 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' D' ' 16' ' ' GLN . . . -80.44 -33.68 36.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.996 . . . . 0.0 109.972 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.87 -32.28 20.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.084 -1.01 . . . . 0.0 111.423 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' D' ' 9' ' ' ASP . 5.3 mmt-85 -90.44 -27.23 19.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.735 -1.228 . . . . 0.0 110.986 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' D' ' 14' ' ' PHE . 4.1 m-85 -108.66 -41.59 4.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.793 -1.192 . . . . 0.0 110.153 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.06 139.71 3.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.617 ' HG3' ' HB1' ' D' ' 11' ' ' ALA . 38.6 mt-30 -75.92 -38.47 57.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -1.132 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -44.87 94.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.924 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' D' ' 14' ' ' PHE . 0.5 OUTLIER -71.56 -29.11 64.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.749 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . 0.773 HG23 ' CD2' ' D' ' 10' ' ' TYR . 90.0 m -68.88 -30.84 69.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.53 35.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.414 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -80.0 -24.36 40.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 108.849 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' ASP . . . . . 0.791 ' HB3' HG21 ' D' ' 50' ' ' VAL . 0.4 OUTLIER -78.96 -39.03 35.55 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.202 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.683 HD12 ' O ' ' D' ' 19' ' ' THR . 2.9 mt -89.83 -9.01 50.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.76 23.02 78.58 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.679 HG11 ' HE1' ' E' ' 58' ' ' PHE . 2.2 m -109.64 -171.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -1.198 . . . . 0.0 109.501 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.897 ' CE2' ' HB2' ' D' ' 29' ' ' ALA . 0.1 OUTLIER -102.62 156.07 17.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.101 -1.0 . . . . 0.0 109.411 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -68.37 -27.12 65.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.21 63.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.147 -0.971 . . . . 0.0 109.013 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.897 ' HB2' ' CE2' ' D' ' 26' ' ' TYR . . . -81.36 -42.87 19.85 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.33 -25.55 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' D' ' 35' ' ' HIS . 61.7 t-20 -69.79 -51.06 37.08 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.61 -27.48 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.3 -0.875 . . . . 0.0 108.737 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' D' ' 40' ' ' ILE . . . -67.77 -38.38 83.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.208 -0.933 . . . . 0.0 109.003 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' D' ' 8' ' ' LYS . 16.9 mm -74.92 -32.44 27.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' D' ' 31' ' ' ASN . 18.7 m-70 -73.93 -21.53 60.01 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' D' ' 38' ' ' ARG . . . -79.99 -21.48 43.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.425 -0.797 . . . . 0.0 109.306 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.82 28.9 5.75 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.817 ' HG3' ' HB1' ' D' ' 36' ' ' ALA . 16.6 mtp180 -80.41 -162.47 0.46 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 109.253 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' LYS . . . . . 0.585 ' HB3' ' CZ ' ' D' ' 41' ' ' PHE . 51.1 mmtt -99.49 77.88 2.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.723 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' ILE . . . . . 0.56 HD13 ' HB1' ' D' ' 33' ' ' ALA . 5.4 mt -107.25 92.52 2.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' D' ' 55' ' ' VAL . 1.5 m-30 -79.54 169.01 18.66 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.643 -0.661 . . . . 0.0 109.556 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.872 HD12 ' HB2' ' D' ' 52' ' ' ALA . 0.8 OUTLIER -142.07 107.42 5.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 110.408 -178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' THR . . . . . 0.576 HG23 ' O ' ' D' ' 43' ' ' THR . 2.1 t -96.44 115.76 27.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.017 -1.052 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.91 127.35 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.877 -1.139 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' CB ' ' D' ' 49' ' ' SER . 1.9 m-80 -89.62 141.52 28.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.411 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.33 -21.3 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 110.602 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' D' ' 45' ' ' ASN . 31.0 m-20 -85.34 32.72 0.56 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.863 -1.148 . . . . 0.0 109.748 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' GLY . . . . . . . . . . . . . . . 56.47 26.29 51.5 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.469 ' CB ' ' HB2' ' D' ' 45' ' ' ASN . 0.1 OUTLIER -91.13 159.56 16.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.365 -1.08 . . . . 0.0 110.144 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.791 HG21 ' HB3' ' D' ' 22' ' ' ASP . 2.7 t -134.5 119.09 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 109.682 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' TYR . . . . . 0.569 ' O ' HG22 ' D' ' 43' ' ' THR . 9.8 t80 -127.43 87.22 2.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -79.76 147.57 31.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.383 -0.823 . . . . 0.0 109.635 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' E' ' 57' ' ' PRO . 11.5 mt-10 -130.54 163.26 27.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.772 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' E' ' 55' ' ' VAL . 22.1 tp10 -116.6 142.61 46.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' E' ' 55' ' ' VAL . 0.0 OUTLIER -159.03 110.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' HD2' ' D' ' 57' ' ' PRO . 0.1 OUTLIER -148.35 130.57 7.64 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.259 -0.901 . . . . 0.0 109.315 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' E' ' 53' ' ' GLU . 33.9 Cg_endo -76.15 148.49 31.01 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.508 2.138 . . . . 0.0 111.415 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' PHE . . . . . 0.83 ' CE2' ' HB1' ' E' ' 52' ' ' ALA . 0.8 OUTLIER -128.11 148.36 67.19 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.428 -0.795 . . . . 0.0 109.403 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.36 -169.05 7.49 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.118 -1.618 . . . . 0.0 110.233 0.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.09 115.51 4.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 109.429 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -111.36 -171.77 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.56 149.1 40.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.9 . . . . 0.0 109.587 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -99.18 -173.62 2.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.333 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.97 88.65 4.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.46 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.77 41.38 3.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.478 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.328 0.585 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.86 35.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -60.8 96.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.555 ' C ' HD12 ' E' ' 5' ' ' ILE . 0.1 OUTLIER -110.13 127.78 55.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 5' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 44' ' ' ILE . 4.4 mp -147.92 131.23 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.062 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 6' ' ' THR . . . . . 0.504 ' HB ' ' HG2' ' E' ' 8' ' ' LYS . 0.2 OUTLIER -65.25 157.49 28.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.777 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 7' ' ' LEU . . . . . 0.799 ' CD1' HG21 ' E' ' 19' ' ' THR . 23.8 tp -61.36 -15.21 33.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.117 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 8' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' E' ' 9' ' ' ASP . 6.0 pttt -89.94 -28.25 19.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.0 109.727 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 9' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' E' ' 8' ' ' LYS . 0.9 OUTLIER -81.64 -32.53 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 10' ' ' TYR . . . . . 0.559 ' HD2' HG23 ' E' ' 19' ' ' THR . 30.7 t80 -81.41 -29.27 33.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.27 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.744 ' HB1' ' HG3' ' E' ' 16' ' ' GLN . . . -84.62 -24.99 28.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 12' ' ' MET . . . . . . . . . . . . . 65.4 mtt -89.85 -41.09 12.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.702 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 13' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' E' ' 9' ' ' ASP . 2.9 mtp180 -79.58 -27.43 41.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 14' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' E' ' 14' ' ' PHE . 4.1 m-85 -113.61 -8.51 13.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.076 -1.015 . . . . 0.0 109.461 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' E' ' 11' ' ' ALA . . . 97.27 147.08 22.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.744 ' HG3' ' HB1' ' E' ' 11' ' ' ALA . 0.0 OUTLIER -69.71 -38.46 76.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -1.142 . . . . 0.0 109.284 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -62.29 -27.52 69.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.384 -0.823 . . . . 0.0 109.154 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.79 -42.8 26.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.12 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.799 HG21 ' CD1' ' E' ' 7' ' ' LEU . 38.3 m -60.12 -31.61 70.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 108.968 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.779 ' HB2' ' CD1' ' E' ' 30' ' ' ILE . . . -82.37 -20.03 38.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.165 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -37.83 51.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 22' ' ' ASP . . . . . 0.709 ' HB3' HG21 ' E' ' 50' ' ' VAL . 2.1 t0 -80.0 -37.01 35.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.754 ' HG ' HG11 ' E' ' 50' ' ' VAL . 3.3 mt -86.16 -12.34 50.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.431 -0.793 . . . . 0.0 109.323 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.03 41.77 98.44 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.637 HG12 ' H ' ' E' ' 26' ' ' TYR . 1.4 t -114.54 -174.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -1.176 . . . . 0.0 109.404 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 26' ' ' TYR . . . . . 0.637 ' H ' HG12 ' E' ' 25' ' ' VAL . 0.5 OUTLIER -91.83 154.61 18.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.15 -29.58 70.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.212 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 28' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' E' ' 32' ' ' LYS . 0.1 OUTLIER -78.68 -12.96 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' E' ' 26' ' ' TYR . . . -83.06 -39.49 21.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 108.764 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 30' ' ' ILE . . . . . 0.779 ' CD1' ' HB2' ' E' ' 20' ' ' ALA . 1.1 mt -74.69 -34.82 35.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 31' ' ' ASN . . . . . 0.559 ' ND2' ' NE2' ' E' ' 35' ' ' HIS . 5.1 t30 -73.74 -30.11 62.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.206 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 32' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' E' ' 28' ' ' SER . 7.3 mtpm? -74.7 -40.84 61.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.878 . . . . 0.0 109.408 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.74 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.848 . . . . 0.0 108.813 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' E' ' 8' ' ' LYS . 16.2 mm -83.36 -24.48 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.349 -0.844 . . . . 0.0 108.971 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 35' ' ' HIS . . . . . 0.559 ' NE2' ' ND2' ' E' ' 31' ' ' ASN . 11.1 m-70 -74.8 -25.27 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.68 -10.73 57.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 109.545 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 37' ' ' GLY . . . . . . . . . . . . . . . 54.47 26.88 39.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -174.79 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -1.123 . . . . 0.0 109.433 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 39' ' ' LYS . . . . . 0.499 ' HB3' ' CZ ' ' E' ' 41' ' ' PHE . 14.5 mmtt -88.69 81.61 7.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.67 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.77 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 41' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' E' ' 55' ' ' VAL . 4.2 m-85 -98.93 159.24 15.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' E' ' 7' ' ' LEU . 1.2 tp -124.74 102.13 7.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.113 -0.992 . . . . 0.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 43' ' ' THR . . . . . . . . . . . . . 17.1 m -93.06 112.99 25.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.144 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 44' ' ' ILE . . . . . 0.588 HD13 HD13 ' E' ' 5' ' ' ILE . 1.7 mp -100.91 112.26 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.935 . . . . 0.0 109.756 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 9.4 m-20 -56.71 139.29 51.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.61 -21.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.717 -0.614 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' E' ' 45' ' ' ASN . 9.4 t70 -83.23 30.14 0.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.897 -1.127 . . . . 0.0 110.067 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.38 19.69 60.18 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' E' ' 45' ' ' ASN . 0.3 OUTLIER -90.8 148.1 22.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.351 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.754 HG11 ' HG ' ' E' ' 23' ' ' LEU . 34.5 t -103.37 144.33 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.461 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 51' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -147.81 81.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.273 -0.892 . . . . 0.0 108.731 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.83 ' HB1' ' CE2' ' D' ' 58' ' ' PHE . . . -77.82 141.37 39.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 0.0 109.515 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 53' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 57' ' ' PRO . 0.2 OUTLIER -140.44 161.78 36.88 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.405 -0.809 . . . . 0.0 109.907 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 54' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' D' ' 55' ' ' VAL . 17.9 tt0 -112.66 149.54 32.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 1.014 HG13 HG13 ' D' ' 55' ' ' VAL . 0.0 OUTLIER -154.19 115.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.841 -1.143 . . . . 0.0 109.805 -178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' E' ' 57' ' ' PRO . 0.1 OUTLIER -150.26 133.45 8.57 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' E' ' 56' ' ' LYS . 36.3 Cg_endo -78.21 141.84 18.7 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.687 2.258 . . . . 0.0 111.136 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 58' ' ' PHE . . . . . 0.679 ' HE1' HG11 ' D' ' 25' ' ' VAL . 18.4 t80 -94.76 138.71 22.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.238 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 59' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' E' ' 58' ' ' PHE . 36.4 Cg_endo -81.81 -166.57 5.16 Favored 'Cis proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.53 -1.446 . . . . 0.0 110.343 -0.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 60' ' ' SER . . . . . 0.433 ' O ' ' O ' ' E' ' 59' ' ' PRO . 87.2 p -47.35 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.672 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 61' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -111.77 116.85 31.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -141.41 38.33 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.75 116.97 26.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 67.8 p -108.31 11.77 26.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.267 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.07 111.92 8.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.424 -0.798 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.482 -179.922 . . . . . . . . 0 0 . 1 stop_ save_